







DEVELOPMENT OF BIOMIMETIC, HYBRID PROTEIN-SYNTHETIC MEMBRANES: 
DETERMINING PROTEIN INSERTION EFFICIENCY, MEMBRANE MATERIAL 











Submitted in partial fulfillment of the requirements 
for the degree of Doctor of Philosophy of Environmental Engineering in Civil Engineering 
in the Graduate College of the 








Research Assistant Professor Julie L. Zilles, Chair and Director of Research
Emeritus Professor Mark M. Clark 
Associate Professor Mark W. Fitch, Missouri University of Science and Technology 








Biomimetic membranes are designed to mimic the selective permeability of cell membranes, and 
can be engineered for a multitude of environmental applications including water purification, 
remediation, and sensing. Biomimetic membranes consist of membrane proteins, such as the 
bacterial water channel protein aquaporin Z (AqpZ), embedded in a lipid bilayer or a polymer that 
mimics a cell’s natural lipid bilayer. Permeability and stability pose critical barriers to 
implementation of biomimetic AqpZ-based membranes. To achieve maximum permeability, it is 
essential to understand the relationship between protein insertion and membrane permeability. 
This work introduces a method using fluorescence correlation spectroscopy to quantify the number 
of AqpZ embedded in the membrane. This work demonstrates that membrane permeability is a 
function of protein insertion and that detergent inhibits protein insertion. Substantial variation was 
observed in protein insertion and permeability between protein batches, perhaps due to differences 
in the multimeric state of the protein. 
 
For many applications, biomimetic technologies will only be pursued if they can be formed into 
planar sheets and if they remain stable under environmental or membrane cleaning stress 
conditions. This work provides proof of concept for the synthesis of solid-supported, planar mixed 
lipid-polymer membranes. While lipid and polymer membranes both insert proteins, lipids are 
more readily available and more closely mimic natural cell membranes. However, polymer 
improves vesicle toughness and stability. The mixed lipid-polymer membranes I created exhibited 
the desirable characteristics of both lipid and polymer membranes. I also demonstrated that in 
Escherichia coli, the presence of AqpZ increased permeability at neutral pH, and reduced survival 
under acid shock conditions. These findings may suggest possible physiological relevance for 
AqpZ. 
 
Highly permeable and selective biomimetic membranes are a promising technology for water 
purification, and understanding their formation and properties are crucial for development and 
implementation. Development of hybrid protein-synthetic membranes for water treatment will 
allow for small energy savings. More importantly, these membranes will make it more feasible to 
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Available sources of freshwater are becoming increasingly stressed due to population growth, 
economic growth and climate change (1). Currently, the number of people suffering from lack of 
freshwater is in the billions and is expected to quadruple by 2050 (2, 3). Membrane desalination 
technologies, such as reverse osmosis (RO) and forward osmosis (FO), have come to the forefront 
as important means to develop new water sources from seawater (4), brackish water (5), recycled 
wastewaters for reuse (6-8), and waters impaired with persistent emerging contaminants (9, 10). 
Membranes are a promising technology for addressing emerging water treatment concerns 
including saltwater intrusion issues, wastewater recycling, and increasingly stringent drinking 
water standards. First, intrusion of saline and other pollutants into freshwater aquifers continues to 
contaminant previously usable waters (11). Second, recycling of wastewaters is becoming more 
common practice for a variety of uses (12). Third, drinking water standards are beginning to 
include emerging contaminants such as endocrine disruptors and other difficult-to-treat 
contaminants (13). Development of impaired and recycled waters will lessen current stress on 
scarce freshwater sources and the environmental burden of once-through water practices. 
Predictions suggest that water reuse will grow 14% annually (12) and desalination will expand 
globally (14) through 2020. As a result, higher quality water may also become available for 
consumers. In addition, while reverse osmosis plants operate near the thermodynamic equilibrium, 
there may be small energy savings of up to 10-20% (15) by increasing membrane permeability 
without sacrificing selectivity. To attend to water quality needs, we must meet the clear need for 





Biomimetic membranes are designed to mimic the selective permeability and enhanced 
efficiencies of cell membranes, and can be engineered for a multitude of environmental 
applications including water purification, remediation, and sensing, as depicted in Figure 1.1. 
Biomimetic membranes consist of membrane proteins embedded in a lipid bilayer or polymer that 
mimics cells’ natural lipid bilayer. In this simplified form, the engineer can control the functions 
of biologically-derived materials, without competing with a cell’s goal of reproduction.  
 
 
Figure 1.1. Schematics of hybrid, biomimetic protein-synthetic membrane-based technology 
applications  
In all of the schematics, a protein is embedded in a membrane for the following applications: (A) 
water purification membranes, (B) remediation nanoreactors, and (C) membrane-based biosensors.  
Application: Water purification membranes 
Additionally, due to the highly specialized machinery developed through millions of evolutionary 
years, biological materials have the potential to significantly outperform existing synthetic 
technologies. For example, for water purification (Figure 1.1A), the bacterial water channel protein 
aquaporin Z (AqpZ) embedded in a polymer membrane has been shown to transport water rapidly 






available membranes (16, 17). These highly permeable, yet selective, membranes have the 
potential to allow for careful control of contaminant separation. 
Application: Remediation nanoreactors 
Membrane-based remediation nanoreactors are also being developed for water remediation 
purposes. Remediation nanoreactors are simplified synthetic “cells” that concentrate and treat trace 
or hard-to-treat contaminants. They include proteins in a membrane enclosing enzymes to degrade 
environmental contaminants from surface or ground water (Figure 1.1B) (18-21). A prime example 
is a nanoreactor designed to treat perchlorate, an environmental contaminant found in drinking 
water of 16 million Americans (13, 22). Hypothetical perchlorate-reducing nanoreactors are 
composed of outer membrane porin (OmpF) embedded in a hollow, spherical lipid or polymer 
vesicle membrane with the encapsulated perchlorate biocatalysts perchlorate reductase and 
chlorite dismutase. The OmpF transports perchlorate across the membrane to the interior of the 
vesicle where the enzymes systematically reduce perchlorate to innocuous chloride and oxygen in 
the protected environment (23). To this end, increasing the OmpF incorporation and vesicle 
stability will increase performance of these remediation nanoreactors.  
 
A different example describes the treatment of polycyclic aromatic hydrocarbons (PAH), which 
also provide remediation challenges (24). In this situation, gold nanoparticle catalysts embedded 
in the outside of the polymer membrane amended with naphthalene groups would allow for high 
local concentration and chemical degradation of 4-nitrophenol with the addition of sodium 
borohydride (25). In this situation, increasing gold nanoparticle incorporation and vesicle stability 
would be critical for implementation. 
Application: Membrane-based biosensors 
Membrane protein-based biosensor applications are also emerging as important environmental 
tools for detection of molecules ranging from metal ions to macromolecules and microorganisms 
(26-29). These biosensors consist of either a membrane-embedded receptor protein that senses and 
transfers a signal, or a channel that transports molecules directly as the signal (26, 27, 29) (Figure 




advantages of membrane protein-based sensors are low detection limits and high signal-to-noise 
ratios. For example, a detection limit of 30 nM was demonstrated for a sensor consisting of 
glutamate receptor ion channel protein embedded in planar lipid bilayer (30). For potential 
environmental applications, a gramicidin A-based gated ion channel biosensor device is being 
developed that could detect heavy metals. The gramicidin A channels transport ions and detection 
is initiated by receptors including metal chelates (31). An alpha-hemolysin-based ion channel 
biosensor is also being developed to detect divalent metal ions using the membrane protein itself. 
The protein was amended to contain histidine residues making it sensitive to submicromolar 
concentrations of zinc and cobalt ions (26). As with all hybrid protein-synthetic membrane 
applications, increasing the concentration of proteins in the membrane would increase 
permeability, or signal, of the sensor. To be useful, the sensor must also be stable under 
environmental conditions. 
1.2 Proposed directions to improve biomimetic applications 
Understanding the relationship between membrane permeability and protein insertion 
In all of these applications, protein insertion and membrane assembly are key. To optimize these 
biomimetic materials, the relationship between the amount of protein added during membrane 
formation and the final membrane permeability needs to be determined. Many studies have 
investigated the functional insertion of membrane proteins into lipid and polymer membranes by 
measuring the permeability of small molecules. The literature review chapter (Chapter 2) describes 
previous studies on AqpZ insertion into lipid and polymer membranes, and discusses OmpF 
reconstitution as well. However, in most protein-membrane studies, insertion was not measured, 
even though unexpected decreases in or leveling off of permeability were sometimes observed. I 
hypothesize that membrane permeability is related to protein insertion, and that these effects are 
due to presence of polymer (88), high detergent concentrations (13, 20), and/or the synthesis 
methods (75, 87). Due to the recent interest in developing hybrid protein-synthetic membrane 
systems and the potential impact on water treatment and sensing if permeability is optimized, the 





Developing planar membranes  
Other important hurdles for developing biomimetic membrane technology are membrane stability 
and configuration. To improve membrane stability, the formation of hybrid lipid-polymer 
membranes should be investigated. Lipids and polymer membranes both have advantages and 
disadvantages. Briefly, lipid membranes may be better suited for membrane protein insertion, but 
are less stable. Copolymer membranes, synthetic analogs of lipid membranes, are more stable (32, 
33) and water impermeable, but are less similar to the natural membrane environment. The 
literature review chapter (Chapter 2) describes the advantages and disadvantages of these materials 
in more detail. Studies have examined the membrane integrity or half-life of lipid vesicles for 
fundamental study and drug delivery applications and report that membrane integrity is mainly a 
function of membrane composition (34). I hypothesize that a membrane comprised of both lipid 
and polymer would be advantageous because it would exhibit the desired attributes of both 
membrane materials: good membrane protein insertion in a stable membrane environment.  
 
In addition to controlling the insertion capability and stability of membranes, it is also of interest 
to control the configuration of membranes. Specifically, while the vesicular form may be 
preferable for remediation nanoreactors, planar membranes would be advantageous for many 
applications to mirror existing technologies and provide flexibility in application. While planar 
membranes have been demonstrated for both lipid (35, 36) and polymer (37-40) materials, to our 
knowledge, neither hybrid lipid-polymer vesicles, nor hybrid lipid-polymer planar membranes, 
have been previously reported. Further discussion on planar membrane development is presented 
in the literature review chapter (Chapter 2). I hypothesize that hybrid lipid-polymer vesicles can 
form planar membranes when the material ratios and the solution and solid surface chemistry are 
optimized. Development of planar hybrid lipid-polymer membranes would offer tremendous 
opportunity for future development and application of biomimetic membranes.  
Understanding protein response to stress conditions 
For a membrane to be useful, it must be able to withstand chemical, physical, and biological 
stresses. Specifically, water purification membranes need to be able to withstand acid cleaning to 




variety of environmental stresses. Fortunately, AqpZ-polymer membranes have demonstrated 
reduced and reversible permeability under acid shock conditions due to potential AqpZ gating 
activity (41). This behavior would be advantageous for the cleaning processes necessary for 
efficient membrane operation. Additionally, as described in the literature review chapter (Chapter 
2), the physiological relevance of bacterial aquaporins is unknown. I hypothesize that investigating 
the behavior of E. coli under shock conditions may demonstrate the physiological relevance of 
AqpZ in E. coli. For these reasons, determining the permeability and survival of E. coli with and 
without aqpZ under acid conditions is warranted. Highly permeable biomimetic membranes are a 
promising technology for a variety of environmental applications. Understanding the behavior of 
their components under stress conditions is necessary for their development. 
 
Overall, my findings will serve as a platform from which insertion, permeability, and stability 
information can be translated to emerging environmental applications. The results of my work will 
greatly advance hybrid protein-synthetic technologies for water treatment. 
1.3 Research goals and objectives 
The overarching goal of this thesis is to further development of hybrid protein-synthetic 
membranes for environmental applications. In this work, I demonstrated that membrane 
permeability is related to protein insertion, mixed lipid-polymer membranes can be fabricated, and 
aqpZ increases permeability and survival in E. coli under acid shock conditions. Below are the 
specific objectives and brief descriptions of the work completed to achieve them. 
Objective 1: Quantify membrane protein insertion efficiency in polymer and lipid membrane 
(Chapter 3) 
This chapter elucidates the relationship between membrane permeability and protein insertion. 
Using the novel method I developed to count the number of membrane proteins in vesicles using 
fluorescence correlation spectroscopy (FCS), I show quantitatively and directly that vesicle 
permeability is a function of protein insertion. I also demonstrate that high detergent 




permeability. I also discovered that protein preparation matters, as the insertion and permeability 
behavior for AqpZ in lipid membranes, varied with the protein batch. 
Objective 2: Develop planar, mixed lipid and polymer membranes (Chapter 4) 
This chapter demonstrates formation of mixed lipid and polymer membranes. I demonstrate that 
mixed material membranes exhibit characteristic attributes of both lipid and polymer vesicles. 
Depending on the ratio of the polymer to lipid of the depositing vesicles, supported planar mixed 
membranes are formed on negatively-charged quartz and mica surfaces. I found that the percentage 
of lipid to polymer in the mixed membranes determined if they acted more like lipid (permeable, 
more readily formed planar membranes), or polymer (water-tight, more resistant to forming planar 
membranes). As such, these mixed membranes could be tailored for a variety of biomimetic 
applications.  
Objective 3: Examine the behavior of AqpZ in E. coli under acid and osmotic stress conditions 
(Chapter 5) 
In this chapter, my findings confirm that aqpZ increased permeability of E. coli at neutral pH 
conditions. I also demonstrated that aqpZ reduced cell survival under acid shock and combined 
acid and osmotic shock conditions. These findings verify the benefit of AqpZ to E. coli. 
1.4 Dissertation organization 
This dissertation begins with introduction (Chapter 1) and literature review (Chapter 2) chapters, 
followed by chapters describing my experimental work to achieve the objectives defined above 
(Chapters 3-5). Chapter 6 provides an overall summary of my work, focusing on its significance 





CHAPTER 2:  LITERATURE REVIEW ON KEY 




This literature review chapter examines the existing literature on topics pertinent to my work on 
developing hybrid protein-synthetic membranes for environmental applications. Specifically, this 
review first looks at reconstitution of AqpZ and OmpF in membranes, discrepancies in the 
resulting permeability trends obtained from those attempts, and the possible factors affecting 
insertion. Second, this review discusses the types of membranes used for reconstitution in vesicle 
and planar form and the methods for forming those membranes. Third, this review describes the 
roles of AqpZ and OmpF in natural membranes.  
 
2.2 Reconstitution of AqpZ and OmpF in lipid and polymer membranes  
Many transmembrane proteins have been functionally reconstituted in both lipids and polymer 
membranes. Proteins important to this work include the bacterial water channel protein, AqpZ, 
and outer membrane porin, OmpF. AqpZ specifically and passively transports water across 
bacterial cell membranes and was first discovered in E. coli (42). AqpZ functional reconstitution 
was initially demonstrated in E. coli lipid extract (43) and subsequently in synthetic triblock 
copolymer poly(2-methuloxazoline)-poly(dimethylsiloxane)-poly(2-methuloxazoline) 
(PMOXA15-PDMS110-PMOXA15) (16). The AqpZ-polymer membranes were found to be 80 times 
more permeable than commercially available water treatment membranes (16). Existing studies 
describing incorporation of AqpZ in lipid and polymer membranes are detailed in Table 2.1. 
Recent research efforts have focused on developing planar AqpZ polymer membranes (44, 45) and 




purple photosynthetic bacteria, Rhodobacter sphaeroides, was reconstituted in lipid and polymer 
membranes. The R. sphaeroides AqpZ polymer membrane exhibited greater water permeability 
than membranes with E. coli AqpZ (47).  
 
Because OmpF is a well-characterized, slightly cation-specific porin, it has been used extensively 
to study lipids, protein reconstitution, and proof of concept for biomimetic technologies. OmpF 
was first purified and reconstituted into lipid membranes in 1976 (48); since then OmpF has been 
used extensively in reconstitution studies in lipids (49, 50). Given the well-studied nature of OmpF, 
it was natural for researchers to test its reconstitution and design applications in block copolymer 
materials as well (18, 19, 51-55). OmpF was reconstituted in lipid and polymer vesicles to control 
the enzymatic activity of encapsulated enzymes for drug delivery (21) and environmental 
remediation (23) purposes. OmpF has also been crystallized in polymer to form a planar membrane 
(56).  
 
The development of artificial water channels that mimic the high permeability and selectivity of 
aquaporins provides another potential route to stable and reproducible biomimetic materials for 
membrane applications. While in early development, the current approaches are to either 
functionalize carbon nanotubes or construct nanochannels from organic building blocks such as 
amino acids or DNA (57). An artificial water channel comprised of alkylureido-ethylimidazole 
that forms imidazole-quartet channels transported water at approximately 106 water molecules/s 
(within 2 orders of magnitude of some aquaporins). While these channels were able to reject most 
ions, they were still permeated by protons (58). For these artificial water channels, the challenge 





Table 2.1. Summary of previously reported AqpZ insertion in lipid and polymer membranes  
Abbreviations are defined as follows: poly(methyloxazoline)–poly(dimethylsiloxane)–poly(methyloxazoline) (PMOXA–PDMS–PMOXA); 1,2-dioleoyl-sn-
glycero-3-phosphocholine (DOPC), 1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC) , and 75% L-α-phosphatidylcholine (egg PC) with 25% L-α-
lysophosphatidylserine (porcine PS), reference (Ref), E. coli AqpZ (EcAqpZ), R. sphaeroides AqpZ (RsAqpZ). 
a Permeability values were corrected to 10⁰C using an activation energy of 3.4 kcal/mol (16) for EcAqpZ and 2.93 kcal/mol for RsAqpZ (34). 
b No temperature was reported. 
 






behavior at high 













E. coli total lipid extract Functional reconstitution in vesicles 1/7467-1/467 Decreased 1/467 53.9 38.8 (43) 
PMOXA15-PDMS110-
PMOXA15 
Functional reconstitution in polymer 
vesicles 1/500-1/25 Decreased 1/25 3032.2 220.5 (16) 
E. coli total lipid extract Determine ion conductivity  3/56-30/56 Increased --- 41.4 --- (59) 
DOPC Form planar membrane on nanofiltration membrane support 1/800 & 1/200  Increased --- 279.0 --- (60) 
DOPC Form stable, immobilized vesicles on microporous membrane support  1/3562-1/356 Increased --- 459.3 --- (61) 
DMPC Form planar, polymer cushioned membrane 1/6000-1/1000 Decreased 1/1000 368.8 73.8 (46) 
PMOXA12-PDMS54-
PMOXA12 
Form planar membrane on 
polycarbonate support 1/400-1/50 Decreased 1/50 2180.9 1222.0 (62) 
DOPC Form planar, thin film composite membrane 1/200 --- --- 60 
b --- (63) 
PMOXA1000-b-
PDMS4000-PMOXA1000 
Form planar membranes on cellulose 
acetate substrate 1/200-1/50 Increased --- 1733 --- (44) 
PMOXA8-PDMS55-
PMOXA8 
Functional reconstitution of EcAqpZ 
and insertion efficiency in vesicles 1/1031-1/516 Decreased 1/516 617.7 287.9 (47) 
PMOXA8-PDMS55-
PMOXA8 
Functional reconstitution of RsAqpZ 
and insertion efficiency in vesicles 1/1878-1/939 Decreased --- 1500.7 --- (47) 
PC4-PS 
Functional reconstitution of EcAqpZ 
and insertion efficiency in vesicles 1/35723-1/893 Leveled-off 1/3572 623.9 623.9 (47) 
PC4-PS 
Functional reconstitution of RsAqpZ 
and insertion efficiency in vesicles 
1/65065-




Membrane permeability behavior and factors inhibiting protein insertion 
For the studies listed in Table 2.1, protein insertion was not measured, with one exception (47) 
However, unexpected decreases in or leveling-off of permeability were sometimes observed. 
When observing permeability behavior at high protein reconstitution ratios, reports have 
hypothesized that use of polymers (64, 65), high detergent concentrations (16, 43), and/or synthesis 
methods (66) might impact protein insertion, and thus membrane permeability.  
i. Presence and properties of polymer 
Generally, theoretical models describe that protein insertion should cause an energetic penalty in 
lipid and polymer membranes as a function of hydrophobic mismatch and vesicle curvature (67). 
When there is mismatch between the length of the hydrophobic residue band of a membrane 
protein and the hydrophobic membrane thickness, the membrane will stretch or compress to 
accommodate the protein. This can cause perturbations in the membrane, characterized as the 
coherence length, or perturbation decay length. The perturbation decay length is the length along 
the membrane where the influence of the protein is observed (membrane stretches or compresses 
to accommodate protein) and has been studied quite extensively in lipid models (67-71).  
 
In polymer, it has been proposed that protein insertion would decrease as a function of the 
mismatch in hydrophobic thickness between the hydrophobic portions of the protein and the 
polymer (64). While polymer vesicles are stiffer than lipid vesicles, the perturbation decay length 
was estimated to still be large. Using a mean field analysis modeling approach, the energetic 
penalty from protein insertion into the polymer membrane was estimated to increase slowly as a 
function of polymer length such that membrane proteins could still insert into polymer membranes 
that were thick and exhibited a large hydrophobic mismatch (64). Polymer membranes can be up 
to several times thicker than the 4 to 5 nm thickness of lipid membranes. Molecular dynamic 
simulations demonstrate that thicker polymer membranes may even close around the opening of 





Experimentally, shorter polymer chains were found to better mimic natural lipid membranes and 
allow proteins to functionally insert (28, 65). Two studies experimentally demonstrated that the 
thickness of the polymer might inhibit protein insertion. These studies tested protein incorporation 
into polymer membranes with different hydrophobic band thicknesses. One study tested 
PMOXA15-PDMS68-PMOXA15 which was 10.2 nm in length, and PMOXA13-PDMS33-PMOXA13 
which was 6.1 nm in length. In this study, alpha-haemolysin was unable to insert in the longer 
polymer, and alamethicin took much longer to insert even in the shorter chain polymer than it did 
in lipid membranes (28). Another study tested two methacrylated PMOXA-PDMS-PMOXA 
polymers that were 4 and 8 nm in thickness. In this study, the shorter polymer was able to 
incorporate more OmpF than the longer polymer (65). These observations were attributed to the 
ability of the shorter polymer to better mimic the natural membrane environment (28, 65). 
ii. High detergent concentrations 
Detergent is necessary for purification of all membrane proteins, including AqpZ, and is thus 
inevitably present during AqpZ reconstitution in lipid or polymer. Detergent concentration has 
been hypothesized to cause reduced permeability of membranes by decreasing AqpZ insertion 
efficiency during vesicle formation (16, 43). Vesicle formation method could affect the detergent 
concentration. In some cases, vesicles were formed by film rehydration where a thin film of 
membrane material is mechanically dispersed in the presence of the protein-detergent buffer 
solution (16, 73). In previous studies using this method, detergent concentration was invariably 
increased as more AqpZ was added. Sometimes, detergent was removed by adding detergent-
absorptive biobeads SM-2 after vesicle formation (44, 46, 62). In other studies, the vesicles were 
formed by dialysis (43, 47) and enough detergent was removed from the lipid-protein mixture to 
form vesicles. In studies utilizing dialysis or biobeads, it is possible that detergent removal could 
have been less complete at higher concentrations of AqpZ added, especially when the detergent n-
Dodecyl β-D-maltoside (DDM) was used because it has a low critical micelle concentration 
(CMC) and is gentle. Octyl β-D-glucopyranoside (OG) has a CMC two orders of magnitude larger 
than DDM and while it is harsher than DDM, it is more readily removed from solution (74). OG 
was used in some studies as an alternative detergent for AqpZ purification, and for vesicle 




and the final amount of detergent was not quantified. Collectively, these studies report a large 
range of detergent concentrations used during vesicle formation. A summary of the estimated 
detergent characteristics in previous work is presented in Table 2.2. Estimated detergent 
concentrations at peak vesicle permeability ranged from 0.01-0.3%. It should be noted, however, 
that it is impossible to know actual detergent concentrations because they were not measured in 
the previous work, and size exclusion chromatography was also often employed to separate 
































? denotes values that could not be estimated because dialysis was used as the vesicle formation method.  
* denotes that the AqpZ/polymer ratios were not defined as molar or weight; for calculations in this table, they were assumed to be molar ratios.  































E. coli total lipid 
extract DDM 1.5 
Dialysis 
with OG N/A 1/400-1/25 0.075-1.2 ? ? (43) 
PMOXA15-PDMS11-
PMOXA15 
DDM 1.5 Film rehydration None 1/500-1/25 0.03-0.6 0.3 0.6 (16) 
DMPC DDM 0.5 Film rehydration Bio-beads 1/6000-1/1000 0.003-0.02 0.01 0.02 (46) 
PMOXA12-PDMS54-
PMOXA12 




DDM 1 Film rehydration Bio-beads 1/200-1/50* 0.008-0.03 0.033 --- (44) 
PMOXA8-PDMS55-
PMOXA8 





? ? ? (47) 
PC4-PS OG 1 
Dialysis 









iii. Synthesis methods 
In addition to detergent and the use of polymers, synthesis methods are hypothesized to impact the 
insertion of membrane proteins. It has been previously hypothesized that film rehydration reduced 
protein insertion compared to dialysis based on comparing vesicle permeability values for vesicles 
formed both with film rehydration and dialysis (66). While film rehydration was used successfully 
to create vesicles in this study and others (16), slow detergent removal via dialysis is also used to 
form vesicles with reconstituted proteins (47, 66) and 2D protein crystallization (66, 75-79). Using 
dialysis for vesicle formation, incorporation of the mammalian lens-specific aquaporin-0 (Aqp0) 
into polymer membrane depended on the detergent removal rate (66). Comparing studies, greater 
vesicle water permeability was achieved with Aqp0/polymer vesicles formed via dialysis (66) 
compared to AqpZ/polymer vesicles formed via film rehydration (16). Since Aqp0 is less 
permeable than AqpZ, it was speculated that dialysis was the most efficient method for membrane 
protein insertion (66). However, in these studies, the impact of synthesis method was not 
specifically tested, nor was protein insertion measured.  
2.3 Synthetic membrane materials suitable for protein incorporation 
There are two general classes of membrane materials suitable for membrane protein incorporation: 
lipids and block copolymers. Lipid bilayers are a key component of cell membranes, separating 
and maintaining osmotic, charge and pH differentials (80), and housing membrane proteins that 
transport small molecules into and out of cells. For use in a hybrid protein-synthetic membrane, 
lipids have the advantages of being better studied and more similar to the native environment for 
incorporation of membrane protein. Copolymer membranes are synthetic analogs of lipid 
membranes, and are composed of hydrophilic and hydrophobic blocks that mimic the properties 
of lipid membranes. Polymer membranes typically possess greater stability (32, 33) and 
mechanical strength (32), and are less leaky to water and small molecules (81). In addition, 
polymer membranes offer more options for the engineer to specify the desired properties of the 
membrane (37). However, they are less understood and may be less suited for protein insertion 





The functional insertion of some membrane proteins have been demonstrated in both lipid and 
block copolymers membranes. For lipids, a large number of membrane proteins have been inserted 
into a variety of lipids. For example, Table 2.1 above presents only literature reporting insertion 
of AqpZ in various lipid and polymer membranes. Insertion of OmpF in lipids has been studied 
even more extensively, and it was one of the first membrane proteins studied in block copolymer 
membranes (21, 83). 
Vesicles  
For inserting membrane proteins, lipid or polymer dispersions can self-assemble into vesicles 
through mechanically dispersion, solvent dispersion, dilution, or removal of detergent (84). The 
formation method can impact the size of the vesicle. For forming large unilamellar vesicles (100-
1000 nm (84)) capable of entrapping small molecules and allowing insertion of transmembrane 
proteins for a variety of applications, mechanical dispersion or slow detergent removal via dialysis 
is typically used (73, 75, 85). For film rehydration, a thin film of lipid or polymer is dried from a 
solvent, followed by rehydration in aqueous buffer with the protein solution. For dialysis, 
powdered or solvent dispersed lipid is dissolved in a high concentration of detergent with the 
protein solution followed by buffer exchanges with lower concentrations of detergent (85). In yet 
another approach, protein can also be inserted after vesicle formation where already formed 
vesicles are destabilized by detergent followed by addition of the protein solution. It has been 
suggested that this method is not as reproducible (41, 86).  
Planar membrane configuration  
While many membrane protein reconstitution and other studies have been performed in vesicles, 
substantial recent effort has been spent to form planar membranes that functionally reconstitute 
membrane proteins, especially AqpZ (44-46, 60, 63, 66). In the absence of protein, a planar 
membrane configuration has been achieved for both lipid (35, 36) and polymer (37-40) materials. 
Formed at the air-water interface, Langmuir films have been long used as ideal membrane models 
as they allow for study of the organization of lipid and other molecules introduced to the membrane 
in a monolayer. For preparing supported lipid planar films, the Langmuir-Blodgett vertical transfer 




(87). Other methods include introducing lipid membranes to a small (< 1 mm) hydrophobic 
aperture (80, 88) or a hydrophobic scaffold with apertures on the order of 300 μm for free-standing 
membranes (89, 90). Formation of lipid membranes on a solid support with a polymer-cushion has 
also been useful, especially for studying protein behavior because there is separation between the 
bilayer and the solid support (91). Hydrogels have also been shown to encapsulate and support 
planar lipid membranes (92, 93). A simple and reproducible method to form supported lipid 
bilayers is vesicle collapse on hydrophilic surfaces (35, 94, 95). Along with the Langmuir-Blodgett 
transfer method, vesicle collapse is most common at present for forming supported lipid 
membranes (91). Examining vesicle collapse for forming planar lipid membranes, Table 2.3 






Table 2.3. Summary of factors that can affect the deposition and adsorbing behavior of lipid 






















2.4 Aquaporins and OmpF  
Nature provides a great variety of specific channels that allow passage of small molecules across 
biological membranes. Transmembrane proteins span the entire lipid bilayer membrane and have 
important functions in cells.  
Factor Effect Reference 
Vesicle properties    
Vesicle size (diameter) Larger size increases deformation of adsorbed vesicles (36, 96, 97) 
Lipid composition Greater ratio of positively charged lipids promotes rupture on negatively charged supports (35, 96) 
Surface charge Greater net positive charge promotes rupture on negatively charged supports (35, 36, 97) 
Support surface properties   
Surface chemistry Hydrophilic such as fused silica, borosilicate glass, mica, oxidized silicon work best (91, 98) 
Cleanliness Clean yields best adsorption of vesicles (91) 
Roughness Smooth yields best adsorption of vesicles and defect-free bilayer formation (91, 99) 
Charge Negatively charged supports (mica, SiO2) promote rupture (100) 
Solution chemistry   
pH Slightly basic pH promotes vesicle fusion (91, 99) 
Concentration of vesicles Greater concentrations means less time to rupture  (100, 101) 
Ionic strength Higher ionic strength promotes vesicle adherence (91, 98) 
Presence of Ca2+ Increases rupture and time to rupture for moderately positively- and neutrally-charged vesicles. (35, 91, 96) 
Temperature Higher temperature promotes bilayer formation (91, 98) 





Aquaporins are a type of membrane protein that form water-specific channels, are found across all 
domains of life, and are essential for satisfying water transport needs in mammalian and plant cells 
(102, 103). Aquaporins have a narrow, hour-glass shaped hydrophobic pore with a constriction 
zone diameter of approximately 3 Å and a length of 5 Å through which frictionless, single-file 
water transport can occur (104). Aquaporins are made up of alpha helices that configure into three-
dimensional monomers. They typically exist as a group of four monomers, or tetramers. Agre et 
al. (103) discovered the first aquaporin, aquaporin-1 (105). Since their discovery, aquaporins have 
been studied in a variety of capacities to reveal physiological relevance. The physiological 
relevance in bacteria, however, is unknown. The large surface area to volume ratio of bacteria is 
sufficient to meet water transport needs by diffusive water transport (106). Additionally, 
aquaporins do not exist in some types of microorganisms, suggesting that they are not essential 
(106, 107). Some studies have disrupted AqpZ and found subtle detectable changes in cellular 
growth or function, if any (106, 108, 109). Studies suggest that AqpZ may help alleviate cellular 
dehydration or osmotic stress conditions by providing rapid water transport (106, 109-111).  
 
Initial work using AqpZ-polymer vesicles and E. coli demonstrated that AqpZ-polymer vesicles 
exhibited reduced and reversible permeability under acid shock conditions (41). It was also shown 
that whole E. coli cells have reduced permeability and survival under acid shock conditions, 
suggesting that the presence of AqpZ and its gating behavior at low pH may be advantageous, 
especially under combined acid and osmotic shock (41).  
OmpF 
The outer membrane of Gram-negative bacteria contains many porins grouped into 6 families. 
Like other outer membrane porins, OmpF is made of beta barrels that configure into monomers. 
OmpF typically exists as a group of three monomers, or trimers. They have an elliptical 
constriction zone that is approximately 9 Å long with dimensions of 11 x 7 Å (112). OmpF is of 
the general, or non-specific, porin family, and passively transports ions and other small hydrophilic 
molecules across the outer membrane (113). OmpF has a slight preference for cation molecules. 




OmpF pore (114). In addition, environmental conditions have been shown to determine the 
expression of OmpF. The expression of another general porin, OmpC, appears linked with the 
expression of OmpF (115, 116). Higher concentrations of OmpF exist when a cell is exposed to 
low osmotic, poor carbon source or low temperature conditions (115). It has also been reported 
that bacterial strains with lower than average concentrations of OmpF had slight increases in 
antibiotic resistance (115). In general, in conditions where nutrients and salinity are more dilute, 
OmpF is expressed in greater amounts (115), however, loss of OmpF did not lead to cell sensitivity 





CHAPTER 3: INSERTION EFFICIENCY OF AQPZ 
MEMBRANE PROTEINS IN LIPID AND 
POLYMER VESICLES1  
 
3.1 Abstract 
Recent research has attempted to mimic the biological separation properties of cell membranes, 
typically by incorporating membrane proteins into synthetic lipid or polymer membranes. This 
work quantified protein insertion and compared insertion to vesicle permeability using two 
Escherichia coli membrane proteins: aquaporin Z (AqpZ) and an outer membrane porin (OmpF), 
and two membrane materials: block co-polymer and lipids. A fluorescence correlation 
spectroscopy method was developed to measure protein insertion. The detergent dodecyl-
maltoside substantially inhibited AqpZ insertion into and the permeability of 1/100 molar ratio 
AqpZ/lipid vesicles at concentrations beyond 0.3%. Vesicle permeability was found to be a 
function of protein insertion. At high amounts of AqpZ added, decreases or leveling-off in AqpZ 
insertion and vesicle permeability were sometimes observed. This variability was found to be 
affected by protein preparation. For lipid and polymer membranes made with AqpZ, protein 
insertion and maximum water permeability occurred between 1/100-1/25 molar ratio. For 
OmpF/lipid vesicles, protein insertion and permeability was optimal at 1/25 molar ratio. By 
quantifying protein insertion and determining the relationship between protein insertion and 
membrane permeability, these findings benefit future development of biomimetic membranes for 
many environmental applications including water purification, remediation, and biosensors.  
 
 
                                                 
1 Author contributions: I performed all of the experiments described in this chapter and analyzed and interpreted the 





Biological membranes evolved to efficiently separate, organize and protect biological molecules 
in compartments such as cells. Transmembrane proteins found in the bilayers of cellular 
membranes can efficiently transport small molecules across the cell membrane. Biomimetic 
membranes are designed to mimic the highly efficient and selectively permeable nature of 
biological cell membranes. Biomimetic membranes consist of membrane proteins embedded in a 
lipid bilayer or polymer that mimics cells’ natural lipid bilayer. For example, for water purification, 
the bacterial water channel protein aquaporin Z (AqpZ) has been shown to transport water rapidly 
and selectively when reconstituted in lipid and polymer membranes, with a productivity of up to 
80 times that of commercially available reverse osmosis membranes (16). Potential uses for 
biomimetic membrane technology span a wide range and could benefit any process that currently 
employs a membrane for separation or protection, including drug delivery vesicles (20, 117), 
environmental remediation nanoreactors (23, 118), membrane-based biosensors (29-31, 119), and 
desalination membranes (16).  
 
As membrane-based biomimetic technologies have emerged as promising systems for separation 
and sensing, many transmembrane proteins have been functionally reconstituted in lipids and 
polymers. Important proteins to this study are AqpZ, and the bacterial outer membrane porin 
(OmpF). AqpZ specifically and passively transports water across bacterial cell membranes. 
Functional reconstitution has been demonstrated as described in Chapter 2. To reconstitute 
membrane proteins in lipid or polymer vesicles, the detergent-protected protein is typically mixed 
with lipid or polymer. Typically through mechanical dispersion or slow detergent removal via 
dialysis, these mixed micelles, or aggregates of the various molecules, self-assemble into vesicles 
(73, 75, 85). Vesicles on the order of 100-1000 nm are capable of entrapping small molecules and 
allowing insertion of transmembrane proteins for a variety of applications (84). For engineering 
applications, lipids and polymers each have advantages and disadvantages as described in chapter 
2. Lipid vesicles are more understood and biocompatible, but they can have a short half-life, and 
allow leakage of small molecules (73, 85). In contrast, polymer vesicles generally possess greater 




The more robust behavior of polymer vesicles is attributed to its thicker membrane. However, 
polymer is less understood and may be less suited for protein insertion.  
 
To optimize biomimetic materials, high membrane permeability is desired. Many studies have 
investigated the functional insertion of membrane proteins into lipid and polymer membrane by 
measuring the permeability of small molecules. However, in most of these studies protein insertion 
was not measured, even though unexpected decreases in membrane permeability were sometimes 
observed. For example, in comparing the six studies that examined the permeability of AqpZ-
membranes (16, 43, 44, 46, 47, 121), differing trends were reported. In five of these studies, a 
decrease in water permeability was found to occur when AqpZ was reconstituted at high 
concentrations (16, 43, 46, 47, 121). In another study, water permeability leveled off at high 
concentrations (44). While permeability is expected to be a function of insertion, only one study 
has addressed this question (44). Using insertion measurements, Rhodobacter sphaeroides AqpZ 
incorporation efficiency was calculated as 80% for 1/2348-1/722 AqpZ/lipid molar ratio after 
which it decreased for 1/470-1/235 AqpZ/lipid molar ratio (44). However, the direct relationship 
between permeability and insertion has not been reported, and it is prudent to examine this 
relationship with different protein and membrane materials. When observing previous 
permeability behavior at high reconstitution ratios, it was hypothesized that use of polymers (64), 
high detergent concentrations (16, 43), and/or synthesis methods (66, 122) might impact protein 
insertion, and thus, permeability. Supporting the hypothesis that polymer could reduce protein 
insertion, theoretical models describe an energetic penalty due to protein insertion in both polymer 
and lipid (67). Models and some experiments suggest that shorter polymer chains better mimic 
natural membranes in allowing proteins to functionally insert (28, 64, 65), as described in Chapter 
2. The remaining hypotheses, however, have not yet been verified experimentally. 
 
To study the relationship between membrane permeability and protein insertion, protein insertion 
needs to be quantified. Fluorescence correlation spectroscopy (FCS) is a  
single-molecule-sensitive technique that has been used for a variety of cellular and biomaterial 
applications including determination of diffusion coefficients, concentrations, aggregation, rate 
constant and surface interaction kinetics (123-129). The advantage of FCS is that the detection 




fluorophore brightness one at a time (123, 124). FCS was used to quantify the number of 
encapsulated soluble fluorescently-labeled protein in polymer vesicles (52, 130-134). In this 
approach, the brightness of vesicles with encapsulated fluorescently-labeled protein were 
compared to the brightness of freely diffusing fluorescently-labeled protein micelles (130). FCS 
was also used to estimate the abundance of fluorescently-labeled human aquaporin 5 proteins in a 
cell membrane (135). In other studies, the insertion of reconstituted membrane proteins in lipid 
and polymer was determined using FCS where the brightness of vesicles were compared to the 
brightness of resolubilized vesicles (protein micelles) (47, 136, 137). These studies assume 
complete dispersion of vesicle components after resolubilization. Theoretically, it may be more 
accurate to compare the brightness of vesicles to the brightness of freely diffusing protein micelles 
before reconstitution. 
 
In this work, my objectives were to quantify the insertion of membrane proteins in lipid and 
polymer membranes, determine the relationship between membrane permeability and membrane 
protein insertion, and investigate the effects of detergent, membrane material, and membrane 
protein on the insertion and permeability behavior of hybrid protein-synthetic vesicles. To 
accomplish these tasks, I developed an FCS method to quantify membrane protein insertion by 
modifying the method for quantifying encapsulated soluble protein (130). I additionally quantified 
protein using the resolubilization approach previously reported (47).  
3.3 Materials and Methods 
Nanopure water (18 MΩ cm) was purified from deionized water in a Barnstead NANOpure system 
(Pittsburgh, PA) and was used to prepare all solutions. Poly(2-methuloxazoline)-
poly(dimethylsiloxane)-poly(2-methuloxazoline) (PMOXA15-PDMS110-PMOXA15) polymer was 
obtained from Drs. Wolfgang Meier and Mariusz Grezwalski (University of Basel, Switzerland). 
Lipids 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC), 1-palmitoyl-2-oleoyl-sn-
glycero-3-phosphoethanolamine (POPE), and 1,2-dioleoyl-sn-glycero-3-phosphate (DOPA) were 
purchased from Avanti Polar Lipids (Alabaster, AL). Superdex 200 size exclusion 
chromatographic media and high pressure column were purchased from GE Healthcare 




MD) and n-Dodecyl-β-D-Maltopyranoside, sol-grade detergent was purchased from Anatrace 
(Santa Clara, CA, USA). Uranyl acetate was purchased from SPI (West Chester, PA, USA) and 
sodium azide was purchased Sigma Aldrich (St. Louis, MO).  
AqpZ purification 
AqpZ was purified according to Borgnia et al. (43) and Kumar et al. (16) except that cells were 
disrupted using sonication instead of a French press, and to prevent precipitation, isopropyl β-D-
1-thiogalactopyranoside (IPTG) was immediately removed from purified protein using dialysis or 
a desalting column. 
i. Growth 
Ten ml of Lennox Luria broth (LB) (Becton, Dickinson and Co., Franklin Lake, NJ) containing 50 
µg/ml Ampicillin (Amp) was inoculated with a single colony of an ampicillin-resistant Escherichia 
coli AqpZ overexpression strain JM109 pTrc10HisAqpZ (16) and incubated at 37°C with agitation 
at 250 rpm for 18 h. The culture was diluted 1:100 into 1 L LB and incubated at 37°C with agitation 
at 250 rpm for 24 h or until optical density (O.D.) reaches 1.5 (λ=600). At O.D. 1.5, the culture 
was induced with 1 mM IPTG for overexpression of AqpZ for 7 h before centrifugation (20 min, 
4°C at 5,000 × g).  
ii. Extraction and solubilization of membrane fraction 
Pellets were resuspended in 4°C lysis buffer (0.1 M K2HPO4, 1 mM MgSO4, 1 mM 
phenylmethylsulfonyl fluoride (PMSF), 1 mg/ml deoxyribonuclease I (DNAse I), pH 7.0) and cell 
membranes were disrupted by sonication (Branson S-450D, 37% amplitude for 10 min at 5 sec on 
and off rotations) three times with equal periods of rest on ice in between cycles. Disrupted cells 
were centrifuged (20 min, 4°C at 5,000 × g) and the supernatant ultracentrifuged (60 min, 4°C at 
140,000 × g) to extract the membrane fraction. The membrane fraction pellets were homogenized, 
resuspended in solubilization buffer (1.5% (w/v) dodecyl maltoside (DDM) sol grade, 0.1 M 
K2HPO4, 135 mM NaCl, 10 mM imidazole, 0.1% (v/v) glycerol, 5 mM 2-mercaptoethanol (BME), 




iii. AqpZ purification utilizing His-tag  
Pre-washed nickel nitrilotriacetic acid (Ni-NTA)-agarose beads (Qiagen) were incubated with the 
solubilized membrane proteins at 0.08% (v/v) for 2 h before packing a 2 cm diameter gravity 
column. The column was washed with 10 bed volumes of wash buffer 1 (0.03% (w/v) DDM, 0.1 
M K2HPO4, 0.2 M NaCl, 100 mM imidazole, 0.1% (v/v) glycerol, 5 mM BME, pH 7.0) and 50 
bed volumes of wash buffer 2 (0.03% (w/v) DDM, 0.1 M K2HPO4, 0.2 M NaCl, 100 mM 
imidazole, 0.1% (v/v) glycerol, 5 mM BME, pH 7.0). The column was incubated at room 
temperature for 15 minutes midway through washing with wash buffer 2 (0.03% (w/v) DDM, 0.1 
M K2HPO4, 0.2 M NaCl, 20 mM imidazole, 5 mM BME, pH 7.0). AqpZ was eluted with 1 bed 
volume of elution buffer (0.15% (w/v) DDM, 0.1 M K2HPO4, 0.2 M NaCl, 1 M imidazole, 0.1% 
(v/v) glycerol, 5 mM BME, pH 7.0) with 3 passes. Beads were eluted 3-4 times for maximum 
recovery. To prevent precipitation following elution, AqpZ was immediately dialyzed against 
elution buffer without imidazole and with 0.03% (w/v) DDM for at least 48 h and four buffer 
exchanges, or was desalted using PD-10 Desalting Columns with G-25 Sephadex media (GE 
Healthcare, Piscataway, NJ) and subsequently dialyzed. Purity was verified by sodium dodecyl 
sulfate (SDS)-acrylamide gel electrophoresis (10% acrylamide gel, unless noted). Purifed AqpZ 
was incubated in cracking buffer for approximately 15 min (33 mM Tris, 1.3% SDS, 0.67% 
glyucerol, 97 mM ß-mercaptoethanol) at room temperature. Combined elutions yielded 
concentrations between 1-2 mg/ml measured using the 660 Assay kit (Pierce Protein Products, 
Pittsburgh, PA). Multiple batches of AqpZ that were purified at one time were pooled for future 
use. AqpZ was concentrated using 30 kDa MW cut-off Amicon Ultra-4 centrifugal filters 
(Millipore, Billerica, MA) to concentrations suitable for fluorescent labeling (>2 mg/ml).  
OmpF purification 
OmpF was purified according to (55) with modifications as previously reported (23).  
i. Growth 
Ten ml starter cultures of LB containing 50 µg/ml Amp were inoculated with a single colony of 




from a fresh plate. Cultures were incubated at 37°C on a shaker at 250 rpm for 18 h before 1:100 
dilution into 1 L LB. At O.D. 0.5-0.8 (λ=600; after approximately 3-7 h) the cultures were induced 
with 1 mM IPTG for overexpression of OmpF and subsequently grown until O.D. 1.8 was reached 
(λ=600; after approximately 6 h). Cells were harvested by centrifugation (15 min at 6000 x g, 4°C).  
ii. Extraction and solubilization of membrane fraction 
Cell pellets were resuspended in 10 ml per g cell pellet ice cold lysis buffer (20 mM Tric-Cl, pH 
8) and 10 μL DNase I (1 U/μL) per g cell pellet. Cell membranes were disrupted by sonication 
(Branson S-450D, 25% amplitude, 3 sec on and 2 sec off for 5 min). Cells rested 5 min on ice 
between sonication cycles for 3 cycles. One ml per ml of cell suspension of fresh 20% SDS was 
added to the cell suspension, and it was incubated for 1 h at 60°C with gentle mixing. If addition 
of SDS did not turn the cell suspension clear, samples were sonicated for additional time until a 
clear solution was achieved. The cell membrane fractions were removed by centrifugation (60 min. 
at 40,000 x g, 4°C) and subsequently washed with ice cold 20 mM phosphate buffer (pH 7.4) to 
remove residual SDS. Protein pre-extraction was achieved by adding 5 mg/g cell pellet 0.125% n-
Octyl-oligo-oxyethylene (octyl-POE; Enzo Life Sciences) in 20 mM phosphate buffer (pH 7.4) 
and homogenizing the pellet (Wheaton Homogenizer, 7 ml). The suspension was incubated for 1 
h at 37°C and the cell membrane fractions were removed by ultracentrifugation (45 min. at 145,000 
x g, 4°C).  
iii. OmpF extraction 
For OmpF extraction, the fractions were treated with 3% Octyl-POE in 20 mM phosphate buffer 
(pH 7.4), homogenized (Wheaton Homogenizer, 7 ml), and incubated for another 1 h at 37°C 
before the solubilized OmpF was separated from the membrane fraction via centrifugation (45 min 
at 145,000 g, 4°C). Purity was verified by SDS-acrylamide gel electrophoresis (12% acrylamide 
gel). OmpF yields ranged between 1.6-4.4 mg per L of culture. To reduce the detergent 
concentration, OmpF was dialyzed against 20 mM phosphate buffer (PB) with 1% octyl-POE for 
at least 48 h and four buffer exchanges. OmpF was quantified using a BCA assay (Pierce Protein 
Products), and concentrated using 30 kDa MW cut-off Amicon Ultra-4 centrifugal filters 





AqpZ and OmpF were labeled with Alexa Fluor 488 based on the Amine-Reactive Probes Protocol 
from Invitrogen (138) with modifications. A step-by-step protocol is provided in APPENDIX A. 
Ten mg/ml Alexa Fluor 488 carboxylic acid, succinimidyl ester, amine-reactive dye (Thermo-
Fisher Scientific, Pittsburgh, PA) stock was prepared by adding DMSO directly to the Alexa Fluor 
488 powder. Concentrated (>2 mg/ml) AqpZ or OmpF was incubated with 0.2 M NaHCO3, pH 
8.3 and excess Alexa Fluor 488 (protein:dye molar ratio 8.6x10-2 to 4.3x10-2) for 4 h with agitation 
in the dark at room temperature. The labeling reaction was stopped and excess dye separated from 
AqpZ by size exclusion chromatography with a Superdex 200 pressurized Tricorn 50 ml column 
using an Äkta prime plus instrument (GE Healthcare, Chicago, IL). An SDS-PAGE gel (10% 
acrylamide) with BSA standards and stained with Coomasie Brilliant Blue (Sigma-Aldrich, St. 
Louis, MO) was used to quantify labeled protein by analysis with ImageJ Analysis Software 
(v.1.34S; National Institutes of Health, Bethesda, MD). The degree of labeling (DOL) was 
calculated by Equation 3.1 (138). 
 
 
𝐷𝐷𝐷𝐷𝐷𝐷 = 𝐴𝐴𝑚𝑚𝑚𝑚𝑚𝑚 ∗ 𝑀𝑀𝑀𝑀[𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝] ∗ 𝜀𝜀𝑑𝑑𝑑𝑑𝑑𝑑  
Equation 3.1. Degree of labeling 
 
where Amax is the absorbance measured at the known maximum wavelength of 495 nm for Alexa 
Fluor 488 using a UV spectrometer (UV-2450, Shimadzu, Kyoto, Japan), MW is the known 
molecular weight of the protein monomer (AqpZ: 28 kDa, OmpF: 38 kDa), [protein] is the 
concentration of protein in mg/ml determined from a quantification gel as described above, and 
εdye is the known extinction coefficient of 71,000 cm-1M-1 for Alexa Fluor 488 at its absorbance 
maximum (139). DOL values ranging between 1.15-2.62 per AqpZ tetramer and 0.34-2.25 per 






Vesicles were prepared by film rehydration (16) by dissolving 12 mg (poly-(2-methyloxazoline)-
polydimethylsiloxane-poly-(2-methyloxazoline) PMOXA15-PDMS55-PMOXA15 triblock 
copolymer in 2 ml chloroform or combining 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine 
(POPC), 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine (POPE) and 1,2-dioleoyl-sn-
glycero-3-phosphate (DOPA) (each 10 mg/ml in chloroform) at a 70:15:15 molar ratio in a 100-
ml round-bottom flask. A thin polymer or lipid film was formed by removing chloroform with 
rotary vacuum evaporation (vacuum <400 mbar) at room temperature. Trace chloroform was 
removed under a high vacuum (<0.3 mbar) for at least 2 h. For AqpZ-containing vesicles, the films 
were rehydrated with varying amounts of fluorescently labeled AqpZ in phosphate-buffered 
sodium (PBS) and DDM sol grade (final concentrations 0.06% (w/v) AqpZ/polymer, 0.08-0.09% 
(w/v) AqpZ/lipid) pH 7.2 for a final polymer or lipid concentration of 6 mg/ml. For OmpF-
containing vesicles, the films were rehydrated with varying amounts of fluorescently labeled 
OmpF, 20 mM PB, octyl-POE (final concentration 0.3% (w/v)), pH 7.2 for a final lipid 
concentration of 6 mg/ml. Films were rehydrated at 4⁰C with a magnetic stir bar for 36 h and 
extruded using a pneumatic thermobarrel extruder (Northern Lipids, Burnaby, Canada) through a 
1.0 μm track-etched membrane (Millipore, Billerica, MA) at least 5 times. Subsequently, vesicles 
were sequentially extruded through 0.6, 4.0 and 0.2 μm track-etched membranes, at least 5 times 
each. Vesicles were size excluded from any excess materials with a Superdex 200 pressurized 
Tricorn 50 ml column using an Äkta prime plus instrument (GE Healthcare, Chicago, IL). 
Monitoring column flow through (UV-Vis λ=600 nm), care was taken to collect small fractions 
during size exclusion to include only vesicles. 
Cleaving the Alexa Fluor label post-reconstitution 
The protocol by New England Biolabs, Inc. (140) was followed with slight modifications for 
cleaving the Alexa Fluor 488 fluorescent probe from AqpZ. AqpZ/lipid vesicles were incubated 
with Factor Xa (1:50 (w/w) Factor Xa:AqpZ), 2 mM CaCl2, pH 8 overnight at room temperature 
with agitation. To remove cleaved fluorescent label, treated vesicles were size excluded with a 
Superdex 200 pressurized Tricorn 50 ml column using an Äkta prime plus instrument (GE 





Vesicle size was measured by dynamic light scattering (DLS) using a 4W Zetasizer nanoseries 
instrument with a He-Ne standard laser with a wavelength of 632.8 nm at 90⁰ scattering angle at 
room temperature (Zetasizer nano-ZS90, Malvern Instruments, Malvern, UK). An autocorrelation 
function was used to determine vesicle size, and diameter and polydispersivity index (PDI) values 
from three sets of measurements were averaged. Vesicles were also imaged with transmission 
electron microscopy (TEM) (2100 Cryo, JEOL, Tokyo, Japan) at 200 kV using thin film holey 
carbon grids (Ted Pella, Redding, CA, USA) glow-discharged on Denton DPG-1 (Denton Vacuum 
Inc., Moorestown, NJ, USA) at 20 V for 45-60 seconds. Samples were incubated on the grid 
surface for 60 seconds and stained with 0.1% uranylacetate for 60 seconds. The contact angles of 
prepared vesicle solutions were measured as previously described (141). Using a CAM200 optical 
goniometer (Biolin Scientific, Paramus, NJ), 20 μl of sample were deposited on parafilm M 
(Bemis, Neenah, WI), allowed to equilibrate for 30 s, and imaged by a high speed camera. Images 
formed by the droplet with respect to the parafilm substrate were fitted using a Young-Laplace 
drop profile fitting method. 
FCS method developed to quantify membrane protein insertion 
FCS was used to determine the number of molecules of both vesicles with fluorescently labeled 
protein and freely diffusing fluorescently labeled protein. A discussion of the theory and protocol 
used is provided in APPENDIX B. Fluorescence intensity was measured using single-photon FCS 
with an Alba fluorescence correlation spectrometer (ISS, Champaign, IL) with a wavelength of 
467 nm. The instrument was calibrated using nanomolar aqueous solutions of Alexa Fluor 488 
with a pinhole of 50. Three aliquots of each sample were measured for 100 seconds at 30 or 50% 
power three times in fluorescence fluctuation spectroscopy (FFS) mode. Measurements at 50% 
power were corrected to 30% power during fitting by measuring labeled AqpZ at both powers. 
Measurements yielded smooth autocorrelation curves. No decrease in signal intensity was 
observed during these measurements, indicating that bleaching was not a problem.  
 
Autocorrelation data for 10 ten-second measurements were averaged and fit by a single species 
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Equation 3.2. 3D Gaussian diffusion model 
 
where N is the average particle number in the focal volume, wo and zo are half-height dimensions, 
τ is the measurement time, and τD is the 2D lateral diffusion time in the focal volume or the 
characteristic decay time of the correlation function. N can be calculated by the amplitude of the 
of the autocorrelation curve knowing the radius and dimensions wo and zo from calibration 
measurements. When τ = 0, 1/G(0) is the average number of particles, N. The diffusion time, τD, 
is related to the particle’s diffusion coefficient, D, as shown in Equation 3.3. The diffusion 









   
Equation 3.3. Diffusion time 
 
Data was analyzed using the confocal spectroscopy and imaging application, VistaVision (version 
4.0 build 00144; ISS, Champaign, IL, USA). Data was separated into 10, 10-second measurements 
and the correlation curves were averaged into one correlation curve per measurement per aliquot. 
Correlation curves for all measurements were fit using the single species 3D Gaussian 
autocorrelation function (Equation 3.2) and the range of each correlation curve fit was at least 0-
0.2 seconds. For Alexa Fluor 488, the diffusion coefficient was fixed to the known value at 20⁰C 
of 380 µm2s-1 (143), concentrations were fixed, and the excitation volume parameters, ωo and zo, 
were linked to determine the ωo and zo values for each measurement session. For labeled AqpZ 
and OmpF, the excitation volume parameters, ωo and zo, were fixed as obtained from fitting the 
Alexa Fluor 488, and initial values for diffusion coefficients and concentrations were set to 30 
µm2s-1 and 1 nM, respectively. For vesicles, ωo and zo were also fixed and initial values for vesicle 
diffusion coefficients and concentrations were set to 5 µm2s-1 and 1 nM, respectively. Distinct 




(143) for Alexa Fluor 488, 34±8.8 μm2/s for AqpZ micelles, 19.8±6.0 μm2/s for OmpF micelles, 
and 2.5±1.9 μm2/s for vesicles. These findings are discussed in Section 3.4. 
 
The number of protein inserted in an average vesicle was subsequently determined by comparing 
the counts (brightness) per molecule per second (CPMS) of the vesicle to that of the labeled protein 
micelles (130). The CPMS for vesicles was calculated by Equation 3.4. 
 
CPMS = CPS/[1/G(0)]   
Equation 3.4. CPMS for vesicles 
 
where CPS is the counts per second and 1/G(0) is the number of fluorescent molecules. The CPMS 
for protein was calculated by Equation 3.5. 
 
CPMS = CPS/[1/G(0)×DOL]  
Equation 3.5. CPMS for protein 
 
where DOL is the degree of labeling. The degree of labeling ranged from 1.2-2.6 mol dye/mol 
AqpZ monomer and 0.3-0.7 mol dye/mol OmpF monomer. As first described to quantify the 
number of encapsulated soluble proteins in polymer vesicles (130), the number of protein present 
in an average vesicle was determined by the ratio of the counts per molecule of the vesicle to the 
counts per molecule of the labeled protein, as shown in Equation 3.6. 
 
# protein per vesicle = CPMSvesicle/CPMSprotein  
Equation 3.6. Number protein/vesicle 
 
Due to the high photo stability of Alexa Fluor 488 (144), differences in fluoresce intensity in buffer 
and in the vesicle membrane were not expected nor identified by data collected.  Insertion data is 
tabulated in APPENDIX C.  
Resolubilization method to quantify membrane protein insertion 
Following previous studies (47, 136, 137), vesicles with fluorescently-labeled AqpZ and OmpF 




with 2.5-3% octyl-glucoside (OG) for 24-86 h. Vesicles and resolubilized vesicles were measured 
using the same FCS procedure and data fitting techniques already described for vesicles and freely-
diffusing fluorescently-labeled protein micelles. The number of fluorescently labeled species, 
1/G(0), was determined from the 3-D Gaussian diffusion model when τ = 0. The number of protein 
inserted in an average vesicle was determined by comparing the number of vesicles to that of the 
labeled protein (47), as shown in Equation 3.7.  
 
# protein per vesicle = [1/G(0)]vesicle/[1/G(0)]protein  
Equation 3.7. Number protein/vesicle (resolubilization) 
 
Vesicle permeability measurements 
Vesicle permeability was determined using an SX.18MV-R stopped-flow spectrometer (Applied 
Photophysics, Surrey, UK) with light scattering according to Borgnia et al (43). Vesicles were 
mixed with equal volumes of a 1 M NaCl (AqpZ-containing vesicles) or 1 M glucose (OmpF-
containing vesicles) osmotic agent at 10⁰C. Change in vesicle size due to water efflux was 
monitored by light scattering at 600 nm emission wavelength. The light scattering curves (at least 
7) were averaged and fitted using an exponential rise equation in Origin software (Origin v.8.1) 
and permeability (Pf) calculated using Equation 3.8 as previously described (43).  
 
Pf = k/[(S/Vo)×Vw×∆osm]  
Equation 3.8. Vesicle permeability 
 
where k is the exponential rise rate constant, S/Vo the initial vesicle surface area to volume ratio, 
Vw the known molar volume of water (18 cm3/mol), and ∆osm the imposed osmolar gradient. 









3.4 Results and Discussion 
Vesicle characterization 
To ensure that vesicles were formed, each preparation was examined with DLS, and representative 
preparations were examined with TEM. For AqpZ/polymer vesicles, the average diameter was 
234.9±37.1 nm (Figure 3.2). These values were within the range expected for PMOXA-PDMS-
based co-polymer vesicles (145), albeit larger than values reported for polymer vesicles with AqpZ 
inserted (16). For AqpZ/lipid vesicles, the average diameter was 176.4±37.9 nm, (Figure 3.2), 
consistent with previously reported values for phospatidylcholine (PC)-based lipid vesicles (146), 
but approximately 40-50 nm larger than previously reported values for AqpZ/lipid vesicles (43, 
147). For OmpF/lipid vesicles, the average diameter was 124.3±37.2 nm (Figure 3.2), again 
consistent with PC-based lipid vesicles (146). Overall, for AqpZ/polymer and OmpF/lipid vesicles, 
as more protein was added during vesicle reconstitution, I observed a slight increase in vesicle 
diameter. The diameters of AqpZ/lipid vesicles did not appear to change with changing molar 
ratios.  
 
A PDI value of 0.2 is considered low and below which monodisperse vesicles are assumed to exist 
(148, 149). AqpZ/polymer and AqpZ/lipid vesicles had an average PDI value of 0.22±0.08. For 
AqpZ/polymer vesicles, the average PDI value did increase beyond 0.2 for 1/250 to 1/25 molar 
ratio (ranged from 0.21±0.05 to 0.28±0.08). Although these PDI values were not ideal, I included 
these vesicles in the study due to limited polymer availability. AqpZ/lipid and OmpF/lipid vesicles 
had ideal average PDI values of 0.15±0.05 and 0.17±0.06, respectively, with most values falling 
below the 0.2 threshold. As more protein was added during vesicle reconstitution, I observed a 
slight increase in vesicle diameter and PDI value, especially for AqpZ/polymer and OmpF/lipid 










Figure 3.1. Hydrodynamic diameter (Dh) and polydispersivity index (PDI) of vesicles 
Dh indicates vesicle size and PDI indicates vesicle uniformity. (A) AqpZ/polymer, (B) AqpZ/lipid, 
and (C) OmpF/lipid vesicles. The horizontal dashed line indicates a PDI value of 0.2, below which 
fairly uniform vesicles are assumed to exist (148, 149); most lipid vesicle samples fell within this 
range. Error bars represent standard deviations of replicates across all vesicle samples at a 
particular ratio and composition. 
 
TEM images showed formation of polymer and lipid vesicles (Figure 3.2). Polymer vesicles 
exhibited the spherical, vesicle-like aggregates expected of polymer vesicles (16, 52, 132, 150). 
Lipid vesicles also exhibited spherical shapes but appeared more translucent, distorted and 
collapsed or folded compared to polymer vesicles (146, 148), due to the negative staining 
procedure and drying techniques employed in TEM sample preparation which can alter the shape 
of the vesicles (148). Since polymer vesicles have been shown to exhibit much higher resistance 
to rupture than lipid vesicles (144), it is not surprising that they were less affected by the stresses 
of the TEM sample preparation. The images were not visibly affected when AqpZ was 
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Figure 3.2. TEM images of lipid and polymer vesicles with and without AqpZ 
(A) 0 molar ratio AqpZ/polymer vesicles, (B) 1/100 molar ratio AqpZ/polymer vesicles, (C) 1/50 
molar ratio AqpZ/polymer vesicles, (D) 0 molar ratio AqpZ/lipid vesicles, (E) 1/1000 molar ratio 
AqpZ/lipid vesicles, (F) 1/50 molar ratio AqpZ/lipid vesicles, and (G) 1/25 molar ratio AqpZ/lipid 
vesicles. Vesicles were loaded onto ultrathin film holey carbon TEM grids and negatively stained 
with 1% uranyl acetate.  
Development of an FCS method to quantify membrane protein insertion in vesicles 
To measure the amount of membrane protein inserted in vesicle membranes, I developed an FCS 
method building on previous work for quantifying the number of encapsulated soluble proteins in 
polymer vesicles (130). Free Alexa Fluor 488 (AF488) was used to calibrate the FCS instrument 


























Figure 3.3. FCS standards and calibration  
(A) Autocorrelation curves for free label (AF488) used for calibration of the Alba FCS instrument 
and to obtain the confocal dimensions, wo and zo, needed for fitting of the data measured for 
labeled-protein micelles and labeled-protein in vesicles. (B) Representative normalized and fitted 
FCS single species 3D Gaussian autocorrelation curves of free fluorescent label, AqpZ, and 
AqpZ/lipid vesicle data show distinctly different diffusion coefficients and diffusion times. 
 
Free fluorescent label, labeled protein (micelles), and labeled protein in vesicles were measured 
separately to obtain their diffusion coefficients (Figure 3.3B). They ranged from 380 μm2/s (143) 
for free fluorescent label, 34±8.8 μm2/s for AqpZ micelles, 19.8±6.0 μm2/s for OmpF micelles, 
and 2.5±1.9 μm2/s for vesicles. The single species 3D Gaussian diffusion model fit each well, 
suggesting that size exclusion chromatography was effective at removing excess label from the 
protein and unincorporated, labeled protein from vesicles. The number of labeled proteins present 
in an average vesicle was then determined based on the ratio of the counts per molecule of the 
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Quantification of AqpZ insertion and vesicle permeability with varying detergent concentrations 
during reconstitution 
To test the influence of detergent on membrane protein insertion, I quantified the number of AqpZ 
inserted and the permeability of 1/100 molar ratio AqpZ/lipid vesicles when the vesicles were 
reconstituted with varying concentrations (up to 1% (w/v)) of the detergent dodecyl maltoside 
(DDM). Vesicle permeability decreased at 0.6% DDM (Figure 3.4). AqpZ insertion appeared to 
decrease with increasing DDM concentration, but was substantially inhibited at 0.3%. These 
results suggest that detergent does inhibit AqpZ insertion into, and thus the permeability of, 1/100 
molar ratio AqpZ/lipid vesicles at high detergent concentrations.  
 
 
Figure 3.4. Effect of DDM detergent on AqpZ insertion and vesicle permeability  
DDM inhibited AqpZ insertion into and permeability of 1/100 molar ratio AqpZ/lipid vesicles 
beyond 0.3%. Insertion was inhibited even with 0.1% DDM. For no protein vesicles, no change in 
permeability was observed. Error bars represent the propagated standard error from fitting light 
scattering data and of the multiple FCS measurements of each vesicle preparation. Abbreviations 
are as follows: insertion (ins), permeability (Pf). 
 
In previous work, as the amount of AqpZ added increased, so did the detergent concentration 
during reconstitution into membrane materials, up to 1% (w/v) (16, 43), and decreases in vesicle 
permeability were observed. For the rest of the data presented herein, I kept the DDM 




































Ins, 1/100 mol% AqpZ/lipid
Pf, 1/100 mol% AqpZ/lipid
Pf, 0 mol% AqpZ/lipid
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insertion was substantially inhibited. Specifically, AqpZ/polymer and AqpZ/lipid vesicles were 
prepared at 0.06% and 0.08-0.09% (w/v) DDM, respectively. However, difficulty in removing 
detergent via dialysis for low critical micelle concentration (CMC) detergents like DDM have been 
described (151, 152), so it is possible that DDM concentrations were higher than anticipated during 
AqpZ/lipid vesicle formation. Even if no DDM was removed following AqpZ purification, 
vesicles would have no more than 0.12% (w/v) DDM during reconstitution. OmpF/lipid vesicles 
were prepared with a different detergent, n-Octyl-oligo-oxyethylene (Octyl-POE), at 0.3% (w/v).  
 
Additionally, to test if the detergent concentrations during reconstitution reflected an increase in 
bulk detergent concentrations of the vesicle suspensions, contact angles between the solution and 
parafilm were measured (Figure 3.5A). Surprisingly, the contact angles were very similar across 
the range of DDM concentrations tested (exception: 1/100 molar ratio AqpZ/lipid vesicles 
reconstituted at 0.6% DDM), and were similar between the 0 and 1/100 molar ratio AqpZ/lipid 
vesicle preparations. This similarity may be explained by the fact that after the film rehydration 
phase, vesicles were separated from unreacted molecules by size exclusion chromatography in 
detergent-free buffer, further reducing detergent concentrations of the vesicle suspensions. It is 
possible that detergent molecules still resided inside vesicles, or in the membrane itself, which 








Figure 3.5. Contact angle measurements to measure amount of DDM detergent  
(A) 0 and 100 molar ratio AqpZ/lipid vesicles reconstituted at varying DDM concentrations. (B) 
AqpZ/lipid (four replicates, representing two protein preps) and OmpF/lipid (duplicates of single 
protein prep) vesicles. 
 
To determine if there were differences in bulk vesicle detergent concentrations when vesicles were 
prepared with fairly constant detergent concentrations (AqpZ/lipid vesicles: 0.08-0.09% (w/v) 
DDM; OmpF/lipid vesicles: 0.3% (w/v) Octyl-POE), contact angles were measured for AqpZ/lipid 
and OmpF/lipid vesicles made with varying amounts of protein added (Figure 3.5B). Similar bulk 
vesicle detergent concentrations were found across molar ratios, especially for AqpZ/lipid vesicles.  
Quantification of protein insertion and vesicle permeability with varying concentrations of protein 
added 
To determine the influence of the amount of protein added during reconstitution on protein 
insertion and vesicle permeability, I measured insertion and permeability for OmpF/lipid, 
AqpZ/lipid and AqpZ/polymer vesicles with varying amounts of protein added. Generally, I found 
that protein insertion affected vesicle permeability. For OmpF/lipid vesicles, as more protein was 
added, more protein inserted and vesicle permeability increased for 0-1/25 molar ratio (Figure 3.6). 




































Figure 3.6. Insertion and permeability measurements of OmpF trimer in lipid vesicles  
Measurements from duplicate vesicle preparations for two protein preparations were averaged. 
Error bars represent propagated standard error of the permeability measurements from fitting light 
scattering data and of the multiple FCS measurements of each vesicle preparation.  
 
For AqpZ/lipid vesicles, I found that vesicle permeability was linearly related to AqpZ insertion 
(Figure 3.7). Linear regression of AqpZ/lipid vesicle permeability and insertion data yielded a 
good fit (R2 = 0.89). Using a Z-score test, one outlier was not included in the fit. Experimental 
conditions do not suggest an explanation for the existence of the outlier. The linear relationship 



















































Figure 3.7. Permeability versus insertion of AqpZ/lipid vesicles 
All data except for an outlier identified using the Z-score (threshold > 3) were included in the 
linear trendline fit. * denotes the outlier. Vertical error bars represent propagated standard error of 
the permeability measurements from fitting light scattering data and are too small to appear. 
Horizontal error bars represent propagated standard error of the multiple FCS measurements of 
each vesicle preparation. For the insertion analysis, AqpZ was assumed to be in tetramers. 
 
Interestingly, insertion and permeability behavior for AqpZ/lipid and polymer vesicles was 
consistent among replicate vesicle preparations for a single protein preparation (Figure 3.8). 
However, I found variability in permeability behavior between protein preparations for AqpZ/lipid 
vesicles. For AqpZ/lipid vesicles, insertion and permeability data for each protein preparation are 
therefore presented in separate panels of Figure 3.8. For AqpZ/lipid replicates, the decrease in 
permeability beyond the maximum observed at 1/100 or 1/50 molar ratio AqpZ/lipid can be 
explained by a decrease in AqpZ insertion (Figure 3.8A and B). Similarly, the continued increase 
in permeability in Figure 3.8C was a result of increasing AqpZ insertion. AqpZ/lipid vesicles that 
exhibited maximum permeability at 1/50 molar ratio were consistent with previously reported 
optimal permeability (16, 43, 46, 121). For AqpZ/polymer vesicles, the increase in permeability 
through 1/100 molar ratio followed by a decrease at 1/50 molar ratio and again an increase at 1/25 
molar ratio was a result of varying protein insertion (Figure 3.8D). Note that only one protein 
preparation was tested in polymer.  
 
The decreases or leveling off of insertion and permeability at high molar ratios of AqpZ added for 
some replicates of AqpZ/lipid vesicles (Figure 3.8A and B) was similar to previous reports (16, 





























43, 46, 47, 121). However, in this work, detergent concentrations were kept relatively constant and 
well below where I saw severe insertion inhibition (0.3% DDM). As such, detergent concentrations 
cannot be the only factor influencing protein insertion, and thus, the water permeability, of 
vesicles. Due to the high photo stability of Alexa Fluor 488 (144), differences in fluorescence 
intensity in buffer and in the vesicle membrane were not identified by the data collected. 
Additionally, for AqpZ/lipid vesicles, I found the insertion and permeability trends and absolute 
values to depend on protein preparation. It appears that differences in protein concentration or 
AqpZ/lipid vesicles, I found the insertion and permeability trends and aggregation between the 
protein preparations might explain the different insertion behaviors. 
 
Comparing AqpZ multimer state between protein preparations, suggests the possibility that AqpZ 
insertion behavior at high AqpZ reconstitution ratios may be explained by the degree of AqpZ 
aggregation. The AqpZ insertion and vesicle permeability behavior appeared to correlate with the 
AqpZ multimer state observed on SDS-PAGE gels (Figure 3.9). While these gels are not native 
(non-denaturing), AqpZ has been reported as unusually stable under SDS-PAGE conditions (1% 
SDS, 143 mM ß-mercaptoethanol, 1 hr incubation at room temperature) (43). Vesicles where 
insertion and permeability increased overall from 0-1/25 molar ratio AqpZ/membrane material had 
more higher order (octomer or more) AqpZ complexes quantified using pixel analysis and 
summarized in Table 3.1. Conversely, vesicles where insertion and permeability either remained 
constant or decreased beyond the peak at 1/100 or 1/50 had greater amounts of monomer and 
tetramer present. This observation suggests that at high AqpZ concentrations, AqpZ monomers 
were not inserting as expected, whereas the higher order AqpZ were still inserting and active. To 









Figure 3.8. Insertion and permeability measurements of AqpZ in polymer and lipid vesicles at 
varying molar ratios of protein added  
(A-C) AqpZ/lipid vesicles, replicates (at least duplicates) from independent protein preparations. 
(D) AqpZ/polymer vesicles. Error bars represent propagated standard error of the permeability 
measurements from fitting light scattering data and of the multiple FCS measurements of each 
vesicle preparation. Note that scales vary among the panels. For the insertion analysis, AqpZ was 



































































































































































Figure 3.9. SDS-PAGE gels to quantify labeled AqpZ  
AqpZ tetramer has an apparent molecular weight of 53 KDa on 10% (w/v) acrylamide (43). All 
gels were handcast 10% (w/v) acrylamide except as noted. Dilutions are noted and initial or final 
fractions are size exclusion fractions checked separately from the pooled fractions. (A) AqpZ 
corresponding to Figure 3.7A. (B) AqpZ corresponding to Figure 3.7B. The gel shown includes 
both labeled AqpZ (AF488-AqpZ) and unlabeled AqpZ as noted. (C) AqpZ corresponding to 
Figure 3.7C. The gel shown includes both labeled and unlabeled AqpZ as noted. (D) AqpZ 
corresponding to Figure 3.7D, 4-20% acrylamide (w/v) pre-cast gel. The gel shown includes both 
labeled and unlabeled AqpZ as noted. Abbreviations are as follows: Bovine serum albumin (BSA), 
































This work was motivated in part by a decrease or leveling-off of vesicle permeability at high 
AqpZ/membrane material molar ratios in previous studies (16, 43, 44, 46, 47, 121). Some of these 
studies reported the calculated permeability per monomer of AqpZ. I found that the water 
permeability of AqpZ monomers was between 1.1x10-14 to 2.9x10-13 with an average of 
1.0±0.9x10-13 cm/s. Previous experimental studies reported water permeability of E. coli AqpZ 
monomers between 2x10-14 to 1x10-13 cm/s (43, 59, 153, 154). Molecular dynamics simulations 
reported a value of 1.6x10-13 (155, 156). The majority of the water permeability values calculated 
in this work fell within the range of previously reported values, and some values were nearly three 
times greater than the largest reported values. Thus, previous reports that assumed 100% insertion 
efficiency may have been underestimating the water permeability per AqpZ monomer. This 
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Testing the possibility of encapsulation of AqpZ inside vesicles 
A potential issue with the FCS insertion method described in this study is that the number of 
protein measured per vesicle would be artificially high if membrane proteins were encapsulated 
inside of the vesicle (instead of embedded in the membrane). Encapsulation would be of greatest 
concern at high protein to membrane reconstitution rations. To test the possibility of encapsulation, 
several approaches were undertaken. Insertion was measured before and after these treatments: 
using a chemical to cleave the fluorescent probe and labeling the membrane protein post-
reconstitution. The basis for these two approaches is that AqpZ insertion is assumed to not be 
directionally specific and the membrane is assumed to be protective against labeling. Thus, if 
encapsulation was occurring, vesicle brightness should be more than half of the original brightness 
after treatment. If encapsulation was not occurring, vesicle brightness should be one-half of the 
original brightness after treatment.  
i. Approach 1: Cleaving the fluorescent probe  
Trypsin is a protease shown to cleave between the Arg and His residues of the N-terminal domain 
of solubilized 10-His-AqpZ. In initial tests, however, Borgnia et al. reported that no cleavage was 
observed when AqpZ was reconstituted in E. coli total lipid extract (43). They hypothesized that 
the cleavage site was protected by the lipid membrane, but no details were given on conditions of 
their test. Factor Xa is another protease known to cleave after the Arg residue in the recognition 
sequence Ile-(Glu or Asp)-Gly-Arg, which matches exactly the Ile-Glu-Gly-Arg sequence on the 
N-terminal domain of 10-His-AqpZ. However, FCS measurements before and after treatment with 
Factor Xa did not reveal any decrease in vesicle brightness. This finding further supports the 
hypothesis that the protein is well protected by the lipid membrane, including the N-terminal 
domain of 10-His-AqpZ.  
ii. Approach 2: Labeling the protein post-reconstitution  
1/100 and 1/25 molar ratio AqpZ/lipid vesicles were prepared with unlabeled and labeled AqpZ. 
Subsequently, vesicles were labeled with AF488 (pre-labeled vesicles were dummy-labeled). If 




vesicles. However, no difference in insertion was observed at 1/100 molar ratio, and only 30% 
reduction (not significant) was observed for post-labeled 1/25 molar ratio vesicles (Figure 3.10). I 
cannot rule out the possibility that the reduction in AqpZ insertion was based on differences in 
vesicle prep. Additionally, based on the knowledge that small molecules can cross the lipid 
membrane, AF488 may have been able to cross the membrane. Depending on the diffusion rates 
of the labeling buffers and AF488, conditions may or may not have remained favorable for it to 
react inside the vesicle. However, with consistent insertion and permeability results, I did not 
observe evidence of encapsulation. 
 
 
Figure 3.10. Insertion and permeability measurements of AqpZ/lipid vesicles where AqpZ was 
labeled before and, separately, after vesicle formation  
Error bars represent propagated error of the permeability measurements from fitting light 
scattering data and of the multiple FCS measurements of each vesicle preparation. 
Quantification of AqpZ in lipid vesicles after resolubilizing fully-formed vesicles 
For comparison to prior work (47), I also attempted to quantify insertion by resolubilizing vesicles 
and quantifying the labeled protein that was released. I found vesicles to be highly stable and had 
to expose them to detergent significantly longer than reported to observe resolubilization. After 
resolubilization of AqpZ/lipid vesicles, I found micellar diffusion coefficients between 9-17 μm2/s, 











































Resolubilitzation of OmpF/lipid vesicles yielded diffusion coefficients between 7-25 μm2/s, 
approximately 4 times greater than vesicular diffusion coefficients. In contrast, previous findings 
reported micellar diffusion coefficients between 1-2 orders of magnitude greater (47, 136, 137) 
than vesicular ones. In those findings, the diffusion coefficients of the AqpZ micelles were 
reported as slightly smaller than for the original AqpZ micelles. I found the diffusion coefficients 
to be 2-4 times smaller. I hypothesize that this difference between the free and resolubilized AqpZ 
micelles can be attributed to phospholipids remaining with the AqpZ in the resolubilized form 
and/or high detergent concentrations that could affect the diffusion of micelles. After 
resolubilization, detergent concentrations in the samples were almost two orders of magnitude 
greater than beforehand.  
 
For AqpZ vesicles, I observed 3 times (1/100 molar ratio vesicles) to 7 times (1/25 molar ratio 
vesicles) less insertion using the resolubilization approach compared to our FCS approach (Figure 
3.11A). For OmpF/lipid vesicles, insertion measured via resolubilization yielded similar values to 
the number of OmpF measured in vesicle form for 0-1/50 molar ratio (Figure 3.11B). At 1/25 
molar ratio, I observed 2 times less insertion using the resolubilization approach compared to our 
FCS approach. These differences in insertion could be due to incomplete resolubilization of 
vesicles which would lead to artificially low insertion values from the resolubilization method. 
Complete dissolution of vesicles was assumed previously (47). However, if resolubilization was 
not complete, there could be more than one protein (AqpZ or OmpF) per micelle. This situation 
would underestimate protein insertion and could explain the mismatch that I observed between the 
number of free protein and protein measured after resolubilization, especially at high AqpZ/lipid 
ratios. My original FCS approach would underestimate insertion if there were differences in 
molecular brightness of Alexa Fluor 488 in the aqueous and membrane environments. The 
resolubilization approach attempts to measure vesicles and protein micelles in the same lipid 
environment.  If there were differences in molecular brightness of Alexa Fluor 488 based on its 
environment, the resolubilization approach would result in a greater estimated insertion than my 
original FCS approach. Since my original FCS approach estimates greater insertion, a potential 
decrease in brightness does not explain this discrepancy.  Overall, using the resolubilization 
approach, I observed similar trends as found using my original FCS approach: increased protein 





Figure 3.11. Comparison of our FCS method and the resolubilization method  
(A) AqpZ/lipid vesicles. (B) OmpF/lipid vesicles. For resolubilization, vesicles were incubated 
with 2.5-3% OG. Error bars represent propagated error of the multiple FCS measurements of 
duplicate vesicle preparations (single protein preparation).  
 
3.5 Conclusions  
To further development of hybrid protein-synthetic membranes, this work has provided the 
following conclusions:  
 
• Comparing vesicle brightness to protein brightness using FCS is a viable method for 
measuring the number of membrane proteins in vesicles. This work contributes another 
tool to investigate protein insertion. 
 
• DDM concentrations greater than 0.3% (w/v) substantially inhibit AqpZ insertion into lipid 
vesicles, resulting in lower permeability. Lowering the detergent concentration can 












































• Vesicle permeability of AqpZ and OmpF in lipid and polymer vesicles correlate to the 
insertion of AqpZ and OmpF into the membrane material. Vesicle permeability that 
decreases at high resconstitution ratios, is likely due a decreases in protein insertion. 
 
• AqpZ insertion and permeability behavior appeared to depend on the AqpZ preparation. 
Greater insertion, and thus permeability, may be observed when AqpZ exists in higher 
order multimer states. 
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CHAPTER 4: BIOMIMETIC MEMBRANES 
FORMED BY DEPOSITION AND RUPTURE OF 




Biomimetic triblock copolymers were combined with lipids to test whether hybrid planar 
membranes could be formed through vesicle deposition. Poly-(2-methyloxazoline)-
polydimethylsiloxane-poly-(2-methyloxazoline) (PMOXA15-PDMS110-PMOXA15) polymer was 
mixed with either zwitterionic 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) or 
positively charged 1,2-dioleoyl-3-trimethylammonium-propane (DOTAP) lipids at varying ratios. 
Hybrid vesicles were produced containing both polymers and lipids. Depending on the vesicle 
composition, deposition behavior on quartz followed one of three scenarios: I) rupturing 
spontaneously to form planar membranes (pure lipids and 89molar ratio DOTAP), II) rupturing 
with calcium (67molar ratio and 89molar ratio POPC), or III) depositing as intact vesicles (pure 
polymer and high polymer content). Increased rupture was observed for hybrid vesicles as 
compared to pure polymer vesicles and on mica as compared to quartz. Hybrid polymer-lipid 
vesicles with as little as 11molar ratio polymer had 1.4 – 3 times lower water permeability than 
                                                 
2 Author contributions: The data in this chapter was collected during a joint project with Sania Bäckström, a visiting 
PhD student from the Technical University of Denmark. I developed the methods for the transmission emission 
microscopy and stopped flow light scattering measurements, Sania developed the methods for the quartz crystal 
microbalance with dissipation monitoring and zeta-potential measurements, and we worked together to develop the 
methods for imaging using atomic force microscopy; we both generated data from the different methods and 






pure lipid vesicles. Vesicle properties may be adjusted by varying composition, polymer-lipid 
ratio, and surface and solution chemistry. 
4.2 Introduction  
Lipid bilayers and biomimetic triblock copolymer membranes are used to investigate membrane 
protein insertion (157) and activity (54, 158) and show promise for a variety of applications, 
including screening platforms for drug discovery (159), biosensors (160, 161), and immunoassays 
(162). Lipids have the advantages of being better understood and more similar to the native 
environment for incorporation of membrane proteins. However, copolymer membranes are 
typically more stable and can be engineered for the desired combination of properties (37). For 
example, polyethyleneoxide-polyethylethylene vesicles are 5-50 times tougher mechanically than 
lipid membranes (32) and exhibit greater thermal and temporal stability (163). Another promising 
biomimetic membrane, a triblock hydrophilic-hydrophobic-hydrophilic copolymer (poly-(2-
methyloxazoline)-polydimethylsiloxane-poly-(2-methyloxazoline) or PMOXA-PDMS-
PMOXA), shows functional incorporation of a variety of transmembrane proteins (16, 18, 28, 38, 
54, 55, 122, 158, 164-167). The majority of the work conducted with block copolymer membranes 
has been with vesicles, but for many biosensor applications and analytical techniques it is desirable 
to produce planar, solid-supported membranes.  
 
For lipids, planar membranes can be made on a solid support by Langmuir-Blodgett (vertical) or 
Langmuir-Schäfer (horizontal) transfer from a water-air interface (168) or through vesicle collapse 
(35). The adsorption and fusion of vesicles from aqueous solution onto solid supports are affected 
by vesicle properties (size (96, 169), composition (35), and surface charge (35)), support surface 
properties (surface chemistry (170), cleanliness (91), roughness (91), and charge (100)), and 
solution chemistry (pH, ionic strength, temperature (171), and osmotic pressure (91, 170)). 
Calcium has been shown to enhance deposition for anionic and zwitterionic vesicles (35). A free-
standing planar lipid membrane can also be made in a single aperture of less than 1 mm in a 
hydrophobic scaffold either by painting a solvent-containing black lipid membrane across the 





planar lipid membranes (either free-standing (173-175) or on nanoporous supports (92, 176)) 
covering a larger area have been realized by utilizing aperture arrays in hydrophobic scaffolds.  
 
Recently there has also been some progress in synthesizing planar, solid-supported copolymer 
membranes using three different approaches: Langmuir-Blodgett transfer (37, 38, 177), synthesis 
on a gold surface (178), and vesicle deposition (40, 179, 180). In the current work we focused on 
vesicle deposition because it presents the fewest obstacles for incorporation of membrane proteins. 
However, the high rupture strength of triblock copolymer vesicles presents some difficulty for this 
method. This can be resolved by the use of charged or functionalized copolymers to facilitate 
adsorption (40, 179). There is also one report investigating direct deposition of PMOXA7-
PDMS60-PMOXA7 polymer onto solid surfaces; in this case a variety of structures were observed 
using atomic force microscopy (AFM), including spherical and tubular vesicles and areas with a 
thinner layer, possibly planar polymer membranes (180).  
 
The current work investigates the potential use of mixed or hybrid polymer-lipid vesicles to 
facilitate formation of a planar membrane through vesicle deposition and to allow tailoring of 
vesicle properties. The triblock copolymer PMOXA15-PDMS110-PMOXA15 was selected because 
of its suitability for protein insertion (16, 18, 28, 38, 54, 55, 122, 158, 164-167). The formation of 
mixed polymer-lipid vesicles has been documented for poly(ethylene oxide)-poly(propylene 
oxide)-poly(ethylene oxide) (181) and PMOXA-PDMS-PMOXA polymers (182) but to our 
knowledge the deposition and rupture properties of such vesicles have not been reported before. 
Mixed polymer-lipid vesicles with different ratios of PMOXA15-PDMS110-PMOXA15 polymer to 
zwitterionic or positively charged lipids were characterized by transmission electron microscopy 
(TEM), dynamic light scattering (DLS), electrophoretic light scattering (ELS), and osmotic shock 
stopped-flow permeability measurements, and their deposition behavior was investigated on 
quartz with quartz crystal microbalance with dissipation monitoring (QCM-D) and on mica with 
AFM. These mixed polymer-lipid vesicles show promise for selectively tethering vesicles or 







4.3 Materials and methods 
Materials  
PMOXA15-PDMS110-PMOXA15 was obtained from Dr. Wolfgang Meier at the University of 
Basel, Switzerland (183). 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC, 25 mg/ml in 
chloroform) and 1,2-dioleoyl-3-trimethylammonium-propane (DOTAP, 10 mg/ml in chloroform) 
were purchased from Avanti Polar Lipids (Alabaster, USA). Dodecyl maltoside detergent sol grade 
was purchased from Anatrace (Santa Clara, USA). Sodium azide and chloroform were purchased 
from Sigma (St. Louis, USA). 
Vesicle preparation  
Mixed polymer-lipid vesicles were prepared by dissolving PMOXA15-PDMS110-PMOXA15 
polymer in chloroform (2 ml) and adding POPC or DOTAP in specified molar ratios (0, 33, 67, 
89, 100% lipid), then using a film rehydration technique (16). A thin polymer-lipid film was 
formed by evaporating the solvent in a round-bottomed flask using a rotary vacuum evaporator 
(vacuum <110 mbar) at room temperature. Trace chloroform was removed under a high vacuum 
(<2.5 mbar) for 1- 2 h before the dried polymer-lipid film was rehydrated with 2.8 mM PBS (8 g 
L-1 NaCl, 0.2 g L-1 KCl, 0.144 g L-1 Na2HPO4, 0.24 g L-1 KH2PO4, pH 7.2) containing 0.04% 
dodecyl maltoside and 0.13% sodium azide to a final polymer-lipid concentration of 6 mg/ml. The 
films were sonicated to ensure that the polymer lifted off from the bottom of the flask. The films 
were rehydrated at 4° C under continuous rotational stirring for 24 h. The resulting vesicles were 
extruded using a pneumatic thermobarrel extruder (Northern Lipids, Burnaby, Canada) through 
0.6 μm and 0.2 μm track-etched Isopore™ membranes (Millipore, Billerica, MA, USA) 5 and 11 
times respectively to ensure unilamellar vesicles. The vesicles were purified by size-exclusion with 
a flow rate of 0.5 ml/min on a Superdex 200 pressurized column (GE Healthcare, Piscataway, NJ, 
USA) using an Äkta prime plus instrument (GE Healthcare, Piscataway, NJ, USA). The fraction 
corresponding to the vesicles was typically collected after 10 minutes. Unless otherwise noted, 
results are from a single preparation of vesicles at each ratio and composition. Vesicles were stored 
at 4°C for up to 14 days prior to TEM and QCM-D experiments; DLS results did not show a change 





12 days and the PMOXA-PDMS-PMOXA vesicles after 50 days; again none of these samples 
showed a change in DLS results over that time. Eleven molar ratio PMOXA-PDMS-PMOXA:89 
molar ratio DOTAP and pure DOTAP vesicles used for AFM had been stored for 40 days and by 
DLS showed an increase in diameter from 109 nm to 186 nm and from 160 nm to 524 nm 
respectively. 
Vesicle characterization  
The hydrodynamic diameter and zeta potential of the vesicle preparations were determined using 
dynamic light scattering (DLS) and electrophoretic light scattering (ELS), respectively, on a 4W 
Zetasizer Nano-ZS90 (Malvern Instruments, Malvern, UK) with a He-Ne standard laser, 
wavelength 632.8 nm and 90° scattering angle. The DLS results shown here are the average of 
three 10-measurement series for each sample taken directly after introducing the sample. The 
refractive index for the vesicles was set as 1.48 (184). Zeta potential measurements were carried 
out at 25°C in 2.8 mM PBS pH 7.2 buffer with an equilibration time of 2 minutes and signal 
processing used M3-PALS (second generation Phase Analysis Light Scattering) to measure the 
particle electrophoretic mobility. Zeta potential was calculated using a built-in monomodal 
analysis model assuming the Smoluchowski approximation and a dispersant viscosity of 0.8904 
cP (185).  
 
In preparation for TEM, thin film holey carbon grids (Ted Pella, Redding, CA, USA) were treated 
with a Denton DPG-1 glow-discharge system (Denton Vacuum Inc., Moorestown, NJ, USA) at a 
glow current of 200 mAmp for 2 minutes to make them hydrophilic. Vesicle samples were allowed 
to adsorb to the grid surface for 2 minutes, stained with 1% uranyl acetate (SPI, West Chester, PA, 
USA) for 30 seconds, and air-dried. Drying technique employed in TEM sample preparation can 
alter the shape of the vesicles (148). Vesicles were viewed with a JEM 2100 transmission electron 
microscope (JEOL, Tokyo, Japan) with a LaB6 cathode operated at 200 keV. 15-35 images were 
collected from each batch of vesicles. TEM experiments at ratios of 11 molar ratio PMOXA-
PDMS-PMOXA:69 molar ratio POPC and 100% PMOXA-PDMS-PMOXA were performed with 
2 and 3 replicate vesicle preparations respectively. Data shown are from a single vesicle 





Quartz crystal microbalance with dissipation monitoring  
We used a QCM-D300 system and polished AT-cut, 5 MHz quartz crystals with a 50 nm silicon 
dioxide coating (QSX-303, Q-Sense AB, Gothenburg, Sweden) to measure deposition kinetics of 
vesicles on a bare silica surface, using the software Q-Soft for data collection. The application of 
the QCM-D technique for determining deposition kinetics is described by Rodahl et al. (186). 
Briefly, the QCM-D technique monitors the change in frequency (∆f) of vibration due to deposition 
of wet mass on the quartz crystal sensor in a liquid environment. As wet mass deposits onto the 
quartz sensor, the frequency of vibration decreases. The change in energy dissipation (∆D) of the 
quartz crystal is monitored simultaneously. ∆D gives information about the softness of the 
adsorbed film – an increase in ∆D corresponds to an increase in the softness of the adsorbed film. 
Combined frequency and energy dissipation measurements give information about both the 
adsorbed amount (∆f) and the viscoelastic properties (∆D) of the adsorbed film. All data shown 
was measured at the third harmonic, n= 3, i.e., at 15 MHz. For clarity, the frequency response is 
divided by 3 in all graphs (this makes the data directly comparable to data measured at n = 1, for 
ideal conditions). 
 
The fractional bilayer coverage (Equation 4.1) was calculated as previously described by Graneli 
et al(187) based on two assumptions: (i) The water-exposed domains on a planar supported lipid 
bilayer do not contribute significantly to D. (ii) There exists a linear relationship between the 
dissipation change at saturation and liposome size, as previously demonstrated for pure PC 
liposomes in the size range of 25 and 200 nm. The fractional bilayer coverage, α, and fractional 






α = −∆ ∆
∆ = Θ  
Equation 4.1. Fractional bilayer coverage 
 
where ∆Dsat is the dissipation value expected when α=0, i.e., for the whole surface covered by 
intact liposomes, ∆Dfin is the actual measured change in D at saturation, Θ is the liposome diameter 
(Table 1) in nanometers, and x=0.15 is the proportionality constant between ∆Dsat for complete 






The thickness of the adsorbed film was obtained by fitting f and D at the third and fifth overtones 
using a built-in Voigt model in the software Q-tools. In this model the adsorbed film is represented 
by a homogeneous thickness, viscosity, and complex shear modulus. Before each experiment, the 
silica sensors were soaked in 2% Hellmanex II (Hellma GmbH & Co. KG, Müllheim, Germany) 
cleaning solution for 30 min, rinsed thoroughly with DI water, dried with ultra high-purity N2, and 
treated in an ozone/UV chamber (BioForce Nanosciences Inc., Ames, IA) for 30 min. To ensure 
that the silica surface was maintained, each sensor was used only seven times. All test solutions 
were fed into the chamber using a syringe, and adsorption was measured in stagnant conditions. 
For each experiment, the silica sensor frequency and dissipation in air and in double distilled water 
were measured as a quality control of the sensor. A baseline was obtained in PBS buffer pH 
adjusted to 7.2, with the frequency signals stabilized at an approximately 0.2 Hz change in 
frequency over 10 min. One ml of vesicles were injected and allowed to adsorb onto the silica-
coated sensor until the frequency signal stabilized at an approximately 0.2 Hz change in frequency 
over 10 min. To ensure saturation of the surface with vesicles, more vesicles were injected until 
no further increase in frequency was observed. PBS buffer was then added to remove any 
unadsorbed vesicles. Finally, 1 ml of 5 mM CaCl2 was then introduced to encourage formation of 
planar membranes. The frequency signal was monitored for 10 minutes then equilibrated with PBS 
buffer again. Adsorption experiments were repeated 2-3 times for a single preparation at most 
vesicle compositions. QCM-D experiments at ratios of 100% POPC, 11% PMOXA-PDMS-
PMOXA:89%POPC, 33% PMOXA-PDMS-PMOXA:67%POPC and 100% PMOXA-PDMS-
PMOXA were performed with 2 replicate vesicle preparations. Data shown are from a single 
vesicle preparation; similar trends were observed in both preparations. 
Atomic force microscopy  
Visualization of the deposited mixed vesicles on the hydrophilic surface of mica (Structure Probe, 
Inc., West Chester, PA) was determined with an MFP-3D atomic force microscope (Asylum 
Research, Santa Barbara, CA, USA) in tapping mode in air with a Si cantilever with aluminum 
reflex coating (Tap300Al, Budget Sensors, Sofia, Bulgaria) at room temperature. The length of the 





µl of vesicle solution was incubated on a freshly cleaved mica surface for 2 minutes, rinsed with 
1 ml DI water, blotted with a Kimwipe® at the edge of the mica, and allowed to dry for 10 minutes. 
The thickness of the formed layer was obtained by plotting a histogram with the number of pixels 
per height for each image, to give two peaks corresponding to the mica surface and the vesicles. 
The vesicle peak was fit with a Gaussian function to obtain the mean±sd height of the adsorbed 
vesicles. 
Vesicle permeability  
Vesicle permeability to water was determined using an SX.18MV-R stopped-flow spectrometer 
(Applied Photophysics, Surrey, UK) with light scattering (16, 43). The vesicles were subjected to 
a hyperosmotic shock by mixing them with an equal volume of 1 M NaCl PBS pH 7.2 at 10 °C. 
Hybrid vesicles were monitored for 2 s, while pure PMOXA-PDMS-PMOXA vesicles were 
monitored for up to 50 s. The change in vesicle size with water efflux was monitored by light 
scattering at 600 nm. Six or more light scattering curves for a single vesicle batch at each vesicle 
composition were averaged and fitted using an exponential rise equation in Origin (v.8.1) to obtain 
the exponential rise rate constant, k. Water permeability was calculated using Equation 4.2: 
 
( ) / /f o w osmP k S V V= × ×∆    
Equation 4.2. Water permeability 
 
where S/Vo is the initial vesicle surface area to volume ratio, Vw the molar volume of water (18 
cm3/mol), and ∆osm is the difference in osmolarity (1 osmol/L for DOTAP, POPC, and 11 molar 
ratio PMOXA-PDMS-PMOXA:89 molar ratio DOTAP and 0.5 osmol/L for 11 molar ratio 
PMOXA-PDMS-PMOXA:89 molar ratio POPC) driving the shrinkage of the vesicles. The 
hydrodynamic radius of the vesicles was derived from dynamic light scattering data. Stopped-flow 
experiments at ratios of 100% POPC, 11 molar ratio PMOXA-PDMS-PMOXA:89 molar ratio 
POPC, 33 molar ratio PMOXA-PDMS-PMOXA:67 molar ratio POPC, and PMOXA-PDMS-
PMOXA were performed with 2 replicate vesicle preparations. Data shown are from a single 







Throughout this work we compared the properties of unilamellar vesicles of different 
compositions: 100% zwitterionic lipid (POPC), 100% positively charged lipid (DOTAP), 100% 
biomimetic triblock copolymer (PMOXA-PDMS-PMOXA), and mixtures of 11 molar ratio, 33 
molar ratio, and 67 molar ratio of the polymer with each lipid.  
 
Table 4.1. Hydrodynamic diameter and zeta potential 
Measurements were made of lipid vesicles, polymer vesicles and mixed lipid-polymer vesicles 
obtained by DLS and ELS. Abbreviations are as follows: 1-palmitoyl-2-oleoyl-sn-glycero-3-
phosphocholine (POPC), 1,2-dioleoyl-3-trimethylammonium-propane (DOTAP), hydrodynamic 














a Numbers shown are the average ± standard deviation from three 10-measurement series. 
Abbreviations are as follows:  
 
Characterization of lipid, polymer, and polymer-lipid vesicles by DLS and TEM  
DLS measurements showed that all of the vesicle preparations had monodispersed size 
distributions. The average hydrodynamic diameters for the vesicles used in this work varied 
between 105 - 217 nm (Table 4.1). The differences in diameters did not correspond to the different 
compositions, and no trends in size were observed with increasing polymer content. Duplicate 
batches of the same composition showed considerable variation in size while consistently having 
a narrow intrabatch size distribution, as illustrated by 33% polymer:67% POPC vesicles, which 
had hydrodynamic diameters of 126±2 nm and 217±3 nm for duplicate batches. Rather than being 
characteristic of the different compositions, the size differences generally relate to the extrusion 
Polymer:lipid ratio (molar ratio) 
Dh (nm)a PDI ζ(mV) a polymer POPC DOTAP 
- 100 - 159±2 0.13 0.2±0.3 
11 89 - 194±3 0.17 -5.7±0.8 
33 67 - 217±3 0.19 -2.0±0.3 
67 33 - 189±5 0.12 -2.6±0.4 
- - 100 160±3 0.085 35.6±0.4 
11 - 89 109±0 0.24 2.5±0.1 
33 - 67 105±1 0.21 -1.7±0.9 
67 - 33 175±1 0.15 0.8±0.1 





pressure that was required during preparation, as has been documented previously for lipids (188). 
Vesicle size influences the water content of vesicles and therefore the adsorbed mass measured in 
QCM. To eliminate contributions from vesicle size, batch-specific hydrodynamic diameters were 
used in the calculation of the bilayer coverage (Table 4.2). For polymer:DOTAP mixtures, the zeta 
potential was greatly reduced upon addition of even 11 molar ratio polymer (Table 4.1), indicating 
charge screening in the presence of polymer.  
 
In TEM, POPC vesicles formed large collapsed vesicular structures on the hydrophilic grid (Figure 
4.1a). DOTAP vesicles were difficult to find on the hydrophilic grid, which we attribute to rupture 
on the grid, but when present appeared as spherical or fused vesicles (Figure 4.1b). PMOXA-
PDMS-PMOXA vesicles appeared as intact spherical particles (Figure 4.1c). All polymer:POPC 
mixtures resulted in the formation of spheres similar to those obtained for polymer alone (Figure 
4.1d); no evidence for two distinct populations of vesicles was observed. Polymer:DOTAP 
mixtures also formed a single population of spherical vesicles (Figure 4.1e), with the exception of 
11 molar ratio PMOXA-PDMS-PMOXA:89 molar ratio DOTAP (Figure 4.1f), which resulted in 







Figure 4.1. TEM of lipid vesicles, polymer vesicles and mixed polymer:lipid vesicles 
(a) POPC, (b) DOTAP, (c) PMOXA-PDMS-PMOXA, (d) 11 molar ratio PMOXA-PDMS-PMOXA:89 molar ratio POPC, (e) 33 








Table 4.2. Adsorption of mixed lipid polymer vesicles on quartz monitored by QCMa 
 
Composition [Ca2+] -∆fminb -∆ffinc ∆Dmaxd ∆Dfine αf tmaxg tminh -∆Dfin/ ∆ffin 
(molar ratio) (mM) (Hz) (Hz) (x10-6) (x10-6) (%) (nm) (nm) 
100% POPC 0 56±9 36±8 5.9±1.2 1.8±1.2 93±6 12±2 9±1 0.05±0.02 
89% POPC 5 138±20 55±9 24.4±2.1 9.7±2.7 66±8 33±5 16±3 0.17±0.03 
67% POPC 5 188±3 174±16 25.4±4 20.3±2.0 38±6 49±12 47±13 0.12±0.00 
33% POPC 5 300±5 300±5 48.6±1.7 48.6±1.7 0 104±2 104±2 0.17±0.00 
100% DOTAP 5 30±4 30±4 3.6±1.1 3.6±1.1 86±4 7±2 7±2 0.15±0.02 
89% DOTAP 5 70±7 70±7 5.7±0.7 5.7±0.7 79±3 14±1 14±1 0.09±0.02 
67% DOTAP 5 115±19 115±19 16.4±3.5 16.4±3.5 17±15 66±15 66±15 0.15±0.04 
33% DOTAP 5 120±15 120±15 22.4±12 22.4±12 -6±40 101±28 101±28 0.23±0.06 
PMOXA-PDMS-PMOXA 5 42±1 42±1 13.7±3.2 11.8±5.9 --- 81±21 81±21 0.33±0.08 
a All values shown are the average ± standard deviation from 2-3 measurements of one (most) or two (pure POPC and pure PMOXA-PDMS-PMOXA) vesicle 
preparations per composition. 
b ∆fmin, change in frequency from initial buffer baseline to the minimum observed frequency 
c ∆ffin, change in frequency from initial buffer baseline to the final buffer baseline 
d ∆Dmax, change in dissipation from initial buffer baseline to the maximum observed dissipation 
e ∆Dfin, change in dissipation from initial buffer baseline to the final buffer baseline 
f α, fractional bilayer coverage 
g tmax, maximum observed thickness of the adsorbed layer 






Vesicle deposition and rupture on quartz  
The deposition kinetics and average thickness of lipid, polymer, and mixed polymer:lipid vesicles 
on a quartz support were studied with QCM-D, where a decrease in resonance frequency 
corresponds to an increase in adsorbed mass and an increase in dissipation indicates a softer 
adsorbed layer (Figure 4.2 and Table 4.2). The deformation ratio, -∆Dfin / ∆f fin, was used as a 
measure of vesicle flattening. A high ratio corresponds to a low degree of deformation (spherical 
vesicles) and a low ratio to a high degree of deformation (flattened vesicles or bilayers). 
 
Adsorption of pure POPC vesicles onto silica (Figure 4.2a) was a two-phase process. In the first 
phase the frequency decreased and the dissipation increased until reaching extremes of ∆f=-56 Hz 
and ∆D=5.9x10-6 (Table 4.2). This is attributed to vesicle adsorption onto the silica surface. In the 
second phase, which started spontaneously 11 minutes after vesicle addition, the frequency 
increased and the dissipation decreased until reaching equilibrium at ∆f=-36 Hz and ∆D=1.8x10-6. 
These changes are attributed to vesicle rupture and the resulting release of water. The existence of 
a second stage is indicative of POPC vesicle rupture requiring a critical coverage, as has been 
proposed previously (35, 170). Onset of the second stage began at a dissipation corresponding to 
a vesicular coverage of 28 areal %. With vesicle deformation or flattening occurring, as suggested 
by the deformation ratio, the actual surface area covered at the onset of rupture would be greater 
than 28%.  
 
Adsorption of pure DOTAP vesicles onto silica (Figure 4.2b) was a one-phase process. Upon 
adsorption, the frequency decreased to an equilibrium of ∆f=-30 Hz and the dissipation increased 
up to ∆D=3.6x10-6 (Table 4.2). This is interpreted as immediate DOTAP vesicle rupture upon 







Figure 4.2. QCM-D responses for the deposition of different polymer:lipid mixtures on SiO2 
Solid lines show temporal changes in frequency (left column) and dissipation (right column) at 15 
MHz, with symbols added to designate different vesicle compositions. Arrows show addition of 
PBS (solid), 1ml of vesicles (dashed), or 5mM CaCl2 (dotted). (a) POPC vesicles (100 molar ratio 
POPC (∆), 11 molar ratio PMOXA-PDMS-PMOXA:89 molar ratio POPC (□), 33 molar ratio 
PMOXA-PDMS-PMOXA:67 molar ratio POPC (◊), 67 molar ratio PMOXA-PDMS-PMOXA:33 
molar ratio POPC (ο)), (b) DOTAP vesicles (100 molar ratio DOTAP (∆), 11 molar ratio PMOXA-
PDMS-PMOXA:89 molar ratio DOTAP (□), 33 molar ratio PMOXA-PDMS-PMOXA:67 molar 







PMOXA-PDMS-PMOXA vesicles adsorbed on quartz in a one-phase process (Figure 4.2c), with 
an equilibrium of ∆f=-42 Hz and ∆D=11.8x10-6. Although the equilibrium ∆f for PMOXA-PDMS-
PMOXA was similar to that for pure lipid vesicles, indicating that a similar adsorbed mass is 
obtained, the ∆D for PMOXA-PDMS-PMOXA vesicles is 3-7 times larger, indicating that it 
formed a softer layer. This softness is consistent with a layer containing substantial water, typical 
of vesicles. PMOXA-PDMS-PMOXA vesicles adsorbed with a mean thickness of 81 nm. 
Compared to the hydrodynamic diameter of 198 nm from DLS data (Table 4.1), this indicates that 
PMOXA-PDMS-PMOXA vesicles are flattened on the surface. The deformation ratio of pure 
polymer vesicles is the highest out of all the vesicle compositions, indicating that they are less 
deformed than vesicles with lipid content. Both the deformation ratios and the thicknesses indicate 
that all vesicle compositions are at least partially flattened on the silica surface. Upon addition of 
calcium to polymer vesicles, the frequency and dissipation remained unchanged (Figure 4.2 and 
Table 4.2). 
 
Polymer:POPC mixed vesicles (Figure 4.2a) adsorbed on quartz in a one-phase process, rather 
than the two-phase process observed for pure POPC, with equilibrium adsorption values of -300 
Hz<∆f<-138 Hz and 24x10-6<∆D<49x10-6. The ∆f was tenfold higher for mixed polymer:POPC 
vesicles than for pure POPC or pure PMOXA-PDMS-PMOXA vesicles, which corresponds to a 
tenfold higher mass coverage. The high ∆D values, 13-27 times higher than ∆Dfin for lipid bilayers 
made from pure POPC vesicles, are indicative of an adsorbed vesicular layer. For mixed 
polymer:POPC vesicles with 11% and 33% polymer, addition of the known fusogen calcium 
promoted rupture, based on the changes in frequency (from -138 Hz to -55 Hz and from -188 Hz 
to -174 Hz respectively), dissipation (from 24.4x10-6 to 9.7x10-6 and from 25.4x10-6 to 20.3x10-6 
respectively), and mean thickness (from 33 nm to 16 nm and from 49 nm to 47 nm respectively) 
with and without calcium, while at 67% polymer calcium had no effect. 
 
For mixed polymer:DOTAP vesicles, the adsorption depended on the polymer:lipid ratio. 11 molar 
ratio PMOXA-PDMS-PMOXA:89 molar ratio DOTAP (Figure 4.2b) had equilibrium values 
similar to pure lipid vesicles, reaching a low ∆f of -70 Hz and ∆D of 5.7x10-6. In contrast, 33 molar 
ratio PMOXA-PDMS-PMOXA:67 molar ratio DOTAP (Figure 4.2b ◊) and 67 molar ratio 





polymer:POPC vesicles, with a high |∆f| and a high ∆D, reaching ∆f=-115 Hz and ∆f=-120 Hz 
respectively. Upon addition of calcium, the frequency and dissipation remained unchanged, 
indicating that calcium had no effect on mixed polymer:DOTAP vesicles (Figure 4.2 and Table 
4.2).  
Vesicle deposition and rupture on mica  
To visualize the deposition and rupture indicated by the bulk measurements of QCM-D, AFM 
imaging was performed on selected samples. To facilitate imaging we switched from quartz to 
molecularly flat mica. Although silica and mica are both hydrophilic, supported bilayer formation 
on the two surfaces has been reported to differ (100). AFM control images (PBS without any 
vesicles, Figure 4.3a) showed small structures of irregular height, so all images were compared to 
this control. 
 
POPC vesicles on mica formed patches (Figure 4.3b) with a mean thickness of 3.2±1.4 nm, 
consistent with the thickness of a lipid bilayer (189). When pure DOTAP vesicles were deposited 
for AFM, no areas of sufficient height to be a vesicle were observed; they appeared to form a 
continuous bilayer on the surface (Figure 4.3c). PMOXA-PDMS-PMOXA vesicles adsorbed as 
intact vesicles, just as on silica, although the average thickness was greater, 199.3±39.5 nm, on 
mica (Figure 4.3d). 
 
The 11 molar ratio PMOXA-PDMS-PMOXA:89 molar ratio POPC (Figure 4.3e) vesicles formed 
patches with a mean thickness of 5±1.4 nm, even in the absence of calcium. These are interpreted 
as patches of polymer monolayer and lipid bilayer. In contrast, 33 molar ratio PMOXA-PDMS-
PMOXA:67 molar ratio POPC: vesicles gave rise to vesicular structures (Figure 4.3f) with a mean 
thickness of 26.6±48.4 nm and a broad thickness distribution. Vesicles were still visible following 
addition of calcium (Figure 4.3g), but the mean thickness of the vesicular structures decreased to 






Figure 4.3. AFM images 
(a) PBS, (b) POPC, (c) DOTAP, (d) PMOXA-PDMS-PMOXA, (e) 11 molar ratio PMOXA-PDMS-PMOXA:89 molar ratio POPC, (f) 
33 molar ratio PMOXA-PDMS-PMOXA:67 molar ratio POPC, (g) 33 molar ratio PMOXA-PDMS-PMOXA:67 molar ratio POPC: with 
5 mM CaCl2, (h) 11 molar ratio PMOXA-PDMS-PMOXA:89 molar ratio DOTAP. Each block is 5 µm x 5 µm. A height profile is 






Eleven molar ratio PMOXA-PDMS-PMOXA:89 molar ratio DOTAP: mixtures (Figure 4.3h) did 
not show any areas of sufficient height to be a vesicle and appeared to make a continuous bilayer 
on the surface. 
Vesicle water permeability 
One advantage of the PMOXA-PDMS-PMOXA polymers is their low permeability for water (0.8 
µm/s (16)), as compared to lipids (43, 190), so it was of interest to assess the water permeability 
of hybrid polymer-lipid vesicles. Based on stopped-flow measurements under hyperosmotic shock 
(Figure 4.4), the zwitterionic POPC vesicles had a Pf of 22.6 µm/s at 10 °C, similar to previous 
measurements using a fluorescence quenching method (Pf=18.8±4.7 µm/s, converted from 25°C 
measurements (190) to the 10°C equivalent using an activation energy of 15 kcal/mol). Differences 
in permeability values could be due to differences in stopped flow instruments. The osmotic water 
permeability of DOTAP vesicles was 13.2 µm/s at 10 °C, somewhat lower than POPC vesicles. 
Both lipids gave permeability values roughly similar to those reported for Escherichia coli total 
lipid extracts (20.9 µm/s, based on measurements at 6.5°C (43) converted as above). All hybrid 
vesicle compositions were less permeable to water than pure lipid vesicles. In fact, a molar content 
of PMOXA-PDMS-PMOXA exceeding 33% resulted in vesicles that were so impermeable that 







Figure 4.4. Water permeability of hybrid polymer:lipid vesicles from osmotic shock stopped-flow light-scattering experiments  
Average and standard deviation calculated from at least 6 injections. Other vesicle compositions, including pure polymer, did not show 
sufficient water efflux to allow permeability calculations. The reported permeability, Pf, for PMOXA-PDMS-PMOXA is 0.8 µm/s (16).  
 
 
Figure 4.5. Stopped-flow light scattering results 
(a) POPC-containing, (b) DOTAP-containing and (c) PMOXA-PDMS-PMOXA vesicles determined by stopped-flow light-scattering 
experiments. Average and standard deviation calculated from at least 6 injections. Vesicles with at least 89 molar ratio lipid were fitted 
to an exponential function. Hybrid vesicles containing less than 89 molar ratio lipid showed no slope. PMOXA-PDMS-PMOXA data 






For all ratios tested, PMOXA-PDMS-PMOXA polymer formed hybrid vesicles with POPC and 
DOTAP lipids, rather than forming two populations of single material vesicles. Evidence for such 
hybrid vesicles is provided by the screening of the positively charged DOTAP, which is evident 
in the zeta potential measurements (Table 4.1), the consistent morphologies observed with TEM 
(Figure 4.1), and the low variation in stopped-flow light scattering measurements (Figure 4.4 and 
Figure 4.5). Additional evidence for hybrid vesicles is provided by the progressive change in 
adsorption properties (Figure 4.2 and Figure 4.3) and permeability (Figure 4.4 and Figure 4.5) as 
the lipid content in the vesicles is decreased. These results are consistent with a previous study 
(182), which demonstrated the formation of mixed PMOXA-PDMS-PMOXA/egg-PC/egg-PE 
vesicles and provided evidence that the mixing was homogeneous on a molecular scale. 
 
Vesicle adsorption on quartz followed one of three scenarios (Figure 4.6), based on the mean 
thickness of the adsorbed layer and the fractional bilayer coverage (Table 4.2). In scenario I, the 
vesicles ruptured spontaneously to form a planar membrane. This scenario included pure POPC, 
pure DOTAP, and vesicles consisting primarily of DOTAP (11% and 33% polymer). Formation 
of bilayers by pure lipids is consistent with previous studies (35, 191). Consistent with the 
fractional bilayer coverage, which suggests that some vesicles remained intact, the POPC 
deformation ratios (35), the mean thickness (189) for POPC vesicles, and the DOTAP deformation 
ratios (35) were all slightly higher than previous reports for the corresponding bilayers (Table 4.2). 
In scenario II, the vesicles adsorbed as vesicles but could be induced to rupture by the addition of 
calcium. Mixed polymer:POPC vesicles consisting of predominantly POPC (11% and 33% 
polymer) followed this scenario. In scenario III vesicles adsorbed until the quartz surface was 
saturated, but did not rupture even upon addition of the fusogen calcium. Vesicle compositions 
that followed this scenario contained predominately PMOXA-PDMS-PMOXA (100% and 67% 
PMOXA-PDMS-PMOXA with POPC or DOTAP). The increased ease of rupturing DOTAP-
containing vesicles, as compared to POPC, is consistent with the expected stronger electrostatic 
interactions between positively charged DOTAP and the negatively charged quartz surface, as 







Figure 4.6. The type of supported membrane formed can be controlled by varying the ratio of 
polymer to lipid and the types of lipids 
(I) Planar membrane, (II) tethered vesicles that can be triggered to form a planar membrane by 
addition of calcium, and (III) tethered vesicles. The data presented here indicate that the surface 
becomes saturated, but do not distinguish whether or not a continuous layer of vesicles is formed. 
 
The results on mica were generally similar to those on quartz. 100% DOTAP and 11 molar ratio 
PMOXA-PDMS-PMOXA:89 molar ratio DOTAP vesicles did not produce intact vesicles on mica, 
consistent with rupture, but inconsistent results were obtained with other ratios of 
polymer:DOTAP. For POPC-containing vesicles the overall trend was similar on quartz and mica, 
but the division between scenarios I and II shifted somewhat. On mica the 11 molar ratio 
polymer:89% POPC vesicles followed scenario I, deposition and rupture, rather than requiring 
calcium to promote rupture as on quartz. For 33 molar ratio polymer:67% POPC, adsorbed vesicles 
were detected with and without calcium, but the mean thickness decreased with calcium, 
suggesting that some rupture was occurring. These vesicles also had a significantly lower thickness 
on mica than on silica (both with and without calcium). Together these results show a trend for 
lower resistance to rupture, or stronger lipid-surface interactions, of polymer:POPC vesicles on 
mica than on silica. This is consistent with the results of Richter et al., where charged lipid vesicles 
experienced stronger interactions with mica than with silica, and suggests that mica is more 






For both POPC and DOTAP, the addition of a relatively low molar percentage polymer provided 
higher rupture stability and decreased water permeability. On quartz the transition from rupture to 
stability occurred between 11 and 33% PMOXA-PDMS-PMOXA for polymer:DOTAP vesicles 
and between 0 and 11% PMOXA-PDMS-PMOXA for polymer:POPC vesicles. Similarly, for 
mixed vesicles with 33% and higher polymer content, the water permeability values were low, 
similar to those of the polymer vesicles. This relatively large effect from a low molar percentage 
of polymer may be explained by its larger size. Assuming that individual PMOXA-PDMS-
PMOXA molecules span the membrane, that one PMOXA-PDMS-PMOXA polymer molecule 
has a surface area of 4 nm2 (from surface pressure isotherm measurements (177)), and that one 
lipid has a head group area of 0.68 nm2,(192) then 11 molar ratio PMOXA-PDMS-PMOXA 
corresponds to 59% of the vesicle surface area and 33 molar ratio PMOXA-PDMS-PMOXA 
corresponds to 85% of the surface area.  
 
Several properties of the PMOXA-PDMS-PMOXA polymer may be contributing to the observed 
increases in resistance to rupture and decreases in water permeability in hybrid vesicles. First, the 
increased thickness of the hydrophobic block of the polymer is likely to be affecting both 
properties. In the PMOXA-PDMS-PMOXA polymer used here, the hydrophobic PDMS block has 
a thickness of 10 nm (182), whereas a typical lipid membrane has a hydrophobic region around 3 
nm thick (189). The longer polymer length may also allow the PMOXA to physically shield the 
lipids, resulting in steric repulsion between vesicles and reducing fusion. Second, in mixed 
DOTAP/PMOXA-PDMS-PMOXA vesicles, the polymer screens the positive charge of the 
DOTAP, based on zeta potential measurements. This is expected to decrease the electrostatic 
attraction of DOTAP to the quartz and mica surfaces, reducing vesicle-surface interactions and 
thereby increasing vesicle stability. Third, with PMOXA-PDMS-PMOXA a single molecule may 
span the entire membrane. As compared to the bilayer structure formed by lipids, this should make 
the membrane more rigid and provide stability from mechanical stress. This is analogous to some 
archaeal membranes, which have increased structural stability (193) due to membrane spanning, 
bipolar bolalipids (193, 194). Fourth, the block copolymers can be stretched by up to 21% of their 
original area (163), whereas lipid membranes cannot be stretched beyond 5% without rupture 






Mixing PMOXA-PDMS-PMOXA polymer and lipids produced hybrid vesicles containing both 
lipids and polymers. Either adsorbed vesicles or supported planar membranes were formed on 
negatively charged quartz and mica surfaces, depending on the polymer:lipid ratio of the 
depositing vesicles. Hybrid vesicles exhibited characteristic attributes of both lipid and polymer 
vesicles: adsorption and surface-induced or calcium-induced rupture similar to lipids and polymer 
characteristics of surface-induced rupture stability and low water permeability. Hybrid vesicles 
and planar membranes formed through vesicle deposition should be compatible with incorporation 
of functional transmembrane proteins, and the properties demonstrated here for hybrid vesicles are 
attractive for a variety of applications, including drug delivery and formation of solid-supported 
polymer-lipid membranes for biosensors or water purification membranes. 
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CHAPTER 5: PH EFFECT ON PERMEABILITY 
AND SURVIVAL OF ESCHERICHIA COLI3 
 
5.1 Abstract 
Aquaporins exist across all domains of life and are essential for satisfying water transport needs in 
mammalian and plant cells. The physiological relevance of bacterial aquaporins (AqpZ), however, 
is unknown. Previous work demonstrated that AqpZ-polymer vesicles exhibited reduced 
permeability under acid shock conditions, and presented preliminary evidence that this 
phenomenon might also occur in whole cells of E. coli. The current work therefore examines 
Escherichia coli permeability under acid shock, and survival under acid, hypoosmotic, and 
combined acid and osmotic shock. I found that at neutral pH, the presence of AqpZ increased E. 
coli permeability compared to aqpZ null mutants due to AqpZ facilitating rapid water egress under 
an osmotic gradient. Additionally, aqpZ reduced E. coli. survival under acid and combined acid 
and osmotic shocks. This work provides insight into the physiological role of AqpZ. 
5.2 Introduction 
Existing across all domains of life, aquaporins facilitate rapid and selective water transport across 
membranes (106, 196). They are essential for the water transport needs of mammalian and plant 
cells. Yet, in microorganisms, their physiological relevance is unknown. The large surface area to 
volume ratio of microorganisms can supply the necessary water transport via diffusion (106). 
Additionally, aquaporins are not present in all types of microorganisms (106, 107); for example, 
they are less represented across Gram-positive than gram-negative bacteria (107). Even in bacteria 
where aquaporins are present, they do not seem to be essential. When the aquaporin gene was 
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knocked out, it was not lethal to Escherichia coli (109) or Brucella abortus (110). Therefore, in 
bacteria, aquaporins are not essential.  
 
In attempting to uncover the role of bacterial aquaporins (AqpZ), studies have eliminated aqpZ 
genes and found, at most, subtle changes in cellular growth or function (106, 108, 109). In one 
study, aqpZ null mutant colonies were smaller than aqpZ wild type colonies. When aqpZ wild type 
and null mutants were co-cultured in hypoosmolar conditions, the aqpZ null mutant colonies were 
also smaller in size and less viable. Additionally, gene expression levels of aqpZ were higher in 
hypoosmotic environments and lower in hyperosmotic environments (109). In another study, no 
changes in growth were observed at hypoosmotic or hyperosmotic conditions, or when changed 
from one condition to the other (108). While these data are contradictory, cryoelectron microscopy 
experiments demonstrated that osmotically shocked E. coli exhibited AqpZ-mediated water 
transport (197). Unlike the aqpZ wild type strain, cytoplasm shrinkage and rehydration did not 
occur for aqpZ null mutants when subjected to hyperosmotic followed by hypoosmotic shock 
(197). However, aqpZ null mutants containing a plasmid with aqpZ allowed for cytoplasm changes 
under these conditions, implicating aqpZ in osmolarity regulation. In eukaryotic microorganisms 
and in plants, aquaporins have generally been implicated in providing freeze tolerance and survival 
under hypoosmotic conditions (106, 109, 110).  
 
Some clues to AqpZ’s physiological role in Bacteria may arise from its characteristics. In previous 
work in our lab, AqpZ was found to reversibly close under acidic conditions. The permeability of 
AqpZ reconstituted in biomimetic triblock copolymer vesicles decreased when pH was reduced 
from 7.2 to 4.0. At acidic pH, vesicles only exhibited 19% of the permeability at 7.2. When the pH 
was restored to neutral, permeability returned to 123% of the permeability before the acid shock 
manipulation (41). In initial experiments with whole cells, the effect of acid shock was less 
pronounced than in the synthetic environment. In whole cells, permeability at pH 4.0 was 84% of 
permeability at neutral pH. The permeability of an aqpZ null strain (JW0859) was even less 
affected by acidic conditions, exhibiting 95% of its permeability at neutral pH. In addition, even 
at neutral pH, absolute permeability values vary from group to group, ranging from 2020 μm/s 
(198) to 691 μm/s (199) for aqpZ wild type in the same strain background (NCM3105). Thus, 





our lab (190 μm/s (41) in a different strain background). Surprisingly, not only did the absolute 
permeability values differ, the percent difference between the permeability values of the parent 
and aqpZ null strain differed, especially in our lab. Previous reports noted an aqpZ null mutant 
exhibited only 3% (198) and 1.3% (199) of the permeability of the wild type. Previous work in our 
lab found the aqpZ null strain exhibited 84% of the permeability of the wild type (41) in a different 
strain background. These very different findings show that in our lab, aqpZ had much less effect 
(by an order of magnitude) on permeability than previous reports (198, 199). However, these 
studies were carried out in different strains. 
 
Based on the potential closure at low pH, previous work also investigated the effects of eliminating 
or overexpressing aqpZ on acid shock. Of all strains tested, the most permeable strain, JM109 
pTrc10HisAqpZ, was the most susceptible to acid shock (41). However, based on the observed 
differences in permeability, a key control was missing in those survival experiments. While 
survival of parent ME9062 was reported, the survival of the relevant control strain for the 
overexpression strain (JM109 pTrc10His1) was not tested. These findings and limitations demand 
further investigation into the effect of aqpZ on cell permeability and survival.  
 
In this work, my objectives were to quantify the effects of aqpZ on E. coli permeability and 
survival under acid shock. Based on the reversible gating behavior reported previously (41), I 
expect aqpZ to cause reduced permeability under acid shock compared to neutral pH. Additionally, 
I expect reduced survival for these strains. By investigating the impact of aqpZ on permeability 
and survival in E. coli, this work provides insight into the physiological role of AqpZ. While the 
benefit in E. coli is unknown, this work demonstrates that AqpZ must provide one. 
5.3 Materials and Methods  
Preparation of strains and cell growth 
The E. coli strains used in this study are described in Table 5.1. Plasmids were introduced by 
electroporation (Bio-Rad MicroPulser, Hercules, CA) according to the Bio-Rad MicroPulser E. 
coli standard procedure (200). Cells were grown and prepared according to Mallo and Ashby (198) 





Luria-Bertani (LB) (5 g/L NaCl, 10 g/L tryptone, 5 g/L yeast extract) media, and subcultured in 
LB with a total concentration of 0.2 M NaCl (11.7 g/L NaCl, 10 g/L tryptone, 5 g/L yeast extract) 
with antibiotics at 30 μg/ml kanamycin (Km), 25 μg/ml chloramphenicol (Cm), or 50 μg/ml Amp 
as appropriate. Starter cultures were inoculated with a single colony from a freshly grown streak 
plate and incubated at 37°C with agitation for 15 h. Strains with plasmids were grown with 50 







Table 5.1. Strains used in this study  
 





---  F-, Δ(araD-araB)567, ΔlacZ4787(::rrnB-3), λ-, rph-1, Δ(rhaD-rhaB)568, hsdR514 (201) 
JW0859 AqpZ null mutant Keio collection Km F-, Δ(araD-araB)567, ΔlacZ4787(::rrnB-3), λ-, rph-1, Δ(rhaD-rhaB)568, hsdR514, ∆aqpZ (201) 
NCM3105 
(MG1655) parent Kustu Lab --- ilvG, rfb-50, rph-1, fnr-267 eut (202) 
NCM3105 
pTrc10HisAqpZ 
Parent with AqpZ 
overexpression plasmid this work Amp ilvG, rfb-50, rph-1, fnr-267 eut, pTrc10HisAqpZ  
NCM3105 
pTrc10His1 
Parent with control 
plasmid this work Amp ilvG, rfb-50, rph-1, fnr-267 eut, pTrc10His1  
NCM3306 AqpZ null mutant Kustu Lab Cm ilvG, rfb-50, rph-1, fnr-267 eut, ∆aqpZ (202) 
NCM3306 
pTrc10HisAqpZ 
Parent with AqpZ 
overexpression plasmid this work Cm, Amp ilvG, rfb-50, rph-1, fnr-267 eut, ∆AqpZ, pTrc10HisAqpZ  
NCM3306 
pTrc10His1 
Parent with control 
plasmid this work Cm, Amp ilvG, rfb-50, rph-1, fnr-267 eut, ∆AqpZ, pTrc10His1  
JM109 AqpZ null mutant Purchased from Promega Amp 
endA1, recA1, gyrA96, thi, hsdR17 (rk–, mk+), relA1, supE44,  
Δ( lac-proAB), [F´ traD36, proAB, laqIqZΔM15]  
JM109 
pTrc10HisAqpZ 
Parent with AqpZ 
overexpression plasmid this work Amp 
endA1, recA1, gyrA96, thi, hsdR17 (rk–, mk+), relA1, supE44,  
Δ( lac-proAB), [F´ traD36, proAB, laqIqZΔM15], pTrc10HisAqpZ (41) 
JM109 
pTrc10His1 
Parent with control 
plasmid this work Amp 
endA1, recA1, gyrA96, thi, hsdR17 (rk–, mk+), relA1, supE44,  





Whole cell permeability measurements 
The standard procedure for permeability measurements is presented here. Modifications were also 
tested as described in Section 5.4. Starter cultures were diluted 1:100 into fresh LB media (0.086 
M NaCl) with antibiotics as needed. These subcultures were incubated with agitation for 8 to 13 
h, and until cells were in stationary phase as measured by optical density (O.D., λ=600) of 1.8-2.0. 
For the last 4 hours of the 8-13 hours of incubation, strains containing plasmids were induced with 
1 mM isopropyl β-D-1-thiogalactopyranoside (IPTG) for overexpression of AqpZ. On the 
pTrc10HisAqpZ plasmid, when transcription of the lac operon is activated by IPTG, protein 
overexpression occurs. All cells were harvested by centrifugation (5 min, 4°C at 10,000 × g) and 
pellets were rinsed three times with 10 ml of ice cold 100 mM phosphate buffered saline (PBS) at 
the specified pH (pH 7.4 or 4.0) and with 50 μg/ml tetracycline. Cell pellets were finally 
resuspended in ice cold PBS buffer with tetracycline to achieve 70±1% transmittance. Thirty to 60 
min elapsed between cell harvest and stopped-flow measurement.  
 
Cell permeability was determined using stopped-flow spectrometry (SX.18MV-R, Applied 
Photophysics, Surrey, UK) with light scattering according to Borgnia et al. (43). Prepared cells 
were mixed with an equal volume of 1 M L-Proline in PBS osmotic agent at 10o C. Change in 
cellular size (volume) due to water efflux was monitored by light scattering at 600 nm emission 
wavelength. The light scattering curves (at least 7) were averaged and fitted using an exponential 
rise equation in MATLAB (v.8.3.0.532) or Origin (v.8.1) software, and water permeability (Pf) 
was calculated using Equation 5.1 (198): 
 
( ) /f o w osmP k V S V= × × ×∆    
Equation 5.1. Water permeability 
 
where k is the exponential rise rate constant or change in cell volume (d[V/Vo]), Vo and S are the 
respective initial cellular volume and surface area, assuming similarity to the average K-12 E. coli 
strains grown in LB from exponential to the beginning of stationary phases (198, 203). Assuming 
a length of 5 μm and a diameter of 1 μm (198, 203) gives values of Vo= 3.93 μm3 and S = 16.49 





Mixing cells with an equal volume of 1 M proline, the resulting osmolar gradient imposed was 
5×104 mol/cm3. The number of independent biological replicates are noted in the presentation of 
the data. A two sample t-test was used to determine significance using Origin (v.8.1) software. The 
stopped flow instrument used is noted in presentation of the data. Whole cell permeability data is 
tabulated in APPENDIX C.  
E. coli survival measurements 
Survival was measured following Levina et al. (204) with slight modifications. Starter cultures 
were diluted 1:50 into LB media with a total concentration of 0.2 M NaCl and appropriate 
antibiotics as needed. The subcultures were incubated at 37°C with agitation for 8 h before 1:100 
dilution into an appropriate buffer for the desired shock condition: 0.2 M NaCl pH 7.4 LB for the 
control, 0.2 M NaCl pH 4.0 LB for the acidic condition, 0 M NaCl pH 7.4 LB for the osmotic 
condition, 0 M NaCl pH 4.0 LB for the combined acidic and osmotic condition. The cultures were 
incubated at 37°C with agitation in the test conditions for 30 min before they were diluted in LB 
(104-107 dilution) and plated. The number of independent biological replicates are noted in the 
presentation of the data. In the survival data presented in this chapter (2011), one plate was 
prepared for each biological replicate. In additional survival data (2014) presented in APPENDIX 
C, three plates were prepared for each dilution of each biological replicate. Colonies were counted 
manually after 12-16 h incubation at 37°C. Only plates with 25-250 colonies were included in this 
study (205), except when plates with 20-25 colonies allowed inclusion of an independent 
biological replicate. All survival data is tabulated in APPENDIX C.  
5.4 Results 
Factors influencing permeability measurements 
To investigate permeability differences observed in previous reports, I identified differences 
between my protocol and those of previous reports. I tested the impact of the following: presence 
of an antibiotic to suppress protein synthesis during processing of cells, time on ice from harvest 






In my experiments, tetracycline was added to suppress protein synthesis after harvest and during 
the washing and resuspension preparation steps, but antibiotic was not added in previous reports 
(198, 199). In previous experiments in our lab kanamycin was used for ME9062 and JM109 
derived strains, and chloramphenicol was used for JW0859 (41). However, tetracycline did not 
substantially impact the permeability of NCM3105 (Figure 5.1A). Based on these results, 
tetracycline was used in subsequent experiments.  
 
One previous report kept time on ice prior to stopped-flow measurement to 10 min (198). Because 
of the location of one of the stopped-flow instruments, I tested longer times. I did not observe a 
substantial effect with respect to time on ice prior to measurement ((Figure 5.1B). Time on ice was 
minimized and was between 30-60 min.  
 
The phase of growth was previously reported as important (198). In testing the effect of phase of 
growth on permeability, no clear trend emerged between growth phase and permeability ((Figure 








Figure 5.1. Factors that did not impact the permeability of NCM3105 
(A) Presence or absence of tetracycline during cell preparation: Chart shows the permeability of 
NCM3105 with and without tetracycline added to suppress protein synthesis during processing. 
Error bars denote propagated error from curve fitting of multiple (at least 2) preparations from the 
same biological replicate. (B) Processing Time: Permeability of NCM3105 after 10-60 min spent 
on ice between harvest and measurement. Error bars denote propagated error from curve fitting of 
two biological replicates for 10 and 30 min; no error bars shown for 60 min data because only one 
biological replicate was tested. (C) Phase of Growth: Growth of strains in neutral pH LB media 
with agitation at 37⁰C, as measured by O.D. at 600 nm and (D) Permeability of strains as a function 
of growth. Error bars denote error from curve fitting from one biological replicate. All data in this 
figure was obtained using stopped flow instrument 1. 
 
Permeability  
Literature reports conflicting phenotypes in aqpZ null mutants (197-199). I therefore tested the 
permeability of different E. coli strains at neutral pH. The aqpZ null mutants exhibited reduced 
permeability than the aqpZ wild type strains (Figure 5.2). NCM3306 exhibited 68% of the 














































































the differences in permeability were only statistically significant for NCM3105 and NCM3306. 
The aqpZ overexpression strain (JM109 pTrc10HisAqpZ) had the highest permeability. 
Surprisingly, the strain background of the overexpression system also seemed to affect 
permeability. The control strain without aqpZ on the plasmid (JM109 pTrc10His1) had 80-85% 
increased permeability over that of the other wild type aqpZ strains NCM3105 and ME9062.  
 
 
Figure 5.2. Permeability at pH 7.4 of E. coli strains  
The inset provides a more detailed view of the less permeable strains. *Indicates significantly 
different permeability (p < 0.05). Error bars represent propagated error from curve fitting of 
independent biological replicates (9 for NCM3105; 7 for NCM3306; 3 for ME9062 and JW0859; 
and 2 for JM109 pTrc10His1 and JM109 pTrc10HisAqpZ). All data in this figure was obtained 
using stopped flow instrument 1. 
 
Effect of pH on permeability  
Since AqpZ has been shown to reversibly close under acidic conditions in a synthetic membrane, 


































strain ME9062, which had been tested previously in our lab, behaved as expected, having reduced 
permeability at pH 4.0 compared to pH 7.4. However, in contrast to previous results (41), the 
corresponding aqpZ null mutant (JW0859) showed a similar phenotype. Furthermore, the 
permeability of strains in the NCM3105 background was typically greater at pH 4.0 than at pH 
7.4, regardless of the presence, absence, or overexpression of aqpZ. The sole exception was the 
overexpression strain, NCM3105 pTrc10HisAqpZ after expression was induced. Additionally, the 
presence of the overexpression plasmid pTrc10HisAqpZ and its control seemed to increase cell 
permeability at pH 4, with the exception of NCM3105 pTrc10His1 uninduced. This effect was 







Figure 5.3. pH effect on permeability  
(A) Permeability of strains derived from NCM3105 at pH 7.4 and 4.0. (B) Permeability of strains derived from ME9062. Error bars 
denote error from curve fitting of stopped-flow measurements for one biological replicate; exception: NCM3105 from stopped-flow 2 
includes 2 biological replicates. There is no data for NCM3306 pTrc10HisAqpZ under induced conditions. Dashed borders note that 















































Effect of stopped-flow instrument on permeability 
Over the course of this work I tested cell permeability on two different stopped-flow instruments. 
Although the difference was only statistically significant for NCM3105, at pH 7.4, permeability 
values for all strains tested were consistently higher using stopped-flow instrument 2 (Figure 5.4). 
Conversely, at pH 4.0, the permeability of NCM3105 was greater on stopped-flow instrument 1. 
ME9062 and JW0859 were not tested on stopped-flow instrument 1 at pH 4.0. These 
measurements were not made with the same biological preparations and were separated by time 
because the instruments were not available at the same time; they are presented here simply to 
illustrate a potential confounding factor. Additionally, cells measured on stopped-flow instrument 
2 were grown on Miller LB (0.017 M NaCl) as opposed to Lennox LB (0.086 M NaCl).  
 
 
Figure 5.4. Effect of stopped-flow instrument on permeability  
These measurements on two different stopped-flow instruments were not made with the same 
biological preparations and were separated by time. ME9062 and JW0859 were not tested on 
stopped-flow 1 at pH 4.0. Error bars denote propagated error of at least two independent biological 
replicates. *Indicates significantly different permeability (p < 0.05) in the same strain across the 
two instruments. No statistical analyses were performed for the other strains. The number of 
independent biological replicates is as follows for pH 7.4: NCM3105: 8 (SF1) and 2 (SF2), 
NCM3306: 6 (SF1) and 1 (SF2), ME9062 and JW0859: 3 (SF1) and 1 (SF2); for pH 4.0: 
NCM3105: 1 (SF1) and 2 (SF2), NCM3306: 1 (SF1) and 1 (SF2), ME9062 and JW0859: 0 (SF1) 






























Effect of varying AqpZ level on survival 
To investigate the effects of varying aqpZ expression levels on E. coli, I tested survival of different 
strain pairs under acid, hypoosmotic, and combined acid and hypoosmotic shock conditions 




Figure 5.5. Percent survival of parent and null strains after exposure to various shock types  
The acid shock was from pH 7.4 to 4.0 and the osmotic shock was from 300 to 100 mOsm 
(hypoosmotic); all conditions were for 30 min. Survival at the shock conditions were normalized 
to survival of respective strains at control conditions (0.2 M NaCl pH 7.4 LB), indicated by the 
dashed line at 100%. Error bars denote standard deviations between replicates. The number of 
independent biological replicates for each strain is as follows: NCM3105: 4 for acid and osmotic, 
3 for combined; NCM3306: 4 for acid and osmotic, 3 for combined; NCM3105 pTrc10His1: 2 for 
acid, 1 for combined, 2 for osmotic; NCM3105 pTrc10His1 induced: 3 for acid and combined, 2 
for osmotic; NCM3105 pTrc10HisAqpZ: 4 for acid and osmotic, 3 for combined; NCM3105 
pTrc10HisAqpZ induced: 2 for all conditions. 
 
 
Strains that contained aqpZ typically had reduced survival under acid and combined acid and 
osmotic shock. These include strains with the NCM3105 background. The overexpression system 
to produce more AqpZ required the addition of a chemical to induce expression and these strains 



























Surprisingly, induction increased survival under acid shock even when no aqpZ gene had been 
introduced into the overexpression locus. The sole exception was the induced strain with the 
control plasmid (NCM3105 pTrc10His1).  
5.5 Discussion 
The physiological relevance of AqpZ is unknown and clues to its purpose may be discoverable by 
testing the behavior of AqpZ under different conditions and in E. coli with and without aqpZ. In 
this work I found that at neutral pH, the presence of AqpZ increased permeability. Additionally, 
under acid shock conditions, AqpZ reduced survival. In this section I will also discuss data related 
to these conclusions and unexpected findings. 
 
I found reduced permeability for the aqpZ null mutant NCM3306 compared to parent NCM3105. 
This conclusion is based on my extensive experimentation with NCM3105 and the aqpZ null 
mutant NCM3306 at neutral pH (stopped-flow 1). Nine and seven independent biological 
replicates were tested for NCM3105 and NCM3306, respectively (Figure 5.2). The opposite trend 
was observed using stopped-flow 2 (Figure 5.3), but in that experiment only 2 biological replicates 
were tested for NCM3105 and only 1 for NCM3306. This trend of reduced permeability in the 
aqpZ null mutant is in agreement with previous reports (41, 198, 199). However, absolute 
permeability values varied across reports (41, 198, 199) (Table 5.2). I found lower permeability 
values for NCM3105 compared to previous reports (198, 199). Permeability values were bounded 
by previously reported values for NCM3306 (stopped-flow 1). The mutations present in the strains 
tested should not impact permeability. The reasons for these inconsistencies in permeability 
phenotypes is unclear, but not unexpected, given previous variability and the variability I found 
using different stopped-flow instruments.  
 
To investigate the effect of aqpZ on permeability despite differences in absolute permeability 
values, I compared the ratios of the aqpZ null and parent strains. I found that the ratios of 
permeability values between these strains also differed (Table 5.2). The aqpZ null mutant 
NCM3306 had 73% and 60% (stopped-flow 1 and 2, respectively) of NCM3105 permeability 
(Table 5.2). However, previous studies found ≤ 3% of NCM3105 permeability for NCM3306 (198, 





parent ME9062 (stopped-flow 1 and 2), whereas previous work in our lab found JW0859 to have 
83% of the permeability of ME9062 (41). The reason for these differences has not been 
determined, but could reflect differences in stopped flow instruments or secondary mutations. 
 
Table 5.2. Permeability values measured at neutral pH by investigator for parent NCM3105 and 
aqpZ null NCM3306, and parent ME9062 and aqpZ null JW0859  









The results of the pH effect on permeability (Figure 5.3) were inconclusive. Several factors 
contribute to the ambiguity: data was collected from only one biological replicate, I observed 
differences between stopped flow instruments, and the salt concentrations during growth also 
differed between experiments. Based on previous work in our lab which found evidence of AqpZ 
closure under acidic conditions (41), I expected reduced permeability for all strains with aqpZ at 
pH 4.0 compared to their permeability at neutral pH. However, I did not observe that trend. 
Reasons for the different permeability responses to low pH is unexpected and unclear. It is possible 
that AqpZ is not fully closing at acidic pH. Increases in permeability, and any differences in 
permeability of aqpZ null mutants under acidic conditions is especially surprising. Testing 
additional replicates may allow trends to emerge. In addition, testing the permeability of an AqpZ 
mutant without the ability to close at low pH may provide insight on the closure capability of 
AqpZ. It is also possible that between biological replicates, differences arising from secondary 
mutations to rescue stressed cells could affect permeability or acid survival differently. In fact, 
NCM3105 was derived from MG1655 from the E. coli Genetic Stock Center (CGSC). MG1655 
was found to exhibit more growth defects than expected based on its genotype (202). For example, 
MG1655 from CGSC grew slowly on galactose, and the supposed cross regulation of gene 
expression between the metabolism of galactose and lactose, and galactose and N-
acetylglucosamine, was the result of fast growing mutants (15% of cells) with high levels of lac 
Strain pair Pf Parent (μm/s) Pf Null (μm/s) % Pf (null:parent) Source 
NCM3105 & NCM3306 2020.2 ± 50.5 63.1 ± 5.1 3.1 (198) 
NCM3105 & NCM3306 691.4 ± 15.9 8.8 ± 0.2 1.3 (199) 
NCM3105 & NCM3306 61.0 ± 2.6 44.6 ± 0.6 73.2 stopped-flow 1 
NCM3105 & NCM3306 218.2 ± 18.6 130.0 ± 2.7 59.6 stopped-flow 2 
ME9062 & JW0859 190 ± 5 157 ± 3 82.6 (41) 
ME9062 & JW0859 42.3 ± 0.3 36.3 ± 0.3 85.7 stopped-flow 1 





expression. Stocks from other laboratories and stock centers were found to differ (202). These 
differences could result in variability between biological replicates and across strain backgrounds. 
Finally, redundancy in water transport mechanisms combined with these mutations might explain 
the lack of apparent necessity of AqpZ in bacteria.  
 
Surprisingly, permeability was not only increased by increased presence of AqpZ, but also the 
induced overexpression plasmid pTrc10His conditions at neutral pH. While this data was from a 
single biological replicate, it suggests that the plasmid itself may have an effect at pH 4.0. The 
general impact of pTrc10His on permeability is unclear because of the conflicting findings 
between parent NCM3105 and aqpZ null NCM3306. No effect is observed in NCM3105, whereas 
the presence of the control plasmid increased permeability in NCM3306. The reason for this 
increase in permeability with the presence of a control plasmid is unclear. Because of these results, 
it is difficult to distinguish between the effect of the strain background and that of the plasmid. 
Based on the plasmid construction, no unintended gene expression should occur under induced 
conditions. Previous work did not compare strains with the overexpression and control plasmids 
to the aqpZ wild type JM109 strain (41).  
 
In addition, aqpZ reduced cell survival under acid and simultaneous acid and osmotic shocks 
(Figure 5.6); the sole exception was NCM3105 pTrc10His1 under induced conditions. For both 
shock conditions, NCM3105 had reduced survival compared to aqpZ null NCM3306, and the 
induced AqpZ overexpression strain had reduced survival compared to its control. These findings 
are in agreement with previous work in our lab where more permeable strains had reduced survival 
under acid and combined acid and osmotic shocks (41). Specifically, the highly permeable 
overexpression strain JM109 pTrc10HisAqpZ (uninduced) had reduced survival compared to that 
of parent ME9062 and aqpZ null mutant JW0859 (41). However, in the previous work, survival 
of the control strain JM109 pTrc10His1 was not reported. Acidic conditions were critical in 
reducing survival since osmotic shock alone was not especially detrimental. Since the presence of 
AqpZ reduced survival under acidic conditions, this work demonstrates that AqpZ must provide 





Figure 5.6. Comparison of survival and permeability  
(A) % survival is survival under acid shock, and (B) % survival is under combined acid and osmotic shock. Note that the scales differ 
between the panels. Permeability data is identical between the panels. Survival data is presented for all strains. Dashed borders note use 




















































































• At neutral pH, aqpZ increased E. coli permeability compared to aqpZ null mutants. This 
behavior is due to AqpZ mediating water transport across the cell membrane in response 
to an osmotic gradient. 
 
• Overall, aqpZ reduced E. coli. survival under acid and combined acid and osmotic shocks. 
This finding establishes that AqpZ must provide an important benefit to E. coli. 
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CHAPTER 6: CONCLUSIONS AND FUTURE 
DIRECTIONS 
 
6.1 Conclusions  
To investigate the relationship between protein insertion and membrane permeability, I developed 
a method utilizing FCS to quantify membrane proteins in an average vesicle. I found that 
membrane permeability was related to protein insertion. Additionally, DDM concentrations 
greater than 0.3% (w/v) substantially inhibited protein insertion. Insertion and permeability 
behavior varied by protein preparation for AqpZ. I suggest that the aggregation state of AqpZ may 
be responsible for this variation. These contributions provide a basis for optimizing membrane 
permeability for a variety of environmental applications. 
 
To develop stable membranes with good insertion capability, I demonstrated that hybrid polymer-
lipid vesicles could be synthesized. I found that these hybrid material vesicles exhibited 
characteristics of both lipid and polymer vesicles including surface or calcium-induced vesicle 
collapse – a lipid attribute – and low permeability to water – a polymer attribute. To develop planar 
membranes, I synthesized hydrophilic solid-supported planar hybrid lipid-polymer membranes. 
Increasing the ratio of polymer to lipid increased the polymer-mimicking behavior of the vesicles. 
The properties demonstrated for these hybrid vesicles are attractive for a variety of applications, 
including drug delivery and environmental remediation in vesicular form, and water purification 
or biosensors in the solid-supported planar form. 
 
To characterize the effect of acidic conditions on AqpZ and investigate the physiological relevance 
of AqpZ, I demonstrated that in E. coli, presence of AqpZ increased cell permeability at neutral 
pH. This behavior is due to AqpZ allowing for rapid egress of water under an osmotic shock. 
Additionally, I found that the presence of AqpZ caused E. coli to be more susceptible, in terms of 




relevance of AqpZ is still unknown, this finding proves that AqpZ provides a benefit for E. coli. 
These findings contribute to understanding of the behavior of AqpZ under neutral and acidic pH 
conditions, which is important for development of AqpZ-based membranes. 
6.2 Future directions 
Hybrid protein-synthetic membranes have the potential to allow for development of new water 
sources by increasing membrane permeability without sacrificing selectivity. While several 
important questions were examined in this work, further work is needed before hybrid protein-
synthetic membranes can be developed commercially. For water purification, remediation and 
sensing applications, a membrane must be highly permeable, but it also must be highly stable. 
Commercial membranes are routinely subjected to environmental and membrane cleaning stresses. 
Hybrid protein-synthetic membranes must also be able to withstand these operating stresses. 
 
In this work I demonstrated that hybrid lipid-polymer membranes can form. Because they exhibit 
both lipid and polymer attributes, they are a promising platform for protein insertion in a more 
stable membrane environment. However, neither functional protein insertion nor membrane 
stability has been quantified for these systems. To optimize biomimetic membrane materials for 
both permeability and stability, it is crucial to know the relationship between protein insertion and 
membrane integrity. To achieve this goal, it is first necessary to quantify and optimize insertion 
efficiency in hybrid lipid-polymer membranes. Additionally, it is critical to quantify the effect of 
increasing protein insertion on membrane integrity over time and under membrane cleaning 
conditions. Investigation of these topics will elucidate factors controlling insertion and ultimately 
allow the engineer to optimize membrane permeability and stability. 
 
In this work I also demonstrated that AqpZ is harming E. coli under acid and combined acid and 
osmotic shock by reducing survival under these conditions. Since the aqpZ gene has not been lost 
despite this negative impact means that it must have some benefit for E. coli under some condition. 
However, I additionally obtained conflicting results for the effect of aqpZ on the permeability of 
E. coli under acidic conditions and propose that AqpZ is only partially closing in acidic conditions. 




elucidation of the mechanism of AqpZ closure under acidic conditions, allowing for better design 
and implementation of AqpZ-based membranes. 
Insertion efficiency of membrane proteins 
Highly-permeable, selective, and stable membranes are needed for environmental applications. In 
this work, I demonstrated that planar, hybrid lipid-polymer membranes can be formed that exhibit 
advantageous attributes of both lipid and polymer. Functional protein insertion efficiency has not 
been quantified in hybrid lipid-polymer membranes. Additionally in this work, I discovered that 
AqpZ multimer state appeared to affect insertion and thus permeability in lipid vesicles. 
Development of both selective and highly-permeable membranes demands high protein insertion, 
requiring investigation into the impact of AqpZ multimer state on insertion.  
i. Quantify AqpZ insertion in hybrid lipid-polymer membranes 
Protein insertion efficiency and the relationship between insertion and permeability in hybrid lipid-
polymer membranes should be assessed by measuring AqpZ insertion and the resulting membrane 
permeability. Because AqpZ insertion has been demonstrated in both lipid and polymer 
membranes, I hypothesize that AqpZ should functionally insert in hybrid membranes. I 
hypothesize that the permeability of hybrid vesicles will depend on AqpZ insertion as 
demonstrated in chapter 3. The permeability of these membranes could be measured using stopped 
flow light scattering (vesicles) as reported in this work, or using the forward or reverse osmosis 
setups (planar membranes) as previously reported (46, 63). Finally, to quantify insertion and the 
relationship between insertion and permeability, the resolubilization FCS method reported 
previously (47) could be modified for planar membranes.  
 
In this approach, the brightness of vesicles would be measured using FCS and then a sample would 
be resolubilized to measure the brightness of the resolubilized protein (47). After vesicle collapse 
to form the planar membranes, the planar membrane would also be resolubilized to measure the 
brightness of the resolubilized protein from the planar membrane. If the number of proteins 




vesicles, then the insertion was less in the planar membrane. If the number is similar, then insertion 
was similar.  
ii. Quantify the effect of AqpZ multimer state on insertion and permeability  
The multimer state of AqpZ should be assessed using native (non-denaturing) gel electrophoresis 
and compared to insertion and membrane permeability measurements. Although it is unclear why, 
in this work, I found that AqpZ that appeared to exist in higher multimer states inserted more 
efficiently at high protein to membrane material ratios, and thus produced more permeable 
membranes. As my data suggested, I hypothesize that aggregated AqpZ will more readily insert at 
high molar ratios. Native polyacrylamide gel electrophoresis can be used to analyze unlabeled 
AqpZ, or high resolution clear native electrophoresis can be used to analyze fluorescently-labeled 
AqpZ (206, 207). Native, or non-denaturing, gel electropohoresis is run in the absence of SDS and 
can allow for examination of protein multimer state. Careful observations regarding culture 
growth, AqpZ purification, yield, and storage should also be made to investigate factors that could 
affect AqpZ aggregation. Understanding these factors would allow for more precise control over 
AqpZ-membrane synthesis, allowing the engineer to optimize insertion and thus, membrane 
permeability. 
Characterize the membrane integrity of AqpZ-based vesicles 
To be useful, hybrid protein-synthetic membranes must be able to withstand environmental and 
membrane cleaning conditions. In this work, I investigated the behavior of AqpZ in E. coli under 
various stress conditions, but it is necessary to know the behavior of the assembled membrane 
system when exposed to these stress conditions. In addition, as membrane permeability is 
optimized, the tradeoff between membrane permeability and stability is necessary. I expect that 
membrane integrity will decrease with increasing protein insertion. With varying amounts of AqpZ 
inserted in hybrid lipid-polymer membranes, membrane integrity should be quantified in several 
ways: membrane selectivity, leakage, and elasticity. By modifying the protein insertion 
quantification methods developed in this and other work (47), AqpZ insertion can be measured 




i. Monitor the selectivity of vesicles over time 
The temporal stability of AqpZ-containing vesicles should be quantified by measuring changes in 
vesicle selectivity and ion rejection over time. Hybrid lipid-polymer vesicles with varying ratios 
of AqpZ can be subjected to osmotic solutes (NaCl, Na2SO4, MgCl2 and glucose). Glucose can be 
assumed to have a reflection coefficient of 1.0 and serve as the reference solute. Reflection 
coefficients for the other solutes can quantify selectivity and ion rejection properties of the various 
vesicle preparations. In addition, vesicles should be tested under conditions typical for cleaning 
reverse osmosis membranes such as acid (0.2 wt% HCl, pH 2) and base (0.1 wt% NaOH, pH 12) 
conditions and in the presence of 0.1 mg/L free chlorine (208). These experiments would allow 
quantification of membrane integrity by comparing changes in selectivity with insertion over time.  
ii. Monitor the leakage rate of AqpZ/lipid vesicles with varying AqpZ insertion 
Membrane integrity should be assessed by measuring the leak-in rate of fluorescent markers 
through AqpZ/lipid vesicles. Fluorescence leakage is routinely used to measure membrane 
integrity by measuring the dequenching, or the reduction in the fluorescence intensity, of 
encapsulated fluorescent markers using fluorimetry (209). I propose monitoring the leak-in rate 
(34) from exposure to the fluorescent marker calcein. Previous work has demonstrated calcein 
leak-out and leak-in through lipid vesicle membranes at measurable rates (34, 210-212). A 
proposed experimental plan would involve adding 60 mM calcein at a ratio of 2:1 by volume to 
AqpZ/lipid vesicles (34). At weekly intervals for up to 3 months, aliquots would be size excluded, 
and after immediate treatment with 1% Triton X-100, fluorescence would be measured using a 
fluorescence microplate reader (34, 210-212).  
iii. Measure the elasticity of vesicles and planar membranes with varying AqpZ insertion  
Mechanical properties of vesicle membranes, such as elasticity and bending rigidity, determine 
vesicle structure and interaction behaviors, including membrane fusion and adhesion (213-215). 
Previous results demonstrate that gramicidin-AC2-containing lipid vesicles were more rigid than 
pure lipid vesicles when probed using atomic force microscopy (AFM) (216). As such, I 




elasticity. AFM can directly evaluate these mechanical properties (213-215). In this approach, the 
sample surface is probed by a sharp tip at the end of a cantilever to measure deviations in heights 
and surface properties at the atomic scale (215, 217, 218). AFM liquid tapping mode (219) should 
be optimized for imaging vesicles. Specifically, Young’s Modulus should be compared across 
vesicles with varying AqpZ insertion to assess the elastic properties as a function of AqpZ 
insertion. To obtain these data, the initial slope of the approach force curve measured with AFM 
would be fit to the Hertz model (220) or the Shell model (213) using the force-distance plot method 
as described in Mao et al. (220). Force-distance measurements should also be obtained for planar 
membranes to evaluate the relationship between membrane elasticity and protein insertion in the 
planar membrane configuration as well.  
Investigate the behavior of AqpZ under acidic conditions 
In water treatment, AqpZ-based membranes would be exposed to environmental and membrane 
cleaning conditions, including acidic conditions. Understanding the potential closure mechanism 
of AqpZ would allow suitable applications and membrane cleaning procedures to be identified. In 
this work, I investigated the behavior of AqpZ in E. coli under acidic and osmotic shock where I 
found that aqpZ reduced E. coli survival. However, I found the effect of pH on permeability to be 
inconclusive. Previous research in our lab suggested that AqpZ closed at low pH conditions (41). 
However, based on my findings, I hypothesize that AqpZ remains partially open at low pH. While 
this work focused on investigating the impact of aqpZ in E. coli, the function of AqpZ in a synthetic 
environment is important from a water treatment perspective and should be investigated.  
Additionally, use of a synthetic environment would eliminate the possibility of other transport 
proteins interfering with permeability measurements under different conditions.  
 
To determine the ability of AqpZ to close at low pH, the permeability of vesicles containing an 
AqpZ mutant that remains open at low pH should be compared to the permeability of vesicles 
containing the wildtype AqpZ. Site-directed mutagenesis could be used to modify amino acids to 
identify the residues involved in the potential gating mechanism.  Residues sensitive to pH and 
important for proposed gating in mammalian and plant aquaporins include histidine, tyrosine, 




in the potential AqpZ gating mechanism under acidic pH conditions. Additionally, using the FCS 
method I developed, AqpZ insertion could be quantified and the permeability per AqpZ monomer 
calculated for the AqpZ mutant and wildtype under acidic conditions.  Elucidating the behavior of 
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APPENDIX A: ALEXA FLUOR 488 LABELING 
FOR AQPZ AND OMPF 
 
This appendix describes the protocol that was developed to label membrane proteins as described 
in chapter 3 for measurement using fluorescence correlation spectroscopy (FCS). This protocol 
was based on the Amine-Reactive Probes Protocol from Invitrogen (138). 
 
Prepare chemical solutions: 
1. 1 M sodium bicarbonate (Na HCO3) buffer stock, pH 8.3.  
2. 10 mg/ml Alexa Fluor 488 carboxylic acid, succinimidyl ester *mixed isomers* (Thermo-
Fisher Scientific, Pittsburgh, PA) 
a. For 1 g (Cat # A20000), add 100 µl DMSO. Cover vial in aluminum foil and freeze 
unused stock. 
b. For 5 g (Cat # A20100), add 500 µl DMSO. Cover vial in aluminum foil and freeze 
unused stock. 
3. Dialysis buffer for size exclusion chromatography (SEC):  
For AqpZ, 2L: 
Dodecyl maltoside (DDM) (0.05%)   1.000 g  
K2HPO4 (0.1 M)     34.836 g  
2-Mercaptoethanol (BME) (5 mM)   0.6944 ml  
NaCl (0.2 M)      23.4 g  
Glycerol (10%)      200 ml   
water        make up to 2 L 
Adjust to pH 7  
 For OmpF (20 mM phosphate buffer), 2L: 
 NaH2PO4*H2O      4.47 g 
Na2HPO4      1.08 g 
 n-Octyl-oligo-oxyethylene (Octyl-POE) (1%) 20 ml  





1. From 1 M stock, add NaHCO3, pH 8.3 for a final concentration of 0.1 M. Vortex. 
2. Add dye (from 10 mg/ml freezer stock), for a protein:dye molar ratio between 8.6x10-2. 
Protein must be at least 2 mg/ml. The appropriate nolecular weights of 28,000 g/mol for 
AqpZ and 38,000 g/mol for OmpF were used. 
3. Shake for 4 hours at room temperature. Wash the SEC column. 
4. Size exclude using a Superdex 200 pressurized Tricorn 50 ml column with an Äkta prime 
plus instrument (GE Healthcare, Chicago, IL) at a flowrate of 0.5 ml/min.  






Table A.1. Sample calculations for labeling AqpZ 
init AqpZ conc 2 mg/ml   
init AqpZ vol 2 ml   
Add 0.1 ml NaHCO3 to every 1 ml solution   
added NaHCO3 vol 0.2 ml   
new AqpZ conc 1.82 mg/ml   
new AqpZ vol 2.2 ml   
     
MW AqpZ 28000 mg/mmol   
moles AqpZ 1.43E-04 mmol AqpZ   
     
stock dye conc 10 mg/ml   
molar ratio protein:dye 8.58E-02    
 4.29E-02    
added mmol dye 1.67E-03 mmol dye   
 3.33E-03 mmol dye   
added dye vol 1.07E-01 ml dye 107.14 ul dye 
 2.14E-01 ml dye 214.29 ul dye 
rxn AqpZ conc 1.73 mg/ml   
 1.66 mg/ml   
rxn vol 2.307 ml   






APPENDIX B: FLUORESCENCE CORRELATION 
SPECTROSCOPY THEORY AND METHOD FOR 
QUANTIFYING MEMBRANE PROTEIN IN 
VESICLES 
 
This appendix describes the theory behind fluorescence correlation spectroscopy (FCS) and the 
method that was developed as described in chapter 3. This FCS method was developed to quantify 
AqpZ and OmpF membrane protein insertion in lipid and polymer vesicles. The number of 
fluorescent molecules and total counts can be obtained from an FCS measurement. Measurement 
using FCS allows for measurement of small fluctuations in fluorescence intensity within a small 
(~ 1 femtoliter) confocal volume over a short period of time (10 s). The fluctuations of the 
fluorescence signal are defined as the deviations of intensity measured at time t, I(t), from the 
temporal average of the fluorescence signal, ( )I t , shown in Equation B.1 (123, 124, 142).  
 
( ) ( ) ( )I t I t I tδ = −  
Equation B.1. Temporal average of fluorescent signal 
 
These intensity changes were fit to an autocorrelation function which provided a measure of the 
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Equation B.2. Normalized autocorrelation function 
 
The autocorrelation function allows for calculation of various items including the number of 




dependent fluorescence intensity fluctuation, and δI(t+τ) is the intensity fluctuation after a lag time 
of τ. Autocorrelation data for 10 ten-second measurements were averaged and fit by a single 
species 3D Gaussian diffusion model described by Equation B.3: 
 
( ) ( )
1/22
1 1 1( )
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Equation B.3. 3D Gaussian diffusion model 
 
where N is the average particle number in the focal volume which can be calculated by the 
amplitude of the of the autocorrelation curve knowing the radius and half-height dimensions wo 
and zo from calibration measurements. The number of molecules within a focal volume at any time 
is governed by the Poisson distribution. When τ = 0, G(0) = 1/N, which is the variance of the 
fluorescence intensity fluctuation and allows us to know N. Dτ is the 2D lateral diffusion time in 
the focal volume or the characteristic decay time of the correlation function. The diffusion time, 
Dτ , is related to the particle’s diffusion coefficient, D, as shown in Equation B.4. The diffusion 










Equation B.4. Diffusion time 
 
The average concentration of a single species multiplied by the effective volume is also the average 
particle number (Equation B.5): 
 
effN C V= ⋅    
Equation B.5. Average particle number 
 







eff o oV w zπ=    
Equation B.6. Effective volume 
 
Vesicle fluorescence intensity was measured using single-photon FCS with an Alba fluorescence 
correlation spectrometer (ISS, Champaign, IL) with a wavelength of 467 nm. The instrument was 
calibrated using nanomolar aqueous solutions of Alexa-fluor 488 with a pinhole of 50. Three 
aliquots of each sample were measured for 100 seconds at 30 or 50% power three times in 
fluorescence fluctuation spectroscopy (FFS) mode. Measurements at 50% power were corrected 
to 30% power during fitting by measuring labeled AqpZ at both powers. Measurements yielded 
smooth autocorrelation curves. No decrease in signal intensity was observed during these 
measurements, indicating that bleaching was not a problem.  
 
Data was analyzed using confocal spectroscopy and imaging application, VistaVision (version 4.0 
build 00144; ISS, Champaign, IL, USA). Data was separated into 10, 10-second measurements 
and the correlation curves were averaged into one correlation curve per measurement per aliquot. 
Correlation curves for all measurements were fit using a single species 3D Gaussian 
autocorrelation function and the range of each correlation curve fit was at least 0-0.2 seconds. For 
fitting free label data, the diffusion coefficient was fixed to the known value for Alexa-fluor 488 
in water at 20⁰C of 380 µm2s-1 (143), dye concentrations were fixed, and the excitation volume 
parameters, ωo and zo, were linked to determine the ωo and zo values for each measurement session. 
For fitting labeled-protein micelles data, the excitation volume parameters, ωo and zo, were fixed 
and initial values for diffusion coefficients and concentrations were set to 30 µm2s-1 and 1 nM, 
respectively. For fitting labeled-protein in vesicles data, ωo and zo, were also fixed and initial 
values for vesicle diffusion coefficients and concentrations were set to 5 µm2s-1 and 1 nM, 
respectively.  
 
Distinct diffusion coefficients were obtained for three diffusing species ranging from 380 μm2/s 
(143) for free fluorescent label, 34±8.8 μm2/s for AqpZ micelles, 19.8±6.0 μm2/s for OmpF 
micelles, and 2.5±1.9 μm2/s for vesicles. Each of these species were measured independently and 





The number of protein inserted in an average vesicle was subsequently determined by comparing 
the counts (or brightness) per molecule per second (CPMS) of the vesicle to that of the labeled 
protein (130). The CPMS for vesicles was calculated by Equation B.7. 
 
CPMS = CPS/[1/G(0)]   
Equation B.7. CPMS for vesicles 
 
where CPS is the counts per second and 1/G(0) is the number of fluorescent molecules. The CPMS 
for protein was calculated by Equation B.8: 
 
CPMS = CPS/[1/G(0)×DOL]  
Equation B.8. CPMS for protein 
 
where DOL is the degree of labeling. The degree of labeling ranged from 1.2-2.6 mol dye/mol 
AqpZ monomer and 0.3-0.7 mol dye/mol OmpF monomer. As first described by Rigler and Meier 
(130) for quantifying the number of encapsulated soluble proteins in polymer vesicles, the number 
of protein present in an average vesicle was determined by the ratio of the counts per molecule of 
the vesicle to the counts per molecule of the labeled AqpZ, as shown in Equation B.9. 
 
# protein per vesicle = CPMSvesicle/CPMSprotein  
Equation B.9. Number protein/vesicle 
 
Due to the high photo stability of Alexa Fluor 488 (144), differences in fluoresce intensity in 






APPENDIX C: DATA TABLES 
 
This appendix lists the data used to generate the plots in Chapter 3 to describe the effect of DDM 
detergent on insertion and permeability of AqpZ/lipid vesicles (Figure 3.4), the effect of the 
amount of protein added on insertion and permeability of OmpF/lipid vesicles (Figure 3.6), and 
AqpZ/lipid vesicles (Figure 3.8). This appendix also lists the data used to generate plots in Chapter 
5 to describe the pH effect on permeability of E. coli (Figures 5.2, 5.3, 5.4, 5.6) and percent survival 
of E. coli under acid shock (Figures 5.5, 5.6) as well as additional survival data not included in 
those figures. 
 
Tables comprised of insertion data (Table C.1, Table C.3, Table C.5) first list key sample 
differences including detergent concentration, protein batch, membrane material, and/or 
protein/membrane material molar ratio. Data is divided into replicate measurements of each vesicle 
preparation. For FCS measurements, multiple samples of each vesicle replicate were measured, 
three times each. These multiple samples were used to avoid any bleaching that could occur with 
extended measurement of a given sample (none was observed). The autocorrelation curves were 
fit for each of these samples, and the diffusion coefficient (D), number of particles (1/G0), counts 
per second (CPS) and the Chi squared values were obtained. Data presented in these tables are the 
fitted data. The diffusion coefficient was not used in the calculation for the number of 
protein/vesicle, but allowed confirmation of the size of the diffusing species; particle size is 
inversely related to diffusion coefficient. Comparing brightness of vesicles to the brightness of the 
freely diffusing protein allowed calculation of the number of protein/vesicle as described in 
Section 3.3 and APPENDIX B. For these calculations, protein was assumed to exist in its most 
common form (tetramer for AqpZ, trimer for OmpF). For AqpZ-containing vesicles, the calculated 
protein/vesicle values were averaged for each vesicle preparation replicate, and then averaged 
across replicates for each AqpZ batch. For OmpF-containing vesicles, the calculated 
protein/vesicle values were averaged for each vesicle preparation, then averaged for each OmpF 
batch, and finally, because trends were similar between OmpF batches, data was averaged across 




Tables comprised of vesicle permeability data (Table C.2, Table C.4, Table C.6) also first list key 
sample differences including detergent concentration, protein batch, membrane material, and/or 
protein/membrane material molar ratio. Data is divided into replicate measurements of each vesicle 
preparation. For stopped flow measurements, multiple samples of each vesicle replicate were 
measured by mixing the sample with a hyperosmotic solution (NaCl for AqpZ-containing vesicles, 
sucrose for OmpF-containing vesicles, and proline for whole E. coli cells). The osmolyte 
concentration listed in these tables is the concentration of the osmolyte prior to the measurement 
where mixing occurs. The imposed osmolar gradient, ∆osm, was calculated as described in Equation 
C.1: 
 
2osm nCϕ=∆   
Equation C.1. Osmolar gradient 
 
where the osmotic coefficient, φ, accounts for the degree of non-ideality in the solution. 
Concentrations were small enough that ideal conditions and complete dissolution were assumed. 
The number of particles into which a molecule dissociates, n, is 2 for NaCl and 1 for sucrose and 
proline. The concentration of the solute, C, was the stock concentration of the osmotic solution 
prior to mixing. This value is then divided in half as described in Equation C.1 because there was 
1:1 mixing between the sample and osmotic solution for each measurement. For each replicate, at 
least 5 curves were averaged into a single curve for fitting. The curves were fit using an exponential 
rise equation and the exponential rise rate constant (k) and the standard deviation of the fit (SD) 
was obtained. Data presented in these tables are the fitted data. The water permeability was 
calculated as described in Sections 3.3. For AqpZ-containing vesicles, the calculated permeability 
values were averaged for each vesicle preparation replicate, and then averaged across replicates 
for each AqpZ batch. For OmpF-containing vesicles, the calculated permeability values were 
averaged for each vesicle preparation, then averaged for each OmpF batch, and finally, because 
trends were similar between OmpF batches, data was averaged across OmpF batches. The 
variances of the permeability values were used to calculate the standard deviation across replicates 





For whole cells of E. coli, data in Table C.7 is organized by date, strain, which stopped flow 
instrument was used, and the pH of the sample. The data presented is as described above except 
for the following: proline was used as the osmolyte, at least 7 curves were averaged into a single 
curve for fitting for each replicate, water permeability was calculated as described in Section 5.3, 
and data was averaged for each replicate measurement of each independent biological preparation 
and subsequently averaged for each strain. Due to significant differences observed between 
stopped flow instruments, data were separated by the stopped flow instrument used.  
 
E. coli survival data (Table C.8) is organized by E. coli strain and date. Each date represents a 
different biological replicate. The raw plate count data and the calculated % survival is shown. 
Different dilutions were from the same shocked culture. The % survival is the percent ratio of the 
counts from the shocked condition to the counts from the control condition. For 2011 data, the one 
plate with acceptable counts (as described in Section 5.3) for each shock condition was averaged 
across biological replicates for each strain. Additionally, data from 2014 is also presented in Table 
C.8. In 2014, triplicate plates were prepared for each dilution. 
 
 
Table C.1. Insertion data for the effect of DDM detergent on AqpZ tetramer insertion in AqpZ/lipid 
vesicles (Figure 3.4)  
Abbreviations are as follows: replicate (rep), sample (smpl), diffusion coefficient (D), number of 
molecules (1/G0), counts per second (CPS), channel (ch), Chi square (chi-sqr), vesicle (ves). 
[DDM] (%) Rep Smpl D (μm2/s) 1/G(0) CPS-ch1 CPS-ch2 Chi-sqr of fit # AqpZ/ves 
0.01 1 1 2.31 0.16 3236 2343 0.50 828.71 
   1.96 0.25 2843 2008 0.10 452.15 
   1.86 0.22 3120 2229 0.09 575.73 
   2.70 0.49 2657 1842 0.05 213.84 
  2 2.50 0.54 2520 1757 0.19 185.81 
   2.16 0.32 2878 2018 0.16 352.10 
   2.39 0.24 2901 2016 0.39 483.20 
  3 2.80 0.36 2633 1787 0.32 283.52 
   2.13 0.56 2484 1715 0.17 173.75 








Table C.1. cont’d 
[DDM] (%) Rep Meas D (μm2/s) 1/G0 CPS-ch1 CPS-ch2 Chi-sqr # AqpZ/ves 
0.09 1 1 2.45 1.67 9092 6900 0.62 223.23 
   2.44 1.40 9404 7098 0.29 275.15 
   1.58 1.46 9182 6988 0.09 258.62 
  2 1.90 1.13 9648 6869 0.04 341.42 
   1.81 1.67 9409 6746 0.18 226.15 
   1.44 1.14 9894 7104 0.29 347.25 
  3 2.77 1.22 9703 6885 0.14 316.53 
   2.77 1.50 9688 6872 0.20 257.27 
   1.36 1.14 10180 7237 0.15 355.43 
0.3 1 1 2.13 0.86 8280 5884 0.22 383.44 
   0.69 0.58 9026 6364 0.15 617.91 
   1.51 0.80 8257 5827 0.44 412.92 
  2 0.92 0.92 8411 5896 0.38 363.57 
   1.37 1.26 8240 5825 0.19 260.54 
   1.45 1.35 7657 5365 0.13 225.63 
  3 0.93 0.85 8960 6390 0.19 422.61 
   1.53 0.98 9245 6628 0.27 376.14 
   1.29 1.00 8796 6253 0.21 350.26 
0.6 1 1 3.58 9.39 3867 2615 0.34 16.11 
   8.27 8.40 3821 2597 0.40 17.82 
   3.71 7.74 3855 2605 0.16 19.47 
  2 5.47 7.81 3897 2650 0.33 19.57 
   3.97 9.20 3955 2676 0.29 16.81 
   3.49 4.79 3967 2695 0.37 32.45 
  3 2.90 6.11 3986 2670 0.12 25.42 
   2.67 4.51 3999 2678 0.10 34.52 
   3.96 8.32 3934 2629 0.14 18.41 
1 1 1 6.83 47.64 7148 4845 0.71 0.17 
   9.04 52.20 7176 4850 0.81 1.00 
   9.05 57.80 7187 4856 1.27 0.92 
  2 6.52 39.83 7576 4978 0.55 0.83 
   9.16 52.05 7501 4927 0.76 1.25 
   9.79 47.09 7532 4940 1.02 0.95 
  3 6.59 66.75 7096 4983 0.41 1.05 
   7.24 57.04 7148 5016 0.48 0.72 






Table C.1. cont’d 
[DDM] (%) Rep Meas D (μm2/s) 1/G(0) CPS-ch1 CPS-ch2 Chi-sqr of fit # AqpZ/ves 
0.01 2 1 2.70 0.45 15158 10135 0.33 1322.05 
   1.70 0.41 16122 10854 0.10 1518.52 
   1.97 0.52 15537 10468 0.20 1169.52 
   2.70 0.45 15158 10135 0.33 1322.05 
  2 2.49 0.57 18068 12485 0.33 1252.91 
   1.67 0.66 22524 15451 0.24 1333.28 
   2.23 0.74 22081 15132 0.39 1180.85 
  3 1.49 0.60 17134 12899 0.34 1160.51 
   1.42 0.56 9026 6364 0.12 646.96 
   1.77 0.47 18024 13441 0.33 1556.69 
0.09 2 1 2.16 0.48 11036 7918 0.33 916.92 
   1.36 0.48 11341 8133 0.30 954.10 
   2.22 0.59 10251 7406 0.10 699.35 
  2 0.68 7.94 2007 1251 0.30 9.57 
   0.55 9.87 1975 1226 0.23 7.57 
   0.91 12.19 1966 1225 0.20 6.11 
  3 1.98 0.49 10453 7638 0.71 863.34 
   1.52 0.38 12097 8833 0.16 1298.13 
   2.46 0.46 12582 9191 0.65 1107.03 
0.3 2 1 4.15 1.75 2108 1474 0.17 47.72 
   2.52 1.06 2290 1627 0.30 86.53 
   2.95 0.98 2208 1569 0.13 90.01 
   2.34 0.81 2292 1622 0.38 112.22 
  2 1.29 0.18 4250 3163 0.01 986.09 
   2.97 1.24 2446 1721 0.23 78.66 
   1.81 0.83 2556 1824 0.07 122.96 
  3 2.75 0.54 2453 1746 0.81 180.94 
   2.65 1.44 2315 1639 0.28 63.97 
   1.70 0.40 2748 1956 0.34 275.25 
0.6 2 1 1.51 3.17 21644 15738 0.26 0.00 
   2.38 6.43 20928 15235 0.08 1.00 
   2.23 7.12 20747 15153 0.13 0.04 
  2 1.44 7.54 21142 15426 0.02 0.04 
   0.86 4.34 21369 15661 0.03 0.04 
   1.06 7.80 21455 15718 0.18 0.04 
  3 2.04 5.07 22001 15822 0.25 0.04 
   1.76 4.37 22225 16029 0.21 0.04 





Table C.1. cont’d 
[DDM] (%) Rep Meas D (μm2/s) 1/G0 CPS-ch1 CPS-ch2 Chi-sqr # AqpZ/ves 
1 2 1 9.66 4.67 1167 745 0.19 9.55 
   4.78 3.61 1202 764 0.52 12.72 
   17.87 1.50 1219 786 0.20 31.10 
  2 7.08 4.80 975 626 0.83 7.79 
   9.13 52.06 7501 4927 0.76 5.57 
   8.15 5.24 973 624 0.56 7.12 
  3 8.31 6.53 919 580 0.43 5.36 





Table C.2. Permeability data for the effect of DDM detergent on permeability of AqpZ/lipid 
vesicles (Figure 3.4)  
Abbreviations are as follows: n-Dodecyl β-D-maltoside (DDM), replicate (rep), exponential fitting 








(μm/s) SD of fit 
Var of Pf 
(μm/s)2 
0 0.01 1 1 11.64 1.79 0.044 4.88E-10 
 0.09 1 1 17.97 2.80 0.157 6.32E-09 
 0.3 1 1 13.62 2.27 0.052 7.83E-10 
 0.6 1 1 26.69 2.61 0.497 2.48E-08 
 1 1 1 16.87 2.11 0.820 1.11E-07 
 0.01 2 1 10.14 1.55 0.043 4.45E-10 
 0.09 2 1 11.73 1.82 0.037 3.44E-10 
 0.3 2 1 8.83 1.24 0.028 1.66E-10 
 0.6 2 1 18.06 1.34 0.319 5.91E-09 
 1 2 1 16.59 1.24 0.802 3.76E-08 
1/100 0.01 1 1 83.18 13.66 9.654 2.638E-05 
 0.09 1 1 141.10 22.63 6.931 1.297E-05 
 0.3 1 1 118.17 19.85 2.321 1.595E-06 
 0.6 1 1 69.84 6.98 1.507 2.379E-07 
 1 1 1 24.93 1.45 0.689 1.678E-08 
 0.01 2 1 112.63 21.09 4.495 7.440E-06 
 0.09 2 1 100.06 18.39 45.795 7.437E-04 
 0.3 2 1 126.86 22.22 17.256 9.593E-05 
 0.6 2 1 24.58 4.37 0.432 6.184E-08 





Table C.3. Data for the effect of the amount of protein added on insertion in OmpF/lipid vesicles 
(Figure 3.6) 
Abbreviations are as follows: replicate (rep), sample (smpl), diffusion coefficient (D), number of 















1 1/3000 1 1 2.74 0.60 1533 1138 0.14 6.87 
    4.12 2.08 1293 961 0.22 1.67 
    4.77 1.84 1268 941 0.24 1.84 
   2 5.05 1.42 1319 978 0.29 2.49 
    5.69 1.44 1307 972 0.52 2.42 
    4.20 1.67 1351 1016 0.12 2.18 
   3 3.55 1.61 1310 960 0.10 2.16 
    3.40 1.45 1332 979 0.16 2.45 
    5.53 1.54 1306 963 0.71 2.25 
 1/1000 1 1 5.96 0.38 1421 1055 0.49 9.96 
    6.31 0.77 1316 978 0.51 4.60 
    8.50 0.44 1358 1005 0.46 8.21 
   2 12.70 0.44 1444 1068 1.31 8.81 
    6.25 0.44 1475 1111 0.27 9.03 
    3.03 0.30 1592 1181 0.11 14.25 
   3 6.86 0.60 1468 1110 0.41 6.61 
    7.83 0.52 1439 1054 0.35 7.34 
    6.35 0.36 1403 1039 0.28 10.32 
 1/250 1 1 5.00 0.84 4257 3308 0.37 13.87 
    4.09 0.55 4713 3665 0.17 23.26 
    5.12 0.77 4046 3208 0.34 14.47 
   2 5.86 0.57 4589 3768 0.51 22.35 
    5.43 0.62 4875 4009 0.27 21.98 
    6.30 0.63 4774 3906 0.44 21.10 
   3 6.39 0.47 5186 4280 0.35 30.59 
    5.28 0.61 5086 4216 0.18 23.60 





















1 1/100 1 1 5.03 1.51 20123 17054 0.27 37.80 
    5.32 1.98 19047 16131 0.15 27.29 
    5.06 1.59 19934 16891 0.45 35.60 
   2 4.91 1.69 18646 15491 0.31 30.93 
    6.05 1.76 18152 15062 0.22 29.02 
    5.84 1.51 18316 15148 0.18 34.04 
   3 4.84 1.79 21564 18344 0.46 34.14 
    4.77 1.74 21368 18122 0.35 34.88 
    4.83 1.60 21532 18253 0.33 38.07 
1 1/50 1 1 2.61 1.54 47820 41690 1.00 89.34 
    2.39 1.31 49086 42489 0.13 106.93 
    2.82 1.52 44495 38525 0.18 84.01 
   2 2.96 1.46 47761 41758 0.16 94.34 
    2.74 1.36 48986 42746 0.18 103.50 
    2.73 1.38 48844 42606 0.08 101.37 
   3 2.33 1.45 50294 43893 0.49 99.47 
    2.69 1.43 54607 47523 0.14 109.54 
    2.97 1.34 49223 42773 0.12 105.68 
1 1/3000 2 1 5.48 2.16 925 621 0.31 1.10 
    6.60 2.63 942 639 0.60 0.92 
    4.02 1.01 961 660 0.28 2.46 
   2 5.37 2.19 925 621 0.30 1.09 
    6.69 1.91 916 598 0.23 1.22 
    5.78 1.44 918 612 0.23 1.64 
   3 9.88 0.69 948 638 0.30 3.55 
    11.31 1.20 929 627 0.31 1.99 
1 1/1000 2 1 5.03 0.54 1937 1616 0.08 10.17 
    4.50 0.24 2193 1891 0.08 26.41 
    5.96 0.55 1915 1598 0.23 9.75 
   2 5.71 0.68 1861 1545 0.23 7.74 
    6.96 0.96 1778 1469 0.83 5.19 
    5.80 0.50 1938 1653 0.54 11.03 
   3 7.69 0.86 1799 1538 0.52 5.98 
    3.80 0.86 1766 1487 0.09 0.00 





















1 1/250 2 1 3.73 0.83 7115 6797 0.36 25.82 
    4.20 1.10 6979 6504 0.35 18.78 
    4.20 1.00 7237 6754 0.31 21.44 
   2 5.29 0.79 6847 6397 0.47 25.61 
    4.17 1.04 6078 5673 0.23 17.38 
    4.31 1.14 6092 5772 0.97 16.01 
   3 4.22 0.93 5875 5501 0.38 18.70 
    4.81 0.91 6671 6306 0.43 21.98 
    4.15 1.07 6533 6174 0.27 18.17 
1 1/100 2 1 7.01 3.94 22047 20819 0.27 16.70 
    6.76 3.97 21801 20653 0.14 16.42 
    6.21 3.96 21632 20576 0.21 16.38 
   2 6.79 3.73 21621 20650 0.36 17.38 
    6.87 4.14 20999 19972 0.42 15.20 
    6.82 4.01 21086 20166 0.25 15.80 
   3 6.59 4.27 16945 17536 0.20 12.40 
    5.99 4.15 17063 17577 0.19 12.81 
    7.18 4.38 16815 17375 0.19 11.99 
    7.97 3.60 20747 19970 0.45 17.36 
1 1/50 2 1 4.11 3.63 48212 48202 0.17 40.79 
    3.68 3.55 47227 47371 0.11 40.88 
    4.77 3.72 46506 46766 0.85 38.50 
   2 4.13 3.75 45232 45851 0.29 37.32 
    4.55 3.98 44728 45678 0.45 34.88 
    4.47 3.95 43603 44479 0.20 34.21 
   3 4.42 3.57 47701 43966 0.22 39.47 
    4.66 3.62 47513 43983 0.14 38.80 
    4.67 3.63 45573 42389 0.41 37.20 
2 1/3000 1 1 6.84 0.37 2090 1803 1.55 49.16 
    5.22 0.39 2040 1773 0.61 44.94 
    5.10 0.24 2175 1888 0.63 79.69 
   2 8.56 0.36 1809 1495 0.45 42.73 
    7.59 0.51 1815 1520 0.79 30.32 
    4.35 0.25 1868 1553 1.40 62.34 
   3 5.07 0.44 2116 1786 0.33 41.59 
    4.50 0.46 1967 1672 1.08 36.49 





















2 1/1000 1 1 5.93 0.60 4243 3786 0.57 62.02 
    5.87 0.45 4182 3747 0.66 82.33 
   2 5.84 0.89 3582 3237 0.55 35.40 
    5.92 0.62 3633 3319 0.40 52.06 
    5.96 0.44 3775 3413 0.91 76.08 
   3 5.81 0.91 3582 3237 0.60 34.62 
 1/250 1 1 5.58 0.96 13659 12819 0.78 128.11 
    4.96 0.53 14399 13510 0.37 242.00 
    5.37 0.83 14046 13062 1.92 151.95 
   2 6.28 0.77 14999 14035 0.78 175.10 
    6.47 0.42 16753 15927 1.24 362.84 
   3 5.47 0.28 14776 13483 0.72 476.58 
    6.29 0.46 14212 12852 0.87 270.44 
    6.54 0.76 14183 13024 0.87 166.65 
 1/100 1 1 4.55 5.75 53585 47672 0.14 81.66 
    4.38 6.35 53496 47617 0.15 73.81 
    4.43 7.02 52861 46918 0.14 65.96 
   2 3.37 5.16 52900 46985 0.38 89.86 
    5.74 6.06 52683 46656 0.29 76.04 
   3 4.31 5.60 52398 46740 0.23 82.13 
    5.71 7.80 51691 46003 0.35 58.06 
    5.28 6.72 52368 46672 0.17 68.37 
 1/50 1 1 2.42 0.99 71859 69621 1.63 665.60 
    1.42 0.81 71964 69821 1.01 810.96 
    1.33 0.90 76137 74732 1.92 773.67 
   2 1.35 0.79 77418 75803 0.89 898.04 
    2.26 0.85 71289 69589 1.12 765.55 
    2.46 0.84 69553 67385 2.82 752.08 
   3 2.52 0.83 69403 68081 1.44 767.24 
    1.55 0.75 69699 67456 1.19 845.93 




















2 1/25 1 1 3.98 1.50 94231 92791 1.62 579.05 
    3.63 1.60 96595 93968 0.83 553.33 
    3.87 1.60 96315 93200 3.43 549.40 
   2 2.42 1.62 96147 93760 1.09 545.11 
    4.04 1.64 99309 96570 2.32 553.57 
    2.46 1.77 95586 93193 1.71 494.54 
   3 4.53 1.68 99738 97288 2.15 543.96 
    2.41 1.68 92902 91116 1.08 509.59 
    3.56 1.70 94841 92155 1.85 510.78 
2 1/3000 2 1 2.09 0.68 11499 10306 0.43 148.73 
    1.95 0.34 12288 10631 0.64 314.91 
    2.57 0.33 12374 10868 0.36 328.57 
   2 1.68 0.39 13006 11382 0.14 290.32 
    1.15 0.52 12151 10580 0.61 201.60 
    2.95 0.65 11801 10153 0.49 157.17 
   3 2.47 0.37 12080 10481 0.62 282.56 
    2.63 0.48 12052 10394 0.59 218.53 
    1.73 0.51 12097 10801 0.08 208.87 
 1/1000 2 1 8.83 7.35 7565 6545 0.32 8.90 
    8.87 8.02 7676 6667 0.33 8.29 
    7.74 6.83 7733 6705 0.35 9.80 
   2 7.71 7.52 7498 6480 0.22 8.62 
    8.30 6.32 7533 6485 0.30 10.30 
    8.23 4.85 7450 6427 0.24 13.28 
   3 8.16 8.41 7332 6359 0.24 7.56 
    9.19 8.30 7310 6297 0.50 7.61 
    7.60 6.83 7271 6259 0.18 9.19 
 1/250 2 1 3.04 9.12 36649 35540 0.37 36.71 
    2.90 9.01 35726 34723 0.39 36.28 
    1.30 3.88 36562 35715 0.14 86.32 
   2 3.53 7.32 35832 34852 0.46 44.81 
    4.13 6.69 32726 31514 0.34 44.53 
    2.19 5.63 32614 31499 0.13 52.84 
   3 2.68 7.97 33170 33561 0.26 38.82 
    1.83 6.65 33794 34231 0.06 47.42 





















2 1/100 2 1 1.32 1.18 63823 64726 0.04 586.80 
   2 1.98 1.30 63430 63290 0.42 527.88 
    2.02 1.49 60188 60073 0.40 435.38 
    1.88 1.37 62363 61818 0.30 489.45 
   3 1.48 1.41 60000 60042 0.20 460.43 
    1.59 1.15 63282 63619 0.22 596.86 
    1.87 1.31 61009 61231 0.47 503.92 
 1/50 2 1 1.51 1.94 103707 104067 0.27 496.10 
    1.54 2.17 99615 99285 0.46 425.29 
    1.24 1.80 104264 104638 0.08 538.09 
   2 1.71 2.10 100861 101190 0.51 447.16 
    1.92 1.99 100589 100868 0.32 468.80 
    1.65 1.91 99588 99918 0.24 485.59 
   3 1.56 1.91 102028 102129 0.08 496.37 
    2.10 1.96 97401 98495 0.36 463.61 
    1.90 1.96 99532 99525 0.49 471.14 
 1/25 2 1 0.63 1.42 201436 207892 0.06 1340.47 
    0.87 1.30 190898 196285 0.09 1378.26 
    0.65 1.31 187192 191645 0.04 1338.30 
   2 0.68 1.33 198994 221596 0.10 1466.32 
    0.52 1.08 202539 221479 0.15 1821.53 
    1.04 1.36 189150 206017 0.33 1344.99 
   3 0.75 1.37 191351 210846 0.16 1359.73 
    0.76 1.38 188986 207251 0.04 1329.20 





Table C.4. Data for the effect of the amount of protein added on permeability of OmpF/lipid 
vesicles (Figure 3.6)  
Abbreviations are as follows: replicate (rep), exponential fitting parameter (k), permeability (Pf), 







-1) Pf (μm/s) 
SD of k 
(s-1) 
Var of Pf 
(μm/s)2 
1 1 0 1 8.97 24.35 0.04 7.82E-11 
  1/3000 1 7.28 20.18 0.01 6.95E-12 
  1/1000 1 10.24 29.13 0.13 8.99E-10 
  1/250 1 21.32 44.69 0.27 2.11E-09 
  1/100 1 29.43 38.64 1.40 2.21E-08 
  1/50 1 26.58 69.05 0.66 1.93E-08 
 2 0 1 7.49 20.43 0.04 9.23E-11 
  1/3000 1 7.21 14.15 0.07 1.09E-10 
  1/1000 1 3.80 9.87 0.03 4.01E-11 
  1/250 1 15.45 27.43 0.40 3.32E-09 
  1/100 1 45.14 51.07 1.32 1.46E-08 
  1/50 1 40.89 81.13 1.50 5.83E-08 
2 1 0 1 13.35 31.25 0.43 6.55E-09 
  1/3000 1 8.02 26.25 0.11 8.70E-10 
  1/1000 1 16.02 45.17 0.32 5.18E-09 
  1/250 1 70.98 185.54 10.28 4.74E-06 
  1/100 1 353.19 420.27 75.19 5.25E-05 
  1/50 1 34.95 112.00 2.11 3.00E-07 
  1/25 1 370.20 1151.52 42.35 1.14E-04 
 2 0 1 28.05 65.64 0.79476 2.26944E-08 
  1/3000 1 41.83 80.15 3.13865 2.37284E-07 
  1/1000 1 30.89 38.93 2.44 6.22629E-08 
  1/250 1 37.57 65.99 2.97 1.7832E-07 
  1/100 1 64.75 176.57 2.95 4.26078E-07 
  1/50 1 214.45 611.98 32.78 5.74026E-05 





Table C.5. Data for the effect of the amount of protein added on insertion in AqpZ/lipid and 
AqpZ/polymer vesicles (Figure 3.8) 
Abbreviations are as follows: membrane (mem), material (mat’l), replicate (rep), sample (smpl), 
diffusion coefficient (D), number of molecules (1/G0), counts per second (CPS), channel (ch), Chi 
square (chi-sqr), vesicle (ves). 













Polymer 1 1/1000 1 1 1.90266 1.88 26536 21865 0.20 55.26 
     1.96132 1.02 13228 11167 0.22 51.22 
    2 2.62816 2.25 30016 24247 0.63 51.68 
     1.95022 2.72 28248 22712 0.09 40.18 
    3 2.68427 2.81 29471 23808 0.93 40.64 
  1/500 1 1 1.78 1.02 17115 14333 0.24 66.29 
     2.17 1.00 19609 15731 0.10 75.86 
     2.37 2.09 33483 26951 0.15 62.01 
     2.17 1.88 34834 28107 0.31 71.65 
     2.13 1.55 35077 28332 0.19 87.56 
    2 1.50 1.32 37321 30204 0.49 109.95 
     1.79 1.22 36749 29852 0.31 116.87 
     1.61 1.34 37379 30387 0.68 108.63 
     1.42 0.76 19719 15975 0.19 100.77 
     1.97 1.74 17508 14852 0.17 40.00 
  1/250 1 1 2.17 0.45 2034 1687 0.96 17.90 
     2.84 0.38 3531 2815 0.12 35.74 
    2 2.40 0.48 14757 12334 0.07 120.37 
     3.24 0.47 20059 16327 0.18 166.78 
     2.78 0.89 21265 17329 0.16 92.68 
     1.94 0.39 21787 17770 0.88 218.69 
    3 3.06 0.55 9176 7411 0.16 65.13 
     2.48 0.24 11409 9320 0.17 183.04 
     1.50 0.54 8515 6902 0.18 61.49 
     3.23 0.59 9412 7626 0.10 62.08 
  1/100 1 1 1.76 0.34 45384 39482 0.53 529.25 
    2 1.83 0.47 49917 40982 0.59 412.94 
    3 2.50 0.98 99736 81363 0.15 397.75 
     1.72 1.02 99333 81228 0.17 380.66 
     2.04 0.92 103737 84834 0.44 439.17 
  1/50 1 1 0.24 0.26 1571 1385 0.10 24.10 
     0.15 0.12 2042 1541 0.35 64.11 
    2 0.29 0.78 2228 1745 0.46 10.92 
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Polymer 1 1/5000 2 1 1.40 0.71 4744 3628 0.33 25.35 
    2 1.24 0.64 4768 3640 0.26 28.01 
    3 1.32 0.94 4642 3545 0.33 18.73 
  1/1000 2 1 1.80 1.64 22165 16847 0.08 51.17 
     2.28 1.53 22007 16736 0.13 54.17 
     3.24 2.03 21659 16466 0.76 40.21 
    2 2.32 1.59 24149 18414 0.22 57.33 
     1.07 1.63 23676 18061 0.50 55.09 
     1.77 2.16 23293 17760 0.25 40.73 
    3 1.15 0.96 24945 18994 0.12 98.13 
     2.00 0.84 26611 20309 0.45 120.27 
     1.79 1.86 25006 19014 0.19 50.87 
  1/500 2 1 0.89 1.74 25355 19523 0.11 55.21 
     2.53 2.31 23646 18110 0.13 38.75 
    2 1.94 2.72 25034 19159 0.23 34.91 
     2.38 2.07 24140 18443 0.89 44.18 
    3 0.76 1.64 25084 19202 0.05 57.86 
     2.03 2.58 23519 17915 0.12 34.51 
  1/250 2 1 4.42 0.41 2034 1687 0.77 19.63 
    2 2.89 0.48 14757 12334 0.08 121.88 
  1/100 2 1 2.57 0.46 23186 18044 0.33 191.92 
     3.91 0.36 23603 18312 0.49 248.67 
    2 2.14 0.52 12149 9250 0.40 87.80 
     2.00 0.31 12395 9522 0.46 149.74 
    3 3.77 0.26 13647 10315 0.77 198.65 
     2.59 0.61 12222 9159 0.15 75.03 
  1/50 2 1 1.09 2.12 64052 50757 0.40 116.15 
     1.77 3.09 63840 50500 0.38 79.46 
    2 1.42 1.99 63257 50035 0.37 122.22 
     0.47 2.35 67843 53746 0.04 111.15 
    3 1.34 1.21 68107 53962 0.20 215.74 






Table C.5. cont’d 













Polymer 1 1/25 2 1 0.91 0.75 87920 69259 0.08 450.80 
     1.47 0.75 83671 65759 0.31 428.08 
     0.73 0.85 83029 65226 0.33 374.80 
    2 0.72 0.78 79225 61016 0.27 386.36 
     0.77 0.55 84344 65220 0.48 584.67 
     1.18 1.34 80509 61667 0.36 227.18 
     1.35 0.89 86322 66378 0.26 366.58 
    3 0.70 0.58 85947 66273 0.10 567.87 
     1.35 1.12 82176 63443 0.04 279.24 
     0.86 0.62 85617 65800 0.05 525.65 
Lipid 2 1/1000 - - Not measurable     
  1/100 1 1 0.59 0.19 29210 22232 0.04 281.61 
     0.92 0.17 27210 19967 0.10 281.25 
     0.91 0.28 32351 26084 0.09 218.99 
     0.52 0.15 35783 26210 0.15 421.45 
    2 1.00 0.21 33116 25052 0.10 289.63 
     1.07 0.24 25182 18871 0.08 192.31 
    3 0.95 0.19 29449 21902 0.20 280.97 
     1.39 0.17 23293 17234 0.12 248.79 
     0.66 0.14 27789 20944 0.14 361.35 
  1/50 1 1 3.47 2.45 4921 3549 0.03 3.60 
     1.31 0.37 5592 4039 0.10 27.19 
     2.06 1.07 5216 3777 0.08 8.71 
    2 1.59 1.24 5081 3639 0.17 7.31 
     0.71 0.88 5207 3765 0.13 10.59 
     3.17 2.81 4823 3478 0.11 3.08 
    3 0.49 0.40 5486 3946 0.23 24.31 
     1.13 0.64 5158 3704 0.16 14.43 
     1.64 0.46 5369 3905 0.16 20.95 
  1/25 1 1 2.06 1.07 5216 3777 0.15 8.71 
    2 0.00 3.07 15707 11825 0.10 9.34 
    3 0.33 1.17 15162 11400 0.04 23.70 
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Lipid 2 1/1000 2 1 2.23 0.38 3854 2867 0.21 20.40 
     3.48 0.55 3476 2579 0.27 12.74 
     3.42 0.28 3899 2884 0.34 27.64 
    2 1.58 0.31 3950 2880 0.25 25.40 
     2.16 0.49 3457 2521 0.42 13.97 
     2.74 0.42 3614 2636 0.10 17.21 
    3 1.33 0.23 3189 2351 0.30 27.20 
     4.99 0.63 2654 1974 0.22 8.38 
     1.60 0.46 2929 2209 0.06 12.94 
  1/100 2 1 1.35 0.33 29210 22232 0.08 178.83 
     2.27 0.33 6441 4710 0.12 38.38 
     1.93 0.23 6839 4936 0.18 59.37 
     1.40 0.17 7342 5415 0.20 85.75 
    2 1.92 0.22 8403 6280 0.28 74.95 
     0.84 0.21 7447 5623 0.09 70.69 
     1.31 0.21 7844 5796 0.45 73.28 
    3 1.79 0.24 6767 5002 0.18 56.57 
     1.71 0.18 7086 5228 0.07 78.31 
     1.00 0.20 7654 5823 0.03 77.98 
  1/50 2 1 1.34 1.82 5759 4286 0.15 6.33 
     1.25 1.56 5798 4304 0.09 7.45 
     3.02 1.90 5490 4065 0.17 5.76 
    2 2.08 2.59 5509 4079 0.17 4.26 
     2.15 2.25 5553 4106 0.10 4.94 
     1.59 2.06 5543 4122 0.14 5.39 
    3 1.85 2.39 5833 4390 0.43 4.92 
     2.02 2.28 5899 4430 0.31 5.21 
     2.36 0.98 5973 4483 0.20 12.31 
  1/25 2 1 0.62 0.62 33613 24992 0.03 108.86 
     1.18 11.95 14976 11343 0.14 2.53 
    2 0.36 1.41 42306 33045 0.02 61.50 
    3 0.33 1.17 40809 33578 0.04 73.24 
     0.31 1.47 43533 33019 0.04 59.80 
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Lipid 3 1/1000 1 1 2.44 1.66 7946 6527 0.07 2.29 
     1.95 2.87 7416 6045 0.15 1.24 
     3.96 3.05 7170 5851 0.12 1.13 
    2 1.81 1.82 7885 6473 0.08 2.08 
     1.15 1.62 8228 6759 0.04 2.44 
    3 1.26 2.17 7676 6389 0.29 1.71 
     1.61 2.92 7756 6446 0.79 1.28 
     1.84 2.32 7761 6413 0.52 1.61 
  1/100 1 1 0.60 0.86 71159 59688 0.23 40.26 
     0.33 0.97 71107 59534 0.15 35.48 
    2 0.55 1.27 70395 58928 0.10 26.84 
     0.62 0.80 72519 60783 0.08 43.88 
     0.90 1.35 70980 59161 0.11 25.44 
    3 0.46 0.82 80575 68225 0.07 47.91 
     0.34 0.72 81007 68383 0.27 54.96 
     0.43 1.66 77130 65530 0.13 22.65 
  1/50 1 1 0.51 0.77 110430 94919 0.59 70.73 
     1.93 1.02 101922 87619 0.11 48.81 
    2 1.34 1.09 99579 83576 0.28 44.24 
     1.61 0.79 107965 90879 0.08 66.18 
    3 1.43 1.02 96573 80615 0.06 45.82 
     0.95 0.76 103634 87253 0.09 66.32 
     1.21 1.04 94430 79497 0.08 44.23 
  1/25 1 1 0.41 0.35 39757 33884 0.20 55.94 
     1.90 0.47 30971 26032 0.33 31.75 
     0.57 0.36 35998 30281 0.05 48.42 
    2 0.78 0.42 32373 26971 0.20 37.47 
     0.86 0.43 32216 26896 0.07 36.20 
    3 2.05 0.60 30659 25458 0.28 24.58 
     1.55 0.46 34517 28601 0.06 36.53 
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Lipid 3 1/1000 2 1 2.90 0.34 4743 3805 0.79 122.52 
     3.89 0.93 4816 3873 0.63 44.98 
     5.48 0.79 4759 3841 0.38 52.58 
    2 2.03 0.62 5152 4168 0.18 72.40 
     3.24 0.78 5050 4120 0.23 56.35 
     3.63 1.03 5267 4313 0.36 44.85 
    3 2.94 0.84 4886 4022 0.17 50.81 
     3.59 0.57 5104 4389 0.54 80.76 
  1/100 2 1 3.39 0.46 8472 7541 0.09 166.84 
     3.60 0.31 8908 7949 0.18 263.43 
     3.71 0.45 8589 7671 0.38 174.69 
     4.39 0.28 9118 7985 0.52 299.40 
    2 3.36 0.23 17489 14861 0.36 691.91 
     3.24 0.25 16515 13998 0.33 597.41 
     2.44 0.24 18312 15396 0.68 673.93 
    3 2.13 0.23 11691 9986 0.14 449.96 
     3.03 0.22 11163 9620 0.23 457.42 
     2.61 0.24 11540 9772 0.16 424.49 
  1/50 2 1 2.05 0.21 49606 46624 0.08 2189.23 
     1.07 0.27 49428 47495 0.20 1700.06 
     1.82 0.20 43090 40903 0.38 2002.47 
    2 2.04 0.44 35053 33442 0.68 751.10 
     1.44 0.35 45935 39094 0.49 1182.61 
     1.63 0.31 48894 41804 0.34 1388.43 
    3 1.05 0.19 41158 48512 0.16 2313.62 
     2.15 0.27 56024 39828 0.24 1733.74 
     3.59 2.65 46116 46116 4.39 167.45 
  1/25 2 1 1.52 0.18 43386 36807 0.16 2153.70 
     3.69 0.25 31329 26350 0.30 1109.67 
     3.06 0.28 33084 28158 0.47 1046.63 
    2 2.15 0.21 31230 26278 0.10 1339.87 
     2.27 0.22 29469 25207 0.15 1191.71 
     1.85 0.20 41158 34265 0.44 1825.39 
    3 2.67 0.30 40142 29157 0.28 1120.12 
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Lipid 3 1/100 3 1 1.62 0.46 41913 42591 0.25 889.80 
     2.49 0.65 40882 41630 0.11 609.27 
     2.04 0.40 47450 48484 0.07 1154.16 
    2 1.10 0.52 42428 43417 0.26 791.95 
     1.48 0.47 44130 45975 0.11 920.28 
     1.47 0.38 44361 46483 0.14 1160.03 
    3 2.41 1.18 40557 41295 0.17 335.10 
     1.85 0.92 44283 45142 0.21 467.58 
     1.77 1.77 59891 59599 0.16 325.39 
  1/50 3 1 2.18 0.21 22583 21065 0.09 1013.41 
     1.39 0.18 23676 22488 1.11 1260.24 
     1.99 0.24 20312 19089 0.28 788.05 
    2 1.39 0.30 22402 20974 0.60 695.98 
     2.30 0.27 22012 20431 0.12 763.11 
     1.82 0.23 23738 22784 0.11 981.34 
    3 1.82 0.23 23738 22784 0.11 981.34 
     2.93 0.22 22395 22533 0.06 991.43 
     1.27 0.24 21323 20546 0.72 832.97 
  1/25 3 1 1.97 0.28 21472 20367 0.30 711.73 
     2.98 0.26 18859 17716 0.25 665.69 
     3.35 0.29 20119 19693 0.14 666.21 
    2 1.29 0.25 19546 18829 0.38 738.04 
     2.23 0.23 22745 22653 0.16 954.20 
     2.07 0.21 22377 22261 0.20 1016.60 
    3 2.14 0.22 19723 19470 0.11 871.90 
     2.14 0.22 19723 19470 0.11 871.90 
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Lipid 4 1/100 1 1 1.10 1.52 1921 1690 0.78 12.60 
     1.26 1.08 1888 1671 0.86 17.54 
    2 1.38 0.94 1936 1701 0.49 20.60 
     1.97 2.39 1852 1632 1.11 7.76 
     1.31 2.42 1841 1622 0.72 7.60 
    3 0.89 0.97 1913 1823 0.56 20.44 
     1.15 1.99 1820 1690 1.41 9.36 
  1/25 1 1 0.70 0.11 1467 1351 0.25 132.49 
     0.63 0.15 1510 1405 0.81 105.25 
     0.43 0.12 1489 1403 0.38 133.57 
    2 0.62 0.13 1417 1364 0.90 117.43 
     0.52 0.10 1559 1493 0.97 157.52 
    3 0.35 0.15 1557 1448 0.71 107.79 
Lipid 4 1/100 2 1 6.10 0.16 1210 780 0.06 67.12 
     5.04 0.09 1228 868 0.06 124.10 
     6.92 0.22 1093 661 0.36 42.65 
    2 9.46 0.19 1196 765 0.41 55.75 
     7.37 0.12 1301 890 0.08 99.29 
     7.56 0.19 1219 774 0.16 55.30 
    3 8.94 0.14 1230 806 0.35 77.80 
     5.24 0.08 1504 1021 0.10 175.29 
     12.87 0.14 1197 779 1.01 75.73 
  1/25 2 1 2.02 0.14 5816 5146 0.14 421.28 
     3.97 0.16 5587 4967 0.43 356.16 
     3.52 0.18 5580 4862 0.33 308.04 
    2 4.36 0.17 4951 4260 0.04 287.56 
     3.46 0.20 5257 4726 0.30 262.61 
     3.69 0.16 5450 4906 0.20 336.86 
    3 3.72 0.17 4943 4513 0.11 294.61 
     4.06 0.14 5340 4739 0.16 387.01 





Table C.6. Data for the effect of the amount of protein added on permeability of AqpZ/lipid and 
AqpZ/polymer vesicles (Figure 3.8)  
Abbreviations are as follows: membrane (mem), material (mat’l), exponential fitting parameter 









-1) Pf (μm/s) 
SD of k 
(s-1) 
Var of Pf 
(μm/s)2 
Polymer 1 0 1 0.00 0.00 0.00 0.00E+00 
  1/1000 1 47.26 95.62 4.66 9.34E-06 
  1/500 1 43.23 107.07 5.64 2.05E-05 
  1/250 1 57.84 119.28 5.17 1.19E-05 
  1/100 1 240.70 375.98 16.01 6.56E-05 
  1/50 1 131.49 359.40 24.83 4.83E-04 
Polymer 1 0 1 0.00 0.00 0.00 0.00E+00 
  1/5000 1 233.89 452.26 12.65 6.28E-05 
  1/1000 1 245.71 552.32 26.87 3.83E-04 
  1/500 1 233.01 468.89 12.34 6.47E-05 
  1/250 1 200.83 508.09 84.00 4.74E-03 
  1/100 1 464.71 1026.80 87.47 3.92E-03 
  1/50 1 258.60 660.71 132.33 1.20E-02 
  1/25 1 473.67 1256.26 123.35 1.12E-02 
Lipid 2 0 1 16.71 25.10 0.28 1.85E-08 
  1/1000 1 8.38 11.38 0.10 1.97E-09 
  1/100 1 317.87 739.75 19.61 2.19E-04 
  1/50 1 9.06 16.85 0.15 8.31E-09 
  1/25 1 15.22 33.49 0.42 9.02E-08 
Lipid 2 0 1 15.32 20.07 0.10 1.7E-09 
  1/1000 1 16.46 20.77 0.11 2.1E-09 
  1/100 1 48.06 74.85 1.63 6.7E-07 
  1/50 1 21.58 27.08 0.29 1.4E-08 
  1/25 1 21.58 31.42 0.33 2.4E-08 
Lipid 3 0 1 4.26 0.73 0.03 3.0E-10 
  1/1000 1 9.36 1.45 0.09 2.1E-09 
  1/100 1 51.09 9.56 1.37 6.9E-07 
  1/50 1 50.90 10.56 1.06 5.1E-07 
  1/25 1 32.88 5.36 0.33 2.9E-08 
Lipid 3 0 1 11.30 13.60 0.09 1.2E-09 
  1/1000 1 14.87 20.12 0.11 2.4E-09 
  1/100 1 13.74 20.46 0.12 3.4E-09 
  1/50 1 27.43 51.00 0.41 6.0E-08 















-1) Pf (um/s) 
SD of k 
(s-1) 
Var of Pf 
(um/s)2 
Lipid 3 1/100 1 19.32 31.78 0.12 4.0E-09 
  1/50 1 26.20 47.61 0.46 7.3E-08 
  1/25 1 20.24 27.46 0.77 1.2E-07 
Lipid 4 0 1 13.35 15.84 0.43 2.69E-08 
  1/100 1 39.47 56.87 1.25 3.40E-07 
  1/25 1 61.64 114.24 7.00 1.77E-05 
Lipid 4 0 1 16.13 24.78 0.26 1.65E-08 
  1/100 1 19.48 31.40 0.80 1.75E-07 





Table C.7. Data for effect of AqpZ on permeability of E. coli (Figures 5.2, 5.3, 5.4, 5.6)  
The reconstructed NCM3306R strains were not used in Figures 5.2, 5.3, 5.4 and 5.6. Abbreviations 
are as follows: stopped-flow instrument (SF), exponential fitting parameter (k), permeability (Pf), 
standard deviation (SD), error calculated from the standard deviation of the curve fitting (error). 







1/12/2011 NCM3105 1 7.4 1 3.29 83.08  5.35 
1/26/2011 NCM3105 1 7.4 1 2.35 59.22  3.03 
1/26/2011 NCM3105 1 7.4 1 2.70 68.26  5.61 
1/26/2011 NCM3105 1 7.4 1 2.27 57.42  3.81 
1/26/2011 NCM3105 1 7.4 1 2.38 60.03  5.61 
2/22/1/11 NCM3105 1 7.4 2 3.01 38.02 0.038 0.48 
3/1/2011 NCM3105 1 7.4 2 3.49 44.05 0.035 0.44 
3/2/2011 NCM3105 1 7.4 2 3.36 42.37 0.039 0.49 
3/5/2011 NCM3105 1 7.4 2 3.37 42.60 0.039 0.49 
3/8/2011 NCM3105 1 7.4 2 3.28 41.41 0.040 0.50 
3/9/2011 NCM3105 1 7.4 2 9.65 121.89 0.191 2.41 
6/25/2011 NCM3105 1 7.4 1 2.97 75.06 0.045 1.15 
6/25/2011 NCM3105 1 4.0 1 8.06 203.47 0.225 5.69 
6/12/2014 NCM3105 2 7.4 1 6.24 157.48 0.173 2.19 
6/12/2014 NCM3105 2 7.4 2 9.48 119.73 0.168 1.06 
6/12/2014 NCM3105 2 4.0 1 4.01 101.37 0.181 2.29 
6/12/2014 NCM3105 2 4.0 2 6.62 83.61 0.286 1.80 
7/29/2014 NCM3105 2 7.4 1 22.27 562.43 2.939 37.10 
7/29/2014 NCM3105 2 7.4 2 2.62 33.03 0.072 0.45 
7/29/2014 NCM3105 2 4.0 1 3.55 89.68 0.152 1.92 
7/29/2014 NCM3105 2 4.0 2 2.36 29.81 0.103 0.65 
3/1/2011 NCM3306 1 7.4 2 3.50 44.18 0.055 0.70 
3/2/2011 NCM3306 1 7.4 2 2.92 36.82 0.033 0.41 
3/5/2011 NCM3306 1 7.4 2 2.05 25.83 0.027 0.34 
3/8/2011 NCM3306 1 7.4 2 3.28 41.41 0.040 0.50 
3/9/2011 NCM3306 1 7.4 2 5.46 68.95 0.066 0.84 
6/25/2011 NCM3306 1 7.4 1 2.00 50.53 0.027 0.69 
6/25/2011 NCM3306 1 4 1 4.42 111.71 0.133 3.35 
6/12/2014 NCM3306 2 7.4 1 6.27 158.42 0.266 3.36 
6/12/2014 NCM3306 2 7.4 2 8.05 101.65 0.285 1.80 
6/12/2014 NCM3306 2 4.0 1 6.42 162.18 0.217 2.74 
6/12/2014 NCM3306 2 4.0 2 5.63 71.14 0.235 1.49 
7/29/2014 NCM3306 2 7.4 1 1.70 42.95 0.043 0.55 
7/29/2014 NCM3306 2 7.4 2 2.19 27.59 0.214 1.35 
7/29/2014 NCM3306 2 4.0 1 3.85 97.20 0.100 1.26 
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2/22/2011 ME9062 1 7.4 2 2.24 28.29 0.021 0.26 
3/1/2011 ME9062 1 7.4 2 4.16 52.49 0.049 0.62 
3/2/2011 ME9062 1 7.4 2 3.66 46.22 0.040 0.50 
6/12/2014 ME9062 2 7.4 1 6.29 158.92 0.365 4.60 
6/12/2014 ME9062 2 7.4 2 7.82 98.75 0.452 2.85 
6/12/2014 ME9062 2 4.0 1 4.69 118.43 0.134 1.70 
6/12/2014 ME9062 2 4.0 2 8.03 101.42 0.208 1.31 
2/22/1/11 JW0859 1 7.4 2 2.18 27.49 0.033 0.42 
3/1/2011 JW0859 1 7.4 2 3.10 39.12 0.044 0.56 
3/2/2011 JW0859 1 7.4 2 3.35 42.28 0.035 0.45 
6/12/2014 JW0859 2 7.4 1 9.60 242.33 0.408 5.15 
6/12/2014 JW0859 2 7.4 2 10.41 131.38 0.339 2.14 
6/12/2014 JW0859 2 4.0 1 5.22 131.71 0.403 5.09 
6/12/2014 JW0859 2 4.0 2 5.76 72.72 0.114 0.72 
3/8/2011 JM109 pTrcAqpZ, Ind. 1 7.4 2 48.68 614.61 1.565 19.77 
3/9/2011 JM109 pTrcAqpZ, Ind. 1 7.4 2 113.81 1436.95 25.806 325.84 
3/5/2011 JM109 pTrc1 1 7.4 2 14.59 184.18 0.683 8.62 
3/8/2011 JM109 pTrc1, Ind. 1 7.4 2 15.20 191.89 0.241 3.04 
3/9/2011 JM109 pTrc1, Ind. 1 7.4 2 31.03 391.84 0.903 11.40 
7/29/2014 NCM3306R1* 2 7.4 1 1.70 42.95 0.043 0.55 
7/29/2014 NCM3306R1* 2 7.4 2 2.19 27.59 0.214 1.35 
7/29/2014 NCM3306R1* 2 4.0 1 3.85 97.20 0.100 1.26 
7/29/2014 NCM3306R1* 2 4.0 2 2.44 30.76 0.075 0.48 
7/29/2014 NCM3306R2* 2 7.4 1 2.54 64.26 0.121 1.52 
7/29/2014 NCM3306R2* 2 7.4 2 2.71 34.16 0.163 1.03 
7/29/2014 NCM3306R2* 2 4.0 1 4.76 120.32 0.150 1.90 
7/29/2014 NCM3306R2* 2 4.0 2 3.63 45.82 0.071 0.45 
*The NCM3306 strain was reconstructed using recipient strain NCM3105 and donor strain NCM3306 for P1-mediated 
transduction. The P1 lysate was grown on ME9062. The transduction was performed using the protocol by Thomason 
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6/25/2011 NCM3105 1 7.4 1 2.97 75.06 0.045 1.15 
6/12/2014 NCM3105 2 7.4 1 6.24 157.48 0.173 2.19 
6/12/2014 NCM3105 2 7.4 2 9.48 119.73 0.168 1.06 
7/29/2014 NCM3105 2 7.4 1 22.27 562.43 2.939 37.10 
7/29/2014 NCM3105 2 7.4 2 2.62 33.03 0.072 0.45 
6/25/2011 NCM3105 1 4 1 8.06 203.47 0.225 5.69 
6/12/2014 NCM3105 2 4 1 4.01 101.37 0.181 2.29 
6/12/2014 NCM3105 2 4 2 6.62 83.61 0.286 1.80 
7/29/2014 NCM3105 2 4 1 3.55 89.68 0.152 1.92 
7/29/2014 NCM3105 2 4 2 2.36 29.81 0.103 0.65 
6/25/2011 NCM3105 pTrc10His1 1 7.4 1 3.48 87.92 0.056 1.42 
6/25/2011 NCM3105 pTrc10His1 1 4 1 6.32 159.57 0.228 5.75 
6/25/2011 NCM3105 pTrc10His1, Ind. 1 7.4 1 8.17 206.27 0.241 6.08 
6/25/2011 NCM3105 pTrc10His1, Ind. 1 4 1 45.00 1136.38 5.189 131.03 
6/25/2011 NCM3105 pTrc10HisAqpZ 1 7.4 1 29.32 740.43 3.100 78.29 
6/25/2011 NCM3105 pTrc10HisAqpZ 1 4 1 34.72 876.65 5.329 134.58 
6/25/2011 NCM3105 pTrc10HisAqpZ, Ind. 1 7.4 1 35.85 905.18 3.168 79.99 
6/25/2011 NCM3105 pTrc10HisAqpZ, Ind. 1 4 1 25.69 648.81 3.688 93.13 
6/12/2014 NCM3306 2 7.4 1 6.27 158.42 0.266 3.36 
6/13/2014 NCM3306 2 7.4 2 8.05 101.65 0.285 1.80 
6/14/2014 NCM3306 2 4 1 6.42 162.18 0.217 2.74 
6/15/2014 NCM3306 2 4 2 5.63 71.14 0.235 1.49 
6/25/2011 NCM3306 1 7.4 1 2.00 50.53 0.027 0.69 
6/25/2011 NCM3306 1 4 1 4.42 111.71 0.133 3.35 
6/25/2011 NCM3306 pTrc10His1 1 7.4 1 3.02 76.23 0.066 1.66 
6/25/2011 NCM3306 pTrc10His1 1 4 1 25.92 654.59 2.432 61.40 
6/25/2011 NCM3306 pTrc10His1, Ind. 1 7.4 1 23.84 601.96 0.960 24.23 
6/25/2011 NCM3306 pTrc10His1, Ind. 1 4 1 39.76 1003.93 2.612 65.97 
6/25/2011 NCM3306 pTrc10HisAqpZ 1 7.4 1 32.15 811.98 4.153 104.88 
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2/22/2011 ME9062 1 7.4 2 2.24 28.29 0.021 0.26 
3/1/2011 ME9062 1 7.4 2 4.16 52.49 0.049 0.62 
3/2/2011 ME9062 1 7.4 2 3.66 46.22 0.040 0.50 
6/12/2014 ME9062 2 7.4 1 6.29 158.92 0.365 4.60 
6/12/2014 ME9062 2 7.4 2 7.82 98.75 0.452 2.85 
6/12/2014 ME9062 2 4 1 4.69 118.43 0.134 1.70 
6/12/2014 ME9062 2 4 2 8.03 101.42 0.208 1.31 
2/22/2011 JW0859 1 7.4 2 2.18 27.49 0.033 0.42 
3/1/2011 JW0859 1 7.4 2 3.10 39.12 0.044 0.56 
3/2/2011 JW0859 1 7.4 2 3.35 42.28 0.035 0.45 
6/12/2014 JW0859 2 7.4 1 9.60 242.33 0.408 5.15 
6/12/2014 JW0859 2 7.4 2 10.41 131.38 0.339 2.14 
6/12/2014 JW0859 2 4 1 9.60 242.33 0.408 5.15 






Table C.8. Data for percent survival of E. coli under shock conditions (Figures 5.5, 5.6) 
Red text denotes plate counts < 25 and blue text denotes plate counts > 250. Blue shading denotes 
plate counts used for acid shock, light yellow shading denotes plate counts used for osmotic shock, 
and green shading denotes plate counts used for combined shock. Bright yellow shading with bold 
text denotes plate counts between 20-25 used because they allowed use of an additional biological 
replicate. Only 2011 data was used in Figures 5.5 and 5.6. For data from 2014, replicate plates of 
the same biological replicate were averaged before further use.  
NCM3105 (parent)       
7/9/2011 Condition Plate (10^x) Count % Survival Plate (10^x) Count % Survival 
 Control 8 40 100 7 230 100 
 Acid 7 21 5.25 6 144 6.26 
 Osmotic 8 68 170.00 7 508 220.87 
 Both 6 18 0.45 5 193 0.84 
7/11/2011 Condition Plate (10^x) Count % Survival Plate (10^x) Count % Survival 
 Control 8 80 100 7 563 100 
 Acid 8 14 17.50 7 162 28.77 
 Osmotic 8 72 90.00 7 582 103.37 
 Both 7 16 2.00 6 254 4.51 
7/13/2011 Condition Plate (10^x) Count % Survival Plate (10^x) Count % Survival 
 Control 8 79 100 7 568 100 
 Acid 7 38 4.81 6 400 7.04 
 Osmotic 8 65 82.28 7 556 97.89 
 Both 6 29 0.37 5 273 0.48 
7/27/2011 Condition Plate (10^x) Count % Survival Plate (10^x) Count % Survival 
 Control 8 45 100 7 434 100 
 Acid 7 24 5.33 6 252 5.81 
 Osmotic 8 101 224.44 7 946 217.97 




Table C.8. cont’d  
NCM3306 (null mutant)      
7/9/2011 Condition Plate (10^x) Count % Survival Plate (10^x) Count % Survival 
 Control 8 65 100 7 570 100 
 Acid 7 58 8.92 6 680 10.46 
 Osmotic 8 77 118.46 7 722 111.08 
 Both 7 148 22.77    
7/11/2011 Condition Plate (10^x) Count % Survival Plate (10^x) Count % Survival 
 Control 8 76 100 7 684 100 
 Acid 7 128 16.84    
 Osmotic 7 1060 139.47    
 Both 8 9 11.84 7 85 11.18 
7/13/2011 Condition Plate (10^x) Count % Survival Plate (10^x) Count % Survival 
 Control 8 50 100    
 Acid 8 10 20.00 7 137 27.40 
 Osmotic 8 28 56.00    
 Both 6 40 0.80 5 408 0.82 
7/27/2011 Condition Plate (10^x) Count % Survival Plate (10^x) Count % Survival 
 Control 8 46 100 7 394 100 
 Acid    7 738 160.43 
 Osmotic 8 39 84.78 7 488 106.09 






Table C.8. cont’d 
NCM3105 pTrc10HisAqpZ, uninduced     
7/11/2011 Condition Plate (10^x) Count % Survival Plate (10^x) Count % Survival 
 Control 8 75 100    
 Acid 6 262 3.49    
 Osmotic 8 68 90.67 7 712 94.93 
 Both 6 5 0.07 5 63 0.08 
7/13/2011 Condition Plate (10^x) Count % Survival Plate (10^x) Count % Survival 
 Control 8 37 100 7 418 100.00 
 Acid 6 13 0.35 5 129 0.35 
 Osmotic 8 51 137.84 7 564 152.43 
 Both 4 19 0.01 3 348 0.01 
7/27/2011 Condition Plate (10^x) Count % Survival Plate (10^x) Count % Survival 
 Control 8 40 100 7 440 100.00 
 Acid 6 10 0.25 5 119 0.30 
 Osmotic 8 70 175.00 7 494 123.50 
 Both 5 37 0.09 4 648 0.16 
7/29/2011 Condition Plate (10^x) Count % Survival Plate (10^x) Count % Survival 
 Control 8 1364 100    
 Acid 5 26 0.07 4 337 0.00 
 Osmotic 8 3212 8030.00    
 Both 4 108 0.03 3 1248 0.00 
8/9/2011 Condition Plate (10^x) Count % Survival Plate (10^x) Count % Survival 
 Control 8 35 100 7 272 100 
 Acid 5 11 0.03 4 92 0.03 
 Osmotic 8 68 194.29 7 538 153.71 





Table C.8. cont’d  
NCM3105 pTrc10His1, uninduced      
7/27/2011 Condition Plate (10^x) Count % Survival Plate (10^x) Count % Survival 
 Control 8 13 100 7 160 100 
 Acid 4 16 0.01 3 188 0.01 
 Osmotic    7 100 62.50 
 Both 4 50 0.03 3 476 0.03 
7/29/2011 Condition Plate (10^x) Count % Survival Plate (10^x) Count % Survival 
 Control 8 1748 100    
 Acid 4 11 0.01 3 169 0.00 
 Osmotic 8 2628 16425.00    
 Both 4 5 0.00 3 73 0.00 
8/9/2011 Condition Plate (10^x) Count % Survival Plate (10^x) Count % Survival 
 Control 8 23 100 7 191 100 
 Acid 4 42 0.02 3 376 0.02 
 Osmotic 8 15 78.53 7 279 146.07 






Table C.8. cont’d 
NCM3105 pTrc10HisAqpZ, induced      
7/29/2011 Condition Plate (10^x) Count % Survival Plate (10^x) Count % Survival 
 Control 8 5304 100    
 Acid 5 38 0.49 4 268 0.00 
 Osmotic 6 32 4.16 5 327 0.01 
 Both 4 99 0.15 3 964 0.00 
8/9/2011 Condition Plate (10^x) Count % Survival Plate (10^x) Count % Survival 
 Control 7 13 100    
 Acid 5 30 0.39 4 269 2.07 
 Osmotic 7 6 7.79 6 50 38.46 
 Both 4 5 0.01 3 1200 0.92 
8/21/2011 Condition Plate (10^x) Count % Survival Plate (10^x) Count % Survival 
1 Control 8 9 100 7 77 100 
 Acid 6 11 1.43 5 123 1.60 
 Osmotic 7 20 25.97 6 203 26.36 
 Both 4 38 0.05 3 356 0.05 
8/21/2011 Shock Plate (10^x) Count % Survival Plate (10^x) Count % Survival 
2 Control 7 56 100 6 438 100 
 Acid 7 11 19.64 6 99 22.60 
 Osmotic 7 13 23.21 6 124 28.31 





Table C.8. cont’d 
NCM3105 pTrc10His1, induced      
7/29/2011 Condition Plate (10^x) Count % Survival Plate (10^x) Count % Survival 
 Control 8 1520 100    
 Acid 7 223 43.73    
 Osmotic 8 98 192.16    
 Both 7 49 9.61 6 668 0.44 
8/9/2011 Condition Plate (10^x) Count % Survival Plate (10^x) Count % Survival 
 Control 9 10 100 8 51 100 
 Acid 8 48 94.12 7 423 82.94 
 Osmotic    7   
 Both 3 15 0.00 2 200 0.00 
8/21/2011 Condition Plate (10^x) Count % Survival Plate (10^x) Count % Survival 
1 Control 8 108 100 7 794 100 
 Acid 8 24 22.22 7 143 13.24 
 Osmotic 8 71 65.74 7 540 50.00 
 Both 5 24 0.02 4 192 0.02 
8/21/2011 Condition Plate (10^x) Count % Survival Plate (10^x) Count % Survival 
2 Control 8 54 100 7 430 100 
 Acid 8 62 114.81 7 612 113.33 
 Osmotic 8 83 153.70 7 920 170.37 





Table C.8. cont’d 
NCM3105 (parent)         









 Control 6 >250 7 200  8 27 100 
   >250 7 193  8 <25  
   >250 7 168  8 <25  
 Acid 6 >250 7 37 19.8 8 <25  
   >250 7 36 19.3 8 <25  
   >250 7 29 15.5 8 <25  
 Osmotic 6 >250 7 240 128.3 8 <25  
   >250 7 151 80.7 8 <25  
   >250 7 180 96.3 8 <25  
 Both 6 >250 7 213 113.9 8 <25  
   >250 7 192 102.7 8 <25  
   >250 7 234 125.1 8 <25  









 Control 6 >250 7 73  8 <24  
   >250 7 71  8 <25  
   >250 7 81  8 <25  
 Acid 6 >250 7 48 64.0 8 <25  
   >250 7 55 73.3 8 <25  
   >250 7 61 81.3 8 <25  
 Osmotic 6 >250 7 45 60.0 8 <25  
   >250 7 49 65.3 8 <25  
   >250 7 65 86.7 8 <25  
 Both 6 >250 7 >250  8 26 346.7 
   >250 7 >250  8 35 466.7 





Table C.8. cont’d 
NCM3105 (parent)         









 Control 6 >250 7 119  8 <25  
   >250 7 139  8 <25  
   >250 7 120  8 <25  
 Acid 6 >250 7 102 81.0 8 <25  
   >250 7 112 88.9 8 <25  
   >250 7 108 85.7 8 <25  
 Osmotic 6 >250 7 74 58.7 8 <25  
   >250 7 93 73.8 8 <25  
   >250 7 69 54.8 8 <25  
 Both 6 >250 7 >250  8 37 293.7 
   >250 7 >250  8 22 174.6 
   >250 7 >250  8 32 254.0 









 Control 6 >250 7 219  8 19  
   >250 7 196  8 17  
   >250 7 249  8 26  
 Acid 6 >250 7 91 41.1 8 5  
   >250 7 67 30.3 8 7  
   >250 7 94 42.5 8 5  
 Osmotic 6 >250 7 68 30.7 8 4  
   >250 7 56 25.3 8 8  
   >250 7 66 52.4 8 6  
 Both 6 >250 7 >250  8 79 382.3 
   >250 7 >250  8 61 295.2 





Table C.8. cont’d 
ME9062 (parent)         









 Control 6 >250 7 106  8 32  
   >250 7 90  8 <25  
   >250 7 131  8 <25  
 Acid 6 >250 7 29 27.4 8 <25  
   >250 7 41 38.7 8 <25  
   >250 7 38 35.8 8 <25  
 Osmotic 6 >250 7 89 84.0 8 <25  
   >250 7 83 78.3 8 <25  
   >250 7 100 94.3 8 <25  
 Both 6 >250 7 36 34.0 8 <25  
   >250 7 40 37.7 8 <25  
   >250 7 45 42.5 8 <25  









 Control 6 >250 7 163  8 18  
   >250 7 215  8 20  
   >250 7 209  8 30  
 Acid 6 >250 7 60 30.7 8 <25  
   >250 7 52 26.6 8 <25  
   >250 7 92 47.0 8 <25  
 Osmotic 6 >250 7 37 18.9 8 <25  
   >250 7 32 16.4 8 <25  
   >250 7 25 12.8 8 <25  
 Both 6 >250 7 144 73.6 8 12  
   >250 7 151 77.2 8 10  





Table C.8. cont’d 
ME9062 (parent)         









 Control 6 >250 7 45  8 <24  
   >250 7 74  8 <25  
   >250 7 68  8 <25  
 Acid 6 >250 7 93 149.2 8 <25  
   >250 7 73 117.1 8 <25  
   >250 7 84 134.8 8 <25  
 Osmotic 6 >250 7 64 102.7 8 <25  
   >250 7 53 85.0 8 <25  
   >250 7 73 117.1 8 <25  
 Both 6 >250 7 >250  8 29 465.2 
   >250 7 >250  8 46 738.0 
   >250 7 >250  8 34 545.5 
    7   8 36.333 582.9 
          









 Control 6 >250 7 261  8 23 100.0 
   >250 7 280  8 18  
   >250 7 253  8 20  
    7 264.67 100 8 20.333 100 
 Acid 6 >250 7 71 34.9 8 7  
   >250 7 64 31.5 8 3  
          
    7 67.5 36.1    
 Osmotic 6 >250 7 51 25.1 8 3  
   >250 7 53 26.1 8 6  
          
    7 52 27.8    
 Both 6 >250 7 >250  8 42 206.6 
   >250 7 >250  8 44 216.4 
   >250 7 >250  8 44 216.4 





Table C.8. cont’d 
NCM3306R1 (null mutant, reconstructed #1)*      









 Control 6 >250 7 122  8 8  
   >250 7 96  8 14  
   >250 7 98  8 6  
 Acid 6 >250 7 251 238.3 8 26 246.8 
   >250 7 255 242.1 8 19  
   >250 7 268 254.4 8 17  
 Osmotic 6 >250 7 150 142.4 8 15  
   >250 7 183 173.7 8 24 227.8 
   >250 7 218 207.0 8 15  
 Both 6 >250 7 >250  8 126 1196.2 
   >250 7 >250  8 113 1072.8 
   >250 7 >250  8 125 1186.7 










plates) Control 6 >250 7 67 
 8 10  
   >250 7 60  8 4  
   >250 7 288  8 16  
 Acid 6 >250 7 38 27.5 8 0  
   >250 7 48 34.7 8 2  
   >250 7 74 53.5 8 11  
 Osmotic 6 >250 7 30 21.7 8 3  
   >250 7 28 20.2 8 3  
   >250 7 13 9.4 8 6  
 Both 6 >250 7 >250  8 127 918.1 
   >250 7 >250  8 102 737.3 
   >250 7 >250  8 120 867.5 
*The NCM3306 strain was reconstructed using recipient strain NCM3105 and donor strain NCM3306 for P1-mediated 
transduction. The P1 lysate was grown on ME9062. The transduction was performed using the protocol by Thomason 





Table C.8. cont’d 












 Control 6 >250 7 190  8 27  
   >250 7 149  8 19  
   >250 7 178  8 23  
 Acid 6 >250 7 126 73.1 8 7   
   >250 7 102 59.2 8 4  
   >250 7 106 61.5 8 9  
 Osmotic 6 >250 7 98 56.9 8 12   
   >250 7 103 59.8 8 8  
   >250 7 93 54.0 8 16  
 Both 6 >250 7 >250   8 71 308.7 
   >250 7 >250  8 105 456.5 













plates) Control 6 >250 7 54  8 5  
   >250 7 52  8 5  
   >250 7 48  8 7  
 Acid 6 >250 7 122 237.7 8 4   
   >250 7 112 218.2 8 10  
   >250 7 100 194.8 8 15  
 Osmotic 6 >250 7 9 17.5 8 1   
   >250 7 17 33.1 8 2  
   >250 7 36 70.1 8 6   
 Both 6 >250 7 >250   8 72 1402.6 
   >250 7 >250  8 54 1052.0 
   >250 7 >250  8 79 1539.0 
*The NCM3306 strain was reconstructed using recipient strain NCM3105 and donor strain NCM3306 for P1-mediated 
transduction. The P1 lysate was grown on ME9062. The transduction was performed using the protocol by Thomason 
et al. (226) and the new strain was designated NCM3306R. 
 
 
 
